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CHAPTER 1 
GENERAL INTRODUCTION, AIMS AND 
OUTLINES OF TIIE PRESENT STUDY 
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General introduction 
Adequate responses to variations in the internal and external milieu are an absolute 
requirement for all animals to survive. It was long believed that animals were equipped with 
two regulatory systems to fulfill this requirement. In general, the nervous system was 
considered to be involved in the control of rapid short term responses that are evoked by 
stimuli of short duration, whereas the endocrine system was thought to regulate prolonged 
internal alterations being a response to slow changes in the external or internal environment. 
The nervous system consists of cells (neurons) especially designed for the quick 
transfer of messages. The cell bodies of neurons receive input from other neurons and/or 
sensory organs and are able to translate this input into an electrical signal, the action potential. 
These action potentials are sent along axonfibers to other neurons or effector cells, where they 
end and make contact through specialized structures, the synapses. The synapses consist of a 
presynaptic (axon) site, a postsynaptic (effector cell or neuron) site and an intersynaptic space, 
the synaptic cleft. Release of neurotransmitters from the presynaptic site into the synaptic cleft 
can occur as a result of the arriving action potential, hence converting the electrical signal into 
a chemical signal. The neurotransmitters affect the postsynaptic site by binding to receptors 
and thus influence the effector cell. Since the synaptic cleft is small, only small amounts of 
neurotransmitter are required in order to modulate the activity of the effector cell. 
The endocrine system consists of secretory cells, which are grouped together to form 
ductless endocrine glands. Synthesis and release of the secretory products, the hormones, is 
controlled by the nervous system or, in the majority of cases, by chemical messengers from 
other (neuro)endocrine organs. The ultrastructure of endocrine cells reflects the chemical 
nature of the synthesized endocrine products. In general, they can be divided into two cell 
types [72]: 
(A) Steroid producing cells, which are characterized by an extensive smooth-surfaced 
endoplasmic reticulum, a pronounced Golgi complex and specialized mitochondria. These cells 
are specialized in the enzymatic conversion of precursor products (i.e., cholesterol) by 
dehydroxygenations and hydroxylations into a final bioactive steroid. 
(B) Protein producing cells, which have a comprehensive rough-surfaced endoplasmic 
reticulum (RER), a prominent Golgi complex and large numbers of secretory (storage) 
granules. Usually, the proteins are synthesized as part of a larger inactive prohormone, which 
is subsequently processed into biologically active proteins and/or peptides. 
Both types of endocrine cells have in common that the messenger molecules are 
directly liberated into the blood circulation. In contrast to the neurotransmitters released into 
the synaptic cleft, the secreted hormonal message has to be transported over a longer distance 
and is much more diluted. This problem is, in general, circumvented by either the release of 
large amounts of hormone, or by the location of endocrine glands in the proximity of the 
target organs as well as by the presence of highly sensitive and selective receptor proteins in 
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the target organs. The receptor mechanism has also the advantage that endocrine output 
influences multiple target organs at once, depending on the presence and selectivity of 
receptors for the circulating message. 
In recent years, the concept of regulation and communication by dual action of the 
nervous and endocrine system has been extended with the discovery of the neuroendocrine 
system. The neuroendocrine system combines many of the morphological and (bio)chemical 
features of the nervous and (proteinaceous) endocrine systems. Since the first description in 
1928 of neurons in the central nervous system that were able to synthesize peptides that are 
directly released into the blood and act as true hormones, the concept of neuroendocrine 
control has gradually been accepted [178; Review 179]. Neuroendocrine systems have a 
characteristic appearance, as judged by their ultrastructural features: an extensive RER and 
Golgi apparatus, neurosecretory elementary (storage)granules and outgrowth of axon endings 
near bloodvessels that form neurohemal organs. During the last ten years it has been 
demonstrated that peptides are not only released from neurohemal organs but can also be 
liberated at nerve endings in synapses. In addition, the coexistence of neuropeptides with 
classical neurotransmitters is described for an increasing number of neurons [87]. 
Simple neuroendocrine systems form advantageous models for the study of the function 
of neuropeptides and the coordinating role of interacting neuropeptidergic systems. Extensive 
studies during the last forty years indicated that neuroendocrine systems are ubiquitous 
throughout the animal kingdom (for Reviews [22;66;157;179]). Therefore, the neuroendocrine 
systems of invertebrates, due to their relatively uncomplicated structures, are very well suited 
to study the neurobiological aspects of adaptive physiology. 
In the last decade, studies on the neuroendocrine regulation of decapod Crustacea have 
shown that neuropeptides play a major coordinating role in the adaption to variations in the 
external and internal conditions. These aspects make decapod crustaceans good model animals 
for studying neuropeptide regulation. The most intriguing part of crustaceans is that they have 
evolved an extended adaptive way of life and that the neuroendocrine system is endowed with 
all elements of short-, medium- and long-term regulation that in the classical view were 
thought to be the exclusive domain of either the nervous system or the endocrine system. 
Neuropeptides are involved in many aspects of crustacean adaptive physiology. Pigment 
dispersing and- concentration, cardiac contraction, and locomotory activity are examples of 
processes that are subject to short-term regulation. Carbohydrate metabolism, respiration, 
water and ion balance are under medium-term control while endogenous rhythmicity, growth 
and reproduction are processes that are under long-term control [49;113;125;126;167;242]. 
Components of the crustacean neuroendocrine system are found throughout the whole 
central nervous system. Most neurosecretory cell groups are mainly located in the eyestalk and 
cerebral ganglia. Some cells are found in the sub-oesophageal ganglion and throughout the 
thoracic and the abdominal ganglia. Three main neurohaemal regions can be recognized that 
meet the criteria for release sites of neuroendocrine products [9;34]. They are called the 
postcommissural organs, the pericardial organs and the sinus gland. 
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The postcommissural organs possess the typical characteristics of neurohaemal organs 
with neurosecretory elementary granules, many branched axon endings and a hemolymph 
sinus [32;150;151]. The corresponding cell somata of the axons are found in the 
suboesophageal and cerebral ganglia. The function of this neuroendocrine system is thus far 
poorly understood and little is known about the secretory products except that the post­
commissural organs contain chromatophorotropins [32]. 
The pericardial organs form the neurohemal area of axon endings originating in the 
thoracic ganglia and peripheral cell somata [4;5;6]. The pericardial organs store and release 
several neurotransmitters such as octopamin, serotonin and dopamine which are all 
cardioactive [49]. In addition, the presence of (small) cardioactive peptides in pericardial 
organs was suggested by electrophysiological [23;47] and biochemical [15;16] studies. One of 
these peptides was expected to be proctoline [185], a pentapeptide (RYLPT-OH) originally 
isolated from cockroach hindguts with a potential role as a neurotransmitter and 
neuromodulator [29;208]. The presence of proctolin was established by its isolation and 
subsequent sequence analysis from Carcinus maenas pericardial organs [203]. A second 
peptide with cardioactive properties, the Crustacean Cardioactive Peptide (CCAP) was also 
isolated from the pericardial organs of the crab, C. maenas. It is a nonapeptide with the 
following structure: PFCNAFTGC-NHj [204]. Immunocytochemical studies revealed a 
complex system of CCAP immunoreactive neurons in the nervous system of the crab, C. 
maenas [53], and the crayfish, Orconectes limosus [207] suggesting a neurotransmitter and/or 
neuromodulator function. Quantitative determination by a radioimmunoassay in С maenas 
showed that CCAP is particularly abundant in the pericardial organs, but also occurs in the 
hemolymph, thus confirming its role as a neurohormone [205]. Recently the same peptide 
could be isolated and sequenced from nervous systems of the crayfish, O. limosus [207] as 
well as the locust, Locusta migratoria [206]. 
Finally, the pericardial organs may act as release site for the Crustacean 
Hyperglycemic Hormone (CHH), putatively synthesized in the thoracic ganglia. The presence 
of CHH was demonstrated by a radio-immunoassay and some immunopositive fibers were 
detected using an anti-CardniiS CHH serum as an immunocytochemical marker [124]. 
The sinus gland and its corresponding cell somata represents the most important 
system of neuroendocrine regulation in Crustacea. Due to the easy accessibility and its simple 
architecture on the one hand and the diversity of well studied physiological responses of 
application of synthesized neuropeptides on the other hand, it has been used to study many 
aspects of neuroendocrine regulation in crustaceans. 
The first studies concerning the morphology of the four optic ganglia and the 
neuroendocrine system in the eyestalk of decapod crustaceans were made as early as 1882 by 
Bellona [19;20] and in later years, by Hanström [82;83;84]. Bellona was the first to 
recognize the presence of a distinct nervous structure in the eyestalk, which he called the X-
organ because of its unknown function. These observations were extended by Hanström, who 
described the presence of four optic ganglia (lamina ganglionaris, medulla externa, medulla 
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intema and medulla terminalis) in eyestalked crustaceans as well as the secretory nature of the 
X-organ cells. Due to their topographical position on the rostral latero-ventral side of the 
medulla terminalis, he named these clustered cell somata the Medulla Terminalis Ganglionic 
X-organ (MTGXO). He also described a nervous connection between these X-organ cells and 
a gland that was considered to be a conventional (exocrine) gland, the sinus gland. 
As a result of the search for neuroendocrine cell systems in various animal groups, 
initiated by the introduction of the concept of neurosecretion by Scharrer [178], it was 
demonstrated that the sinus gland is a neurohemal organ acting as the liberation site of 
neurosecretory products from the X-organ cells [25;58;166]. Following this discovery, many 
previously reported eyestalk "factors" were found to be neurohormonal, originating from the 
sinus gland and synthesized by the neurosecretory X-organ cells. New techniques that allowed 
a more sophisticated study of the morphology of the MTGXO-sinus gland complex (MTGXO-
SG) revealed that the SG also acts as neurohemal organs, although to a lower extent, for 
neuroendocrine neurons arising from all four optic ganglia and even connections between the 
cerebral ganglia and the sinus gland were found [10;11;100;226; Review [49]]. In addition, 
another cluster of neurosecretory cells was found at the border of the Medulla Externa that 
uses the sinus gland as a neurohemal organ. Fig. 1 demonstrates a schematic representation of 
an longitudinal, median section of a crustacean eyestalk showing the four optic ganglia, both 
X-organs and the sinus gland. A light microscopical picture of a cross section of an eyestalk 
can be found in Chapter 8. 
Immunocytochemical studies were of great value for the understanding of the 
morphology of the MTGXO-SG and associated peptidergic networks. In general two types of 
immunological studies were performed, dealing either with antibodies against (neuro)peptides 
from non-crustecean origin or antibodies against innate crustacean peptides. Results obtained 
with antibodies against "vertebrate" peptides should be interpreted with great care. For 
instance, positive staining reactions using antisera raised against enkephaline and Substance Ρ 
[139], vasopressin/neurophysin or FMRFamide [96] could never be confirmed by isolation of 
the authentic peptide from crustacean eyestalks. The use of these antibodies was, however, 
helpful to identify peptidergic cells and axons in the optic ganglia [226] and could, in addition, 
demonstrate a close relation of these peptidergic neurons with aminergic neurons. Antisera 
raised against "native" sinus gland peptides were of great benefit for the morphological 
identification of the MTGXO-SG system and for (cyto)physiological studies on sinus gland 
neuropeptides. 
The MTGXO-SG complex is, as a result of its anatomical compartimentalization into 
discrete somatic, axonal, and axon terminal regions, very well suited for electrophysiological 
and biosynthesis experiments. For instance, the exposure to radiolabelled amino acids in vitro, 
to investigate biosynthetic properties of the system, can easily be restricted to the somatic 
regions by using a split chamber construction. This system also allows independent 
manipulation, e.g., perfusion or electrical stimulation, of the cellsomata and the axon terminal 
and enables simultaneously monitoring of secretory- and electrical activities of the somata and 
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terminals. Such experiments in combination with chromatographical analysis of biosynthesized 
and released products have revealed many aspects of the biosynthetic route of some crustacean 
neuropeptides [48;162;211;212]. 
Fig. 1. Schematic representation of a longitudinal median section of a crustacean eyestalk 
showing the four optic ganglia and the X-organ sinus gland complex. 
Abbreviations: HO: hemiellipsoidal organ; IN: inter neurons; LG: lamina ganglionaris; ME: 
medulla externa; МЕХ: medulla externa X-organ; MI: medulla interna; MT: medulla 
terminal is; MTGX: medulla terminalis X-organ; NO: nervus opticus; ОС I, ОС II and ОС 
III: optic chiasmata I, II and III; OM: ommatidia; SG: sinus gland; X: dispersed X-organ 
neuroendocrine cells. 
As indicated, the MTGXO-SG system is the most important source of neuroendocrine 
products that are involved in the regulation of a variety of biological processes. In order to 
illustrate the current understanding of the role of the eyestalk in the reception and integration 
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of external and internal stimuli as well as of the responses to these stimuli of the MTGXO-SG 
a schematic overview is presented in Fig. 2. From this illustration it is clear that the MTGXO-
SG system plays an important role in the physiology of crustaceans and that it is responsible 
for fine-tuning of important (neuro)endocrine processes. 
EXTERNAL FACTORS 
Stress Nutrition Photoperiod Temperature 
CNS 
EYESTALK 
neuropeptides and biogenic amines 
X-ORGAN SINUS GLANO COMPLEX 
INTERNAL 
FACTORS 
Y-ORGAN 
ECDYSTEROIDS 
EPIDERMIS MUSCLES HEPATOPANCREAS SEXUALFTY 
Fig. 2. Diagram illustrating the integratory role of the eyestalk neuroendocrine system in the 
(neuro)hormonal control of the physiology of decapod crustaceans. 
Abbreviations: CHH: crustacean hyperglycemic hormone; CNS: central nervous system; 
GIH: gonad inhibiting hormone (or VIH: vilellogenesis inhibiting hormone); JH: juvenoid 
hormones; MIH: molt inhibiting hormone; PCH: pigment concentrating hormones; PDH: 
pigment dispersing hormones; VSOH: vitellogenin stimulating ovarian hormone. (Dashed 
lines indicate putative control pathways). 
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Unfortunately, the easy accessibility of the eyestalk was a drawback in the (early) 
studies on (neuro)hormonal regulation: the existence of many eyestalk factors was only 
predicted on the basis of studies in which the physiological deficiencies were studied that 
occurred as a result of eyestalk ablation, without taking into account the inevitable side-effects 
of such drastic surgery. Therefore, in the figure some putative neuroendocrine signals are 
illustrated with dashed lines and the rest of this introduction will only deal with neuropeptides 
of which the existence has been experimentally confirmed. The Crustacean Hyperglycemic 
Hormone (CHH) is described more extensively, partly as it is has attracted most attention in 
crustacean neuroendocrine research and partly because the elucidation of its 
(prohormone)structure and studies on CHH gene expression are the main objectives of the 
present thesis. 
Chromatophorotropins 
Chromatophorotropins are neurohormones, which induce pigment migration in 
chromatophores of the epidermis, some of the internal organs, as well as certain ommatidial 
cells [170]. This color change is reversible and regulated by the mutually antagonistic actions 
of pigment-concentrating and pigment-dispersing hormones (PCHs and PDHs). The total 
number of pigmentary-effector hormones present in any species is unknown. Until now the 
structures of one PCH and at least four different PDHs have been established. Their mode of 
action on the chromatophores is thus far completely unknown. 
Pigment concentrating hormones. The red-pigment-concentrating hormone (RPCH) 
from Pandalus borealis was the first invertebrate neurohormone to be isolated and fully 
characterized by determining its amino acid sequence, pELNFSPGWamide [59;62]. It was 
also the first invertebrate neuropeptide that was chemically synthesized [60;62] and 
commercially available. It is structurally related to the insect peptides of the adipokinetic 
hormone (ΑΚΗ) family since it shares the pE1, F4 and W8, with the ΑΚΗ members [71]. In 
contrast to the AKHs in insects, RPCH has the same amino acid sequence in all ten crustacean 
species so far studied. This sequence conservation is predicted on the basis of elution 
characteristics of RPCH in studies using HPLC [33;97;98;118;162;217], amino acid 
compositions (Tensen and Janssen, unpublished;69] or confirmed by amino acid sequence 
analyses [69]. 
Studies of the biologically active sites of the peptide by synthesis of structural 
analogues revealed the importance of the C-terminal amide and Tip [45;46] and indicated 
overlapping biological activities of RPCH with members of the ΑΚΗ family. Antibodies raised 
against the synthetic N-terminal tetrapeptide sequence were used for detection of RPCH 
containing cells. These studies revealed the neurosecretory pathway consisting of 
neurosecretory perikarya in the X-organ with axons that run to and end in the sinus gland 
[18;141]. 
The presence of RPCH in other parts of the eyestalk as well as in the central nervous 
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system (brain, thoracic ganglia) of C. maenas and O. limosus [141] suggests that RPCH might 
play an additional role as a neurotransmitter and/or neuromodulator. This idea is supported by 
experiments demonstrating a strong excitatory effect of RPCH on the stomatogastric ganglion 
of Cancer borealis [164]. Another extra-pigmentary function of RPCH, stimulation of the 
secretion of methyl farnesoate by crustacean mandibular organs [134], indicates that RPCH 
may also have a role in the regulation of reproduction. 
Pigment-dispersing hormones. The first structural elucidation of a hormone with 
pigment-dispersing activities, formerly called light-adapting distal retinal pigment hormone 
(DRPH), was performed by Fernlund from eyestalks of the shrimp P. borealis [61]. The 
hormone was shown to be an octadecapeptide which not only elicited ommatidial light 
adaptation, but could also induce chromaiophoral pigment dispersion. It is now called pigment 
dispersion hormone (PDH). Using the chromaiophoral dispersion as a biological marker, at 
least four different PDHs, from five different crustacean species, could be isolated and 
sequenced. All PDHs consist of 18 amino acids, have an amidated С-term i nal and share 
identical amino acids on positions 1,5,6,7,9,10,12,14,15 and 18. This apparent heterogeneity 
in amino acid sequence is in contrast with the entirely conserved sequences of RPCHs from 
different species. Structure-activity relationships were studied by cross-injections of PDHs 
from different species and by the use of synthetic PDH analogues. These studies indicate the 
importance of the N-terminal sequence and the hexapeptide sequence of residue 5-10 which 
are important as a possible message sequence [170;171;172]. Like RPCH, PDHs were also 
found in various insect species (called pigment dispersing factors, PDFs) using the effect on 
crustacean chromatophores as a bioassay [172]. 
Antibodies raised against synthetic PDHs were used to identify PDH containing 
neurons. These studies confirmed the presence of PDH in neurosecretory MTGXO and the 
sinus gland. In addition, PDH positive cell somata and fibers were found in other parts of the 
eyestalk and the central nervous system of several crustacean species, suggesting that PDH 
might also serve a role as neuromodulator and/or transmitter, like RPCH [141;142]. Since 
PDHs inhibit the methyl farnesoate secretion [134], it is plausible that PDHs act also (and 
antagonistic to RPCH) in the regulation of reproduction. 
Gonadotropins 
Crustaceans regulate gonadal and somatic growth to achieve an optimal balance 
between the two processes (See also Fig. 2). In decapod crustaceans, reproduction takes place 
during the intermolt period, eventually leading to several reproduction cycles without molting; 
other crustacean species synchronize reproduction cycles with molting cycles or go through 
several molting cycles during one reproduction period [2;40;41;153]. 
It is known that neuroendocrine regulation of reproduction in decapod crustaceans is 
under the control of an inhibitory sinus gland factor, first demonstrated by Panouse in 1943 
[165] and later confirmed by others [3]. The gonad inhibiting hormone (GIH) delays 
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secondary vitellogenesis and gonad maturation and is non-species specific. During secondary 
vitellogenesis, gonads increase in size and weight by uptake of yolk from endogenous (gonad), 
or unknown exogenous sources [40] therefore this hormone is also referred to as the 
vitellogenisis-inhibiting hormone (VIH). 
Purification and characterization of sinus gland peptides representing VIH from the 
lobster Homarus americanus, was achieved by using a heterologous in vivo bioassay 
measuring retardation of oocyte growth in the prawn Palaemonetes varions 
[197;200;217;225;228]. Two strongly related peptides of -8.000 Da were isolated [199] and 
very recently the complete amino acid sequence of these neuropeptides was established [198]. 
The two isoforms have the following characteristics: both are 77 amino acids long, neutral 
peptides (pl= 6.8), with a free N-terminus and 6 cysteine residues. Somewhat unexpected the 
search for GIH revealed also the presence of peptides in sinus gland extracts with a 
stimulatory effect on the development of oocytes. Since these peptides clearly belong to the 
family of hyperglycemic hormones [219;220;221; Chapter 2 and 3 of this thesis] a critical 
réévaluation of their specific role in oocyte development seems to be required. 
Polyclonal antibodies against purified VIH of H. americanus were used to identify the 
VIH producing cell system in the eyestalks of this lobster. A partial co-localization with 
crustacean hyperglycemic hormone (CHH, see below) producing perikarya in the MTGXO 
was found [106]. In the sinus gland, VIH and CHH were mostly demonstrated in distinct 
axonal endings and it was therefore suggested that both neuropeptides are produced in the 
same cells but are separately packaged and transported in neurosecretory granules after 
maturation. 
Introductory studies on the mode of action of VIH/GIH demonstrated that the 
neuropeptide inhibits the receptor-mediated endocytotic uptake of yolk by oocytes in vitro 
[102;103]. Clearly, additional experiments are needed to understand the cellular interactions of 
VIH with oocytes during vitellogenesis. 
Molt-inhibiting hormone 
Crustaceans need to shed periodically their exoskeleton in order to be able to grow. 
This process is called ecdysis or molting and is under the control of two hormones: ecdysone 
and molt-inhibiting hormone (MIH). The mechanism of molting is initiated and sustained by 
an increase in the production and release of ecdysteroids by the Y-organs affecting many 
target organs [190;239]. Zeleny was in 1905 the first to demonstrate that eyestalk removal can 
induce the molting process [245]. Since then, MIH has been the subject of many 
comprehensive studies attempting to isolate and characterize this neurohormone. MIH inhibits 
the ecdysteroid synthesis by the Y-organs. This could be shown by eyestalk removal resulting 
in an increase in ecdysteroid synthesis as well as hemolymph ecdysteroid titres [36;121], while 
injection of sinus gland extracts in eyestalkless animals prevents synthesis and release of 
ecdysteroids [119;30;196]. Based on these observations several bioassays were developed in 
order to screen the biological activity of purified factors from the sinus gland. An in vitro 
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bioassay measuring the inhibition of ecdysteroid synthesis by isolated Y-organs, after addition 
of purified fractions of the sinus gland, resulted not only in the isolation and identification of 
MIH from C. maenas, but also showed that CHH is active in repressing ecdysteroid synthesis 
[240;241]. MIH, however, is much more potent than CHH and has no hyperglycemic activity, 
which implies that CHH and MIH are two distinct neurohormones. Initial biochemical 
characterization of MIH and CHH in C. maenas indicates that both hormones have 
comparable overall amino acid compositions, and that MIH is slightly larger than CHH [241]. 
Determination of the complete amino acid sequence from MIH of C. maenas, which is 
currently under investigation, will ultimately show the relationship with CHH. 
Using in vivo bioassays, in which the effect of H PLC purified sinus gland fractions on 
ecdysone titers and molt intervals were studied, the isolation of putative MIH from the lobster 
H. americanus was achieved [37]. Recently, the same research group published the sequence 
of a peptide, with molt inhibiting activities, applying the in vivo bioassay [38]. However, from 
the HPLC chromatograms and the results of their bioassays on hyperglycemic activity, one 
can deduce that this "MIH" consists of two peptides and is also the most potent hyperglycemic 
peptide present in the sinus glands of the lobster. Besides, 70 amino acids out of the 
determined sequence of 71 residues, match exactly with the 72 amino acid long CHH 
sequence from H. americanus as could be shown by amino acid sequencing and cDNA cloning 
[219;220;221]. This issue is further discussed in Chapter 6 of this thesis. 
With the use of a polyclonal antiserum against HPLC purified MIH from C. maenas, 
localization of the MIH producing cells within the X-organ of С maenas and four other 
decapod crustacean species was established [54]. Double-staining techniques using anti-sera 
against MIH and CHH revealed two distinct but intermingled neurosecretory pathways: MIH 
producing cells are dispersed among the CHH-producing cells, their axons follow the same 
XO-SG tractus and their axon terminals are distributed among the more numerous CHH axon 
endings. Despite the similarity in the morphology of the CHH and MIH neurosecretory 
system, no colocalization of the two neurohormones was observed. 
Although the action of MIH on the Y-organs is investigated by many research teams, 
the precise underlaying mechanism is still obscure and the current knowledge is based mainly 
on in vitro studies using crude of partially fractionated sinus gland extracts. In summary: some 
experiments show that MIH suppression of ecdysteroid production by Y-organs is 
accompanied by an increase in cAMP levels [147;148;149;239], while other studies indicate 
that inhibition of ecdysteroid synthesis is correlated with a marked increase of cGMP (D. 
Sedlmeier, pers comm). Furthermore, it appears that MIH depresses ecdysteroid synthesis by 
inhibiting protein synthesis in Y-organs although the nature of these Y-organ proteins is not 
clear yet [149]. In this respect the role of protein kinases is currently under investigation (D. 
Sedlmeier, pers. comm.). 
Crustacean hyperglycemic hormone 
The crustacean hyperglycemic hormone (CHH) is probably the most intensively studied 
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neurohormone present in crustacean sinus glands. The first investigations on the existence of a 
"diabetogenic" factor in crustacean eyestalks were performed by Abramowitz et al in 1944 
[1]. They described an increase in the blood sugar level of the crab, Callinectes sapidus, after 
injection of an eyestalk extract and they observed that the sinus gland contained 90% of the 
hyperglycemic activity present in the eyestalk. These findings were soon after confirmed by 
other studies dealing with various decapod crustacean species [112;127;129;130;137]. The 
presence of CHH is not restricted to decapod crustaceans only; CHH activity is also 
demonstrated in two isopod species [70;145] and in a stomatopod species [112]. 
Initial studies on the biochemical structure of CHH were performed using total 
eyestalks as a starting material and "classical" purification methods (i.e., acetone fractionation, 
ammoniumsulphate precipitation, gelfiltration, ion-exchange chromatography and preparative 
gel-electrophoresis; Review Kleinholz, 1985). These approaches were also useful for 
comparative research on the structure and biological cross-reactivity of CHHs in a diversity of 
crustacean species, revealing that CHHs from systematically related species showed a 
comparable electrophoretic behavior, while CHHs from evolutionary diverse groups exhibited 
different migration patterns [124]. Physiological cross-injection experiments indicated a 
species-related hyperglycemic bioactivity of CHH, and it was shown that CHH is biologically 
active on the infra-order level of systematic groups [124; 137]. 
The early purification studies indicated that CHH is an acidic peptide of 6-7.000 Da 
(Reviews in [124;126;228]). Occasionally, CHH activity was also related to a protein of 
20.500 Da [191], however this polypeptide is now regarded as being the CHH prohormone. 
Major improvements in the biochemical characterization of CHH could be made with the 
introduction of HPLC methodology for the purification of peptides and the use of sinus gland 
extracts as starting material instead of whole eyestalks. This approach demonstrated that CHH 
in fact is polymorphic. In most crustaceans studied thus far hyperglycemia is elicited by at 
least two closely related peptides with similar molecular weights and amino acid compositions. 
These related peptides can only be distinguished on the basis of hydrophobicity and isoelectric 
points [91;92;93;94;111;118;160;162;199;211;212;217;221]. HPLC separation was also 
applied to acquire CHH for peptide mapping and amino acid sequence determinations. 
Recently, the complete amino acid sequence of the most abundant form of CHH in the shore 
crab, C. maenas [110], partial amino acid sequences of four different CHH isoforms in the 
lobster Ή. americanus [221; Chapter 3 of the present thesis] and the amino acid sequence of 
the most abundant form of CHH in the crayfish, O. limosus, were determined [111]. 
CHH from C. maenas is a 72 amino acid long acidic peptide, N-terminally blocked 
with a pyroGlutamate residue, an amidated C-terminal and 6 cysteine residues that form three 
intrachain disulphide bridges. These features seem to be common to all CHHs as will be 
illustrated in the present thesis (Chapter 3, 4, 6 and 7). 
The described heterogeneity of CHH is now studied in more detail in several species 
and it can be concluded that this is not caused by the presence of oxidized forms that might 
occur in addition to non-oxidized forms of the same peptides as has previously been suggested 
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by several authors [110;124]. The difference between two bioactive CHH isoforms from the 
crayfish Procambarus bouvieri was located within the first eight amino acids from the N-
terminus [92;93]. Both isoforms differ also in secondary structure as could be determined by 
circular dichroism [95]. The same differences in the N-terminal part of the peptides was also 
demonstrated for CHH isoforms from O. limosus and two sets of two CHH isoforms from H. 
americanus [221; Chapters 4 and S of this thesis]. The nature of this difference is as yet 
unclear, but based on the data given in the present thesis some postulations are proposed 
(Chapter 3). 
The biosynthetic pathway of CHH is best studied among all crustacean neuropeptides. 
The first indication that CHH might be synthesized as part of a larger precursor, came with 
the isolation of a 20.5 kDa protein with hyperglycemic activity from entire eyestalks of the 
shrimp, Crangon crangon [191]. Pulse-chase experiments using whole eyestalk ganglia from 
the crayfish, Orconectes virilis, and the crab, CalUnectes sapidus, showed that two groups of 
polypeptides (of 12-14 kDa and 19-21 kDa, respectively) were predominantly labelled in X-
organ cells, while the label in the sinus glands was mainly related to several 7 kDa peptides 
[11]. Similar results were obtained from biosynthesis experiments with partially isolated CHH-
cells from the crayfish, Astacus leptodactylus [216]. Detailed pulse-chase experiments with the 
MTGXO-sinus gland system of Cardisoma carnifex revealed the presence of one 14 kDa 
precursor protein for one peptide of 4.5 kDa and at least 3 peptides of 6 kDa. It was 
postulated that the 4.5 kDa peptide (Peptide H) and one of the 6 kDa peptides (CHH) initially 
arose from the precursor protein and that the other two 6 kDa peptides were due to 
posttranslational modifications [212]. In vitro translation of eyestalk RNA from O. limosus and 
H. americanus, followed by selective immunoprecipitation confirmed the presence of a 14 kDa 
(precursor) protein reacting with an antiserum against CHH (Tensen CP, unpublished results). 
Recently, final evidence for the structure of the CHH precursor came from molecular cloning 
of a cDNA encoding the sequence of the CHH preprohormone of C. maenas [243]. The 
cDNA sequences encoding preproCHHs in the crayfish, O. limosus, will be presented in this 
thesis (Chapter 7). Summarizing, CHH is synthesized as part of an approximately 13.3 kDa 
precursor, consisting of a putative signal peptide of 26 amino acids followed by a peptide 
(referred to as CHH precursor related peptide, CPRP) of 33 amino acids (O. limosus) or 38 
amino acids (C. maenas) and finally CHH at the C-terminal end. 
The deduced amino sequences of the CPRPs from O. limosus are confirmed by the isolation 
and sequence analysis of these peptides sinus glands. In addition, the CPRP counterparts from 
H. americanus could also be purified and characterized [222]. Results on the purification and 
characterization of these peptides will also be documented in this thesis (Chapter 5). 
Antisera raised against gelpurified CHH were used for immunocytochemical 
demonstration of the CHH neurosecretory pathway in eyestalks of the crayfish A. 
leptodactylus [230]. These studies were in fact the first to apply an antiserum against a native 
sinus gland neuropeptide and could identify a group of approximately 30-35 large (50 μτη) 
perikarya in the MTGXO. Also an axonal tract leading to the sinus gland and axon terminals 
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in the sinus gland itself could be traced. This antibody, in addition, was useful in comparative 
immunocytochemical investigations in the optic ganglia of several decapod crustaceans. The 
large CHH perikarya with an axonal tract leading to the sinus gland were present in all species 
studied although the number of immunopositive cells varied between species [74]. Electron 
microscopical studies revealed the presence of CHH in Golgi sacculi and elementary granules 
in the cell body. These studies furthermore showed that in the sinus gland the immunoreaction 
is restricted to one granule type [73]. Application of an antiserum raised against CHH of C. 
maenas confirmed the aforementioned anatomical pattern of the CHH producing cell system in 
this crab [101;124]. CHH was also demonstrated in the eyestalkless isopod, Porcellio 
dilatatus, where it is present in two large cell bodies in the cerebral ganglia and in a 
connective axonal tract, which is considered as the counterpart of the sinus gland in this 
species [146]. 
A combination of immunocytochemistry, morphometry and physiology allowed the 
study of the secretory dynamics of the CHH producing cell system in A. leptodactylus in 
relation to the observed circadian rhythm of varying blood glucose levels. The day/night cycle 
with hyperglycemia occurring during the night was already described by Hamann in 1974 [80] 
but the interdisciplinary approach revealed also a diurnal rhythm of CHH synthesis/release and 
demonstrated the involvement of CHH in the appearance of the nocturnal glucose peak. CHH 
is released at the onset of the dark period, resulting in a glucose peak two to four hours later. 
Two hours before the liberation of CHH, an increase in synthetic activity occurs which is 
followed by transfer of CHH-containing granules through the axons. The same process, 
though less intense, is repeated at the beginning of the light period [76]. Additional 
experiments indicate an endogenous circadian rhythm entrained by the light/dark cycle and 
predict the presence of a biological clock within the optic lobes [105]. It is postulated that 
integrated signals from both the biological clock and light stimuli act through synaptic contacts 
on CHH axonal ramifications, the only input on the CHH cells [77]. Double immunostaining 
techniques revealed that these neurons probably act through release of serotonin, dopamine 
and Met-enkephalin [229]. This hypothesis is supported by the observations that both serotonin 
and dopamine can only evoke hyperglycemia when injected into intact animals and not in 
destalked animals [105;107;117;144;209], and that CHH is released into the hemolymph after 
serotonin injection [210]. An inhibitory role for Met-enkephaline is expected, since Met-
enkephaline is able to decrease glucose levels and abolishes the nocturnal glucose peak after 
injections in vivo [105;107]. 
Earlier studies on the mode of action of CHH were mainly focussed on the 
hyperglycemic effect of CHH. An increase in blood glucose concentrations is already 
detectable within 5-10 minutes after injection of the hormone in a minimal effective dose of 
approximately 1 - 2 pMol. A maximum response is achieved within 2-3 hours, suggesting a 
direct effect of CHH on the mobilization of glucose from carbohydrate stores [116;114;199]. 
In vitro experiments demonstrated that the hepatopancreas and the abdominal muscle release 
glucose upon application of physiological amounts of CHH. These organ are, therefore, 
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considered to be the main target organs for CHH [187]. CHH is thought to act in a glucagon-
like manner on the target organs by elevation of cyclic AMP and cyclic GMP levels and the 
subsequent phosphorylation of protein kinases [122;187;188]. 
Recent studies suggest a pleiotropic role for CHH and CHH isoforms. CHH was found 
to be involved in the neuroendocrine control of the liberation of digestive enzymes from the 
hepatopancreas, since it stimulates amylase release [242]. Furthermore, a CHH-isoform might 
stimulate oocyte development [217], thus counteracting the action of VIH. Finally, CHH is 
able to inhibit ecdysone release from Y-organs [241], and probably retards molting cycles [38] 
although these effects might be due solely to homology in amino acid sequence with the more 
potent M1H [219;241] (See also Chapter 3 and 4 of the present thesis). 
Aims of the present study 
The present study has three main objectives. The first objective is the elucidation of 
the biochemical nature of CHH, with special attention to the existence of multiple CHH 
isoforms. At the start of this work no information was available on the amino acid sequence of 
CHH in any crustacean species. As it turned out, this was mainly due to the chemical 
characteristics of these peptides making amino acid sequence analyses rather laborious. Most 
knowledge on the structure of CHH from various crustaceans species was obtained from 
experiments exploring gelfiltration, gelelectrophoresis and determination of amino acid 
compositions. The successful introduction of HPLC for the purification of small peptides of 
the sinus gland [97] prompted the exploration of this separation technique in order to isolate 
larger neuropeptides from the sinus gland. Already the first reports dealing with the isolation 
of CHH by means of reversed phase HPLC indicated the existence of multiple CHH isoforms 
[104;118;160;211;225]. Based on these studies, we developed a two-step HPLC separation 
system, which enabled the purification and characterization of several hyperglycemic 
neuropeptides from sinus glands of two crustacean species. 
The second aim was to elucidate the structure of the CHH-prohormone. Introductory 
studies on the biosynthesis of CHH using pulse/chase techniques [216] and in vitro translation 
of eyestalk RNA followed by selective immunoprecipitation (Tensen CP, unpublished results) 
made it clear that the recombinant DNA technology was by far the most suitable technique to 
achieve this objective. In addition, cloning of mRNAs encoding CHH or the entire CHH 
precursor offers the possibility to verify and expand the results obtained by the peptide 
sequencing approach. In the early eighties the structure of many vertebrate neuropeptides and 
their polypeptide prohormones were elucidated by this technique (Reviewed in [57]). Since 
then, numerous aspects concerning the structure and expression of a multitude of invertebrate 
neuropeptides (and their precursors) have been investigated by the recombinant DNA 
technique (e.g., [89;159;163;180;192;237]) although the number of applications in the field of 
crustacean neuroendocrinology was and still is limited. 
The third goal was to explore the mechanisms that regulate CHH gene expression in 
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the CHH-producing cell system. This approach will extend our knowledge on the cellular 
dynamics of the neurosecretory CHH-cells in relation to changes in the internal and external 
environment, thus far mainly based on immunocytochemical studies. 
Outline of the investigations 
The development and use of a two-step HPLC separation system, in order to isolate 
and purify CHH isoforms from sinus glands of the lobster H. americanus is reported in 
Chapter 2, while a more detailed chemical characterization of the CHHs is described in 
Chapter 3. In order to screen the general presence of a family of CHHs in decapod 
crustaceans, the crayfish O. limosus was studied in a comparative way, which is described in 
Chapter 4. CHH is synthesized as part of a larger preprohormone which also contains a 
precursor related peptide, N-terminally flanking CHH. Chapter S depicts the isolation and 
sequence analysis of CHH Precursor Related Peptides (CPRPs) from SGs of O. limosus and 
H. americanus. The sequences of these peptides are compared with the published sequences of 
CPRPs. Chapter 6 describes the isolation and characterization of cDNA clones that encode 
two CHHs from H. americanus. A comparison between the deduced amino acid sequences of 
the two lobster CHHs and the CHH sequence from the shore crab is also presented. Chapter 7 
reports the cloning and characterization of mRNAs encoding two preproCHHs in the crayfish, 
0. limosus. 
The first applications of cDNA sequences in studies on the regulation of expression of the 
gene(s) encoding CHH in lobster and crayfish are introduced in Chapter 8. Non-radioactive 
labelled RNA probes were used succesfully in an in situ hybridization assay in order to detect 
CHH-encoding mRNA in crustacean eyestalks. A sensitive assay (RNase protection assay) in 
order to quantify CHH mRNA levels is presented in Chapter 9. Aside from testing the 
sensitivity and specificity of the assay, also changes in CHH mRNA levels in individual 
animals during a day/night period were measured. Furthermore it is demonstrated that the 
expression of the CHH-gene(s) is not limited to the CHH cells in the X-organs. 
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HYPERGLYCEMIC NEUROPEPTIDES FROM THE SINUS 
GLAND OF THE LOBSTER, HOMARUS AMERICANUS: 
PURIFICATION AND PHYSIOLOGICAL 
CHARACTERIZATION 
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ABSTRACT 
A two-step high performance liquid chromatography separation system, was developed 
in order to isolate and purify hyperglycemic neuropeptides from the sinus gland of the lobster, 
Homarus americanus. Two pairs of closely related peptides, all reacting with a polyclonal 
rabbit antiserum raised against the Crustacean Hyperglycemic Hormone of the crayfish, 
Astacus leptodactylus, could be purified to homogeneity. Sodiumdodecylsulphate-urea-
polyacrylamide gel electrophoresis in combination with Western blotting revealed that one set 
contained two peptides with a molecular weight —6.5 kDa, while the peptides of the other set 
had a molecular weight of —8 kDa. Using a heterologous bioassay for hyperglycemic activity, 
it was demonstrated that both 6.5 kDa peptides and only one of the 8 kDa peptides were able 
to raise the bloodglucose levels in recipient animals (Orconectes limosus) in a dose-response 
dependent manner. 
This chapter is the modified thesis version of: 
Isolation, characterization and physiological specificity of crustacean hyperglycemic factors from (he 
sinus gland of the lobster, Homarus americanus (Milne-Edwards), by: CP Tensen, KPC Janssen and 
F Van Herp. Published in: Invert Reprod Dev 16: 155-164 (1989). 
Part of this chapter is also presented in the form of an abstract entitled: 
Isolation, characterization and physiological specificity of crustacean hyperglycemic factors from the 
sinus gland of the lobster, Homarus americanus (Milne-Ed wards), by: CP Tensen, KPC Janssen and 
F Van Неф. Published in: Gen Comp Endocrinol 74: 262 (1989) 
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INTRODUCTION 
The crustacean hyperglycemic hormone (CHH), first described by Abramowitz et al. 
in 1944 [1], has been the subject of a number of studies concerning its isolation and chemical 
characterization [91;113;114;123;124;127;145;191;233] its cellulair localization and related 
cytophysiological aspects in the neuroendocrine system of the eyestalk [73-
78;101;146;230;231] as well as to its physiology [80;116;186-188;202]. 
In recent years, high performance liquid chromatography (HPLC) has proven to be a 
powerful method for the isolation of neuropeptides (including CHH) from the sinus gland of 
Crustacea. The earlier purification studies of hyperglycemic material from crustacean eyestalk 
or sinus gland indicated a molecular polymorphism not only between different species 
[113;114;124] but also within a single species [127;191;233]. With HPLC, this occurrence of 
molecular polymorphism of CHH in the same species was confirmed by several research 
groups [91;124;160;162;211]. 
Our interest in the physiological specificity and structural differences of these 'multiple 
CHH-forms' in lobster and crayfish stimulated the search for an optimized HPLC system, 
based on differences in molecular properties and which was able to produce peptides pure 
enough for subsequent biochemical analysis, such as peptide mapping and amino acid sequence 
determination. Preliminary studies of the neuropeptides in sinus glands from the lobster, H. 
americanus, using different HPLC-systems revealed a comparable polymorphism for the CHH 
factors [197;200;225;228]. These studies, however, were all carried out using a single 
purification step, based on one separation parameter (hydrophobicity). This chapter describes 
the purification of multiple CHH isoforms from total sinus gland extracts of H. americanus 
using a two-step HPLC system, in which charge differences, ionic strength and hydrophobicity 
were the most important separation parameters. The process of separation was monitored by 
an enzyme-linked immunosorbant assay (ELISA) using a polyclonal antibody against CHH. In 
addition, the hyperglycemic properties of the purified peptides were tested in bioassays. 
Purified peptides were characterized by determination of their molecular weights using SDS-
urea-polyacrylamide gel electrophoresis. 
MATERIALS AND METHODS 
Animah 
Specimens of the crayfish, Orconectes limosus, were obtained from local fishermen 
from the river Meuse (The Netherlands). The animals were kept in the laboratory in running 
tap water (13-15 "С) on a 12 h light/12 h dark cycle and fed with fish once a week. Males 
and females in the C-stage of their molting cycle, were used for the heterologous bioassay. 
Preparation of sinus gland extract 
Eyestalks from the lobster, Я. americanus, imported from Canada, were collected at 
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the Catering Facilities of the Royal Dutch Airlines (KLM Catering, Schiphol Airport) without 
taking into account the sex or the molting stage of the living animals. The eyestalks were 
ablated, frozen on solid CO,, and stored in the laboratory at - 60 CC. Sinus glands were 
routinely dissected in batches of 100 equivalents from freshly thawed eyestalks and collected 
in a dry-ice cooled glass-glass microhomogenizer. 0.1 N HCl was added (10 μΐ/sinus gland) 
and the pooled glands were homogenized, heated at 80 °C for S minutes and immediately 
frozen at - 60 "С for cooling and/or storage. Thawed preparations were centrifuged for 30 
min at 9000 g at 4 0 C; the supernatant was recovered and injected into the HPLC-system. 
HPLC 
HPLC was carried out on a Gilson analytical system, which consisted of two pumps 
(M-302), a manometric module (M-802), a mixing chamber (M-811) and a HM holochrome 
UV-detector (set at 215 nm). Further equipment consisted of a Rheodyne sample injector (M-
17125), a gradient controller and a Gilson fraction collector (M-202). Two columns were used 
(both obtained from Biorad): a cation exchange column (Biogel TSK-SP-5PW; 75 χ 7.5 mm; 
particle size 10 μπι) and a reversed phase column (Hipore, Biogel RP318; 250 χ 4.6 mm). 
Both columns were equipped with a guard column. The elution gradients were formed under 
high pressure. For the first column, elution was carried out with a gradient of solvent A (0.02 
M NaH2P04 buffer, pH = 3.0 / acetonitril 7:3) and a solvent В (0.75 M NaHjPC^ buffer, pH 
= 3.0 / acetonitril 7:3). In the second step, a gradient was formed by mixing 0.05 % 
trifluoracetic acid (TFA) as solvent A and 0.05 % TFA in aqueous acetonitril as solvent B. 
For details on the applied gradients, see legends under the figures. Fractions were collected 
into Minisorb polyethylene tubes (Nunc) and concentrated in a Savant centrifugal evaporator 
(Savant Speed Vac). All chemicals used for separations were HPLC grade (Baker); HPLC 
water was obtained by passing demineralized, double distilled water through a Norganic 
column (Waters). 
Assay of hyperglycemic activity 
The CHH bioassay, using the crayfish, O. limosas, as a recipient was performed 
according to Leuven et al. [137]. Briefly, 50 μΐ of hemolymph were removed both prior to 
and 120 min following the injection of test samples and frozen in liquid nitrogen. The 
hemolymph of thawed samples was combined with 50 μΐ 0.66 N perchloric acid, incubated for 
60 min, centrifuged and the glucose content in the supernatant was determined in duplo with 
the GOD perid testkit (Boehringer). This was achieved by mixing the 25 μ\ of sample with 
250 μΙ 1.5% GOD perid solution and measuring the absorbance at 620 nm after incubation for 
30 min at room temperature. Glucose concentrations were determined from simultaneously 
processed glucose standards. Glycemia is expressed in mg glucose/100 ml hemolymph. Dose 
dependency was tested by injection of different peptide concentrations. Statistical analysis was 
performed using the Student /-test. 
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Immunochemical detection methods 
For immunochemical detection of lobster CHH material, a polyclonal antiserum raised 
against CHH of the crayfish, Astacus leptodactylus, was used. Details of this antiserum are 
described in [73]. 
Enzyme-linked immunosorbent assay (ELISA) Identification of immunoreactive 
CHH material in the eluted HPLC fractions was performed by an ELISA method, set up as 
follows: a microliter plate (Nunc) was treated with 1 % glutaraldehyde for 2 h at 4 °C. After 
three rinses in distilled water, the plate was coated with the antigen (HPLC-fractions) in 
coating buffer (sodiumcarbonate 0.1 M, pH=9.4) for 1 h at 37 "C and overnight at 4 "C. 
Following another three rinses with ELISA-buffer (20 mM sodiumphosphate, pH=7.3, 0.9% 
sodiumchloride, 0.05% Tween-20), the non-specific sites were blocked with blocking solution 
(ELISA-buffer containing 2% bovine serum albumin (BSA) and 1% normal goat serum). After 
an incubation for 30 mins at room temperature, the primary antiserum (znii-Astacus CHH; 
1:200 in blocking solution) and the second antiserum conjugated with peroxidase (GAR/ГО 
from Nordic, 1:2000 in blocking solution) were added and incubated for 1 h each at 37 °C. 
Both antiserum incubations were preceded and followed by rinses with ELISA-buffer. The 
peroxidase activity was detected by using ortho-phenyl diamine substrate (OPD-Sigma: 0.1 
mg/ml in 0.1 M phosphate-citric acid buffer, pH=5.2, containing 0.05% H / y . The reaction 
was stopped after 1-2 min by addition of 4 N H2SO,,. The developed colour was measured in 
an ELISA reader (Easy-reader-Model EAR 400 FW) at 492 nm. 
Western blotting After SDS-urea-PAGE, transfer of proteins from the gel to 
nitrocellulose sheets (Schleicher and Schuell, BA85, 0.45 μπί) was carried out according to the 
method to [224]. The electroblotted nitrocellulose sheets were subsequently rinsed in Tris 
Buffered Saline + Tween (TBST: 50 mM Tris-HCl, pH=7.4; 0.9% sodiumchloride and 
0.05% Tween-20) for 15 min, incubated in TBST + 2 % BSA for 45 min, incubated 
overnight at 4 "C in anti-Astacus CHH serum (1:100 in TBST + 2% BSA), rinsed twice in 
TBST for 10 min, incubated for 2 h in GAR/PO (1:1000 in TBST + 2% BSA) and finally 
rinsed twice in TBST for 10 min. For detection of peroxidase activity, the nitrocellulose sheets 
incubated in a 4-Cl-naphtol solution (containing 30 mg substrate, 10 ml methanol, 50 ml 
TBST and 0.3% H ^ . 
Protein determination 
Protein content of crude sinus gland extract and purified fractions were determined by 
the micromethod as described in [194]. 
Gel electrophoresis 
Sodiumdodecylsulphate-urea-polyacrylamide gel electrophoresis (SDS-urea-PAGE) was 
performed according to [81; 183]. The slab gels with an acrylamide concentration of 12.5% 
(acryl/bisacryl, 37.5:2.5) were 18 χ 16 cm in surface and 0.75 mm thick. After 
electrophoresis, the gels were fixed and silverstained [158]. Prestained markers (Bethesda 
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Research Laboratories) were run along site the samples for estimation of the molecular 
weights. 
RESULTS 
Two-step HPLC purification ofCHHs 
A typical chromatogram of an extract of 100 sinus glands from H. americanus 
(containing 2 mg of protein) separated on the strong cation exchange column is shown in Fig. 
1A. Hyperglycemic immunoreactivity, as identified with the anti-serum in the ELISA (Fig. 2) 
is associated with two double peaks which are numbered I, II, VI and VII in accordance with 
previous reports [217]. Desalting and baseline separation of CHH I/II into two symmetrical 
peaks was achieved by passing the fractions 50+51, 52 and 53 from the first column in three 
consecutive runs on the reversed phase column using a linear gradient followed by isocratic 
elution (Fig. ΙΒ,-lBj). In a similar way CHH VI/VII could also be separated. Fractions 
66+67+68, 69, and 70+71, from the ion exchanger column were rechromatographed on the 
reversed phase column with isocratic elution at 63% В instead of 67%, since these two 
peptides were found to be less hydrophobic compared to I/II (Fig. ΚΙ,-ΙΟ,). The total 
extractable protein content of one sinus gland was 20 μg; the recovery of the CHH peptides 
after two separation steps was calculated to be 148 ng for I, 127 ng for II, 201 ng for VI and 
125 ng for VII per sinus gland. 
SDS-urea-PAGE and Western blotting 
SDS-urea-PAGE of the mentioned peaks, followed by silver staining and 
immunoblotting, was carried out to monitor the degree of purity of the peptides and to 
estimate their molecular weights (Fig. 3). After calculation of the M., according to the 
migration of the markers, CHH I and II have a molecular weight of around 6500 Da, CHH VI 
and VII correspond to about 8000 Da. The results of the immunoblotting clearly demonstrates 
that the immunoreactivity as found in the HPLC fractions is related to 6.5 and 8.0 kDa 
peptides resp. and did not result from putative coeluting proteins. 
Hyperglycemic activity 
The hyperglycemic effect of crude sinus gland extract from H. americanus in the 
crayfish, O. limosus, is shown in Fig. 4. The results demonstrate that a significant increase in 
blood glucose is already obtained after injection of 0.1 sinus gland equivalents. Injection of 
larger amounts of crude sinus gland extract results in a maximal achievable hyperglycemia 
with 0.33 sinus gland equivalents. Purified lobster peptides, clearly exhibiting CHH 
immunoreactivity, were tested in a dose response experiment (Fig. 5). The results demonstrate 
that all, except CHH VI, are able to induce a hyperglycemic respons in the crayfish. 
Furthermore, the injection of low doses (i.e., 0.1 SG equivalent, corresponding to 15, 13 or 
12 ng of resp. CHH I, II and VII) indicates that CHH II is propably the most potent 
hyperglycemic peptide, when assayed in the crayfish, O. limosus. 
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Fig 1. Two-step HPLC purification of the hyperglycemic peptides from sinus elands of 
Homarus americanas. 
^
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 ¡on exchanger column. Sample: Hot hydrochloric extract of 
100 sinus glands. Solutions A and B: See Materials and Methods 
Gradient: linear from 100% A to 100% В in 90 minutes (Flow rate 1.0 ml/min; Fractionsize 
1.0 ml). 
B-C. Reversed phase HPLC separation on a Biogel Hipore RP-318 column 
^ Í f « ^ ^ · * ^ Л д а · B l ) ' # 5 2 F*· ^ # 5 3 O7«· BJ respectively fractions 
#66 + 67 + 68 (Fig C,), # 69 (Fig. Q,) and t 70 (Fig. C3) from the first column 
Solutions A and B: See materials and methods. 
Gradients: 10 min 0% В; from 0% В to 67% В in 10 min; 30 min 67% В for Figs В -В, 
10 min 0% В; from 0% В to 63% В in 10 min; 30 min 63% В for Figs C.-C,. (Flow rate 
1.0 ml/min). 
For clearness, scales of В and С are only represented on the left side of the chromatograms 
and the applied gradients only in the right chromatograms (dashed line). 
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Fig. 2. Representation of 
immunoreactivity in 
HPLC fractions after 
separation of crude sinus 
extract on the strong 
cation exchanger (TSK-
SP5-PW). Ten μ\ of the 
fractions were tested by 
E L I S A , u s i n g a 
polyclonal anti-CHH 
antiserum. 
OD (492nm) 
' VA' 
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FRACTION NUMBER 
SIIVERSTAINING IMMUNOBIOTTING 
Fig. 3. SDS-Urea-PAGE of purified CHH I, II, VI 
and VII and their visualization by silverstaining and 
immunoblotting using the polyclonal anti-CHH 
antiserum. Markers (BRL: prestained Mw protein 
standards): 1: ovalbumine (43 kDa); 2: a-
chymotrypsinogen (25 kDa); 3: /3-lactoglobulin (18 
kDa); 4: lysozyme (15 kDa); 5: Bovine trypsin 
inhibitor (6.2 kDa); 6: insulin (a and /3 chain, 2.3 
and 3.4 kDa resp., average: 3 kDa). 
1
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Fig. 4. Hyperglycemia in recipient animals obtained after injection of crude sinus gland 
extract. A hydrochloric acid extract was lyophilised, washed with HPLC water once and 
redissolved in water. A serial dilution was injected in Orconectes limosus. Values are 
represented as mean +/- SEM obtained from 5 animals. Significant differences compared to 
physiological saline injected animals were determined by means of the Student i-test. No 
difference was found for 0.05 SG; 0.1 SG was significant different from the control at ρ < 
0.01, while 0.33 and 0.5 differed significantly from the controls at ρ < 0.001. 
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Fig. 5. Hyperglycemia in recipient animals (O. limosus) obtained after injection of HPLC 
purified CHH I, II, VI or VII. 
Values are represented as mean +/- SEM obtained from 5 animals, except for controls 
(physiological saline injected animals): n=8. Significant differences, determined by means of 
the Student i-test, are indicated by asterisks: * ρ < 0.05, ** ρ < 0.01, *** ρ < 0.001 
(compared to values from controls). SGE = sinus gland equivalent. 
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DISCUSSION 
The employed two-step HPLC purification procedure, which was based on differences 
in charge, ionic strength and hydrophobicity between the peptides, proved to be a valuable 
tool in the complete separation of four hyperglycemic peptides from crude sinus gland extract 
of the lobster, H. americanus. The first purification step on the cation exchanger, using charge 
differences as separation parameter, could already demonstrate the molecular polymorphism of 
CHH. Pure and bioactive peptides were obtained after the second purification step, which 
discriminated on the basis of hydrophobic properties of the peptides. According to the elution 
characteristics, the four peptides could be divided into two distinct groups, each containing 
two closely related isoforms, CHH I/II and CHH VI/VII. In addition, the analysis of the 
molecular weights of the peptides showed a strong resemblance between the peptides of each 
group i.e., CHH I/II (both 6.5 kDa) and CHH VI/VII (both 8.0 kDa). A comparison of these 
molecular weights with the published molecular weights of hyperglycemic hormones in other 
crustaceans (Table I) shows evident similarities. 
Table I 
Comparison of molecular weights of various CHHs 
Species Molecular weight Reference 
Porcellio dilatatus 
Pandalus borealis 
Crangon crangon 
Cardnus maenas 
Orconectes limosus 
Cardisoma camifex 
Palaemon serratas 
Procambarus bouvieri 
Homarus americanus 
5769-6092 Da 
6300 Da 
7300 Da 
6726 Da 
6812 Da 
6000 Da 
8000 Da 
5769-6812 Da 
6500 Da 
8000 Da 
Ref [145] 
Ref [127] 
Ref [191] 
Ref [123] 
Ref [114] 
Ref [160] 
Ref [233] 
Ref [91] 
This chapter 
Of physiological interest might be that one (CHH VI) out of the four isolated CHH 
immunoreactive peptides did not have a distinct hyperglycemic activity in the crayfish, O. 
limosus, while the other three reacted in a dose dependent manner. This suggests that CHH 
VI, although strongly related to CHH VII, differs in an essential part of the peptide structure 
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and is therefore unable to evoke the hyperglycemic respons. A similar effect was observed 
using the crayfish, A. leptodactylus, as recipient for testing purified CHHs from sinus glands 
of H. amencanus [201]. Screening of HPLC fractions in a homologous bioassay using juvenile 
Ή. amencanus, indicated the presence of four hyperglycemic peptides, while only three out of 
these four CHHs were bioactive in A. leptodactylus [201]. Both results give also additional 
information concerning the species specificity of CHHs. In a previous report it was suggested 
that CHHs are mutually bioactive at the systematic level of infra-orders (i.e., CHH isolated 
from one Astacidean species is bioactive in other Astacidean species [137]). However, in these 
experiments hyperglycemia was tested with crude sinus gland extracts. At present it seems that 
some CHH isoforms are only bioactive at the species level. 
The physiological significance of multiple CHH-isoforms within one animal is at 
present unclear. In view of the proposed multifunctional role of CHH in distinct biological 
processes it one cannot rule out that the different biological effects should be subscribed to 
different CHH-isoforms. 
In conclusion, the two-step HPLC separation system described in the present study, 
allows the purification of four hyperglycemic peptides from sinus gland extracts of the lobster 
H. americanus. This will facilitate comparative research on the molecular aspects of these 
peptides, which may eventually lead to the elucidation of the nature of the CHH 
polymorphism and its possible biological implications. 
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HYPERGLYCEMIC NEUROPEPTIDES FROM THE SINUS 
GLAND OF THE LOBSTER, HOMARUS AMERICANOS : 
BIOCHEMICAL CHARACTERIZATION 
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ABSTRACT 
Two sets of peptides, each consisting of two closely related isoforms of the Crustacean 
Hyperglycemic Hormone, were isolated from sinus glands of the lobster, Homaros 
americanus, and biochemically characterized. On the basis of the analysis of the amino acid 
compositions and partial amino acid sequences, several differences were found between the 
two sets of isoforms indicating the presence of at least two distinct sets of peptides. These 
approaches, however, were insufficient for the discrimination between isoforms within one set. 
This was achieved by means of peptide mapping, which not only demonstrated that the 
difference between two isoforms is located within the first eight amino acids of the N-
terminus, but also proved that isoforms of both sets possess the same features. Since all four 
peptides have an identical amino acid sequence in their N-terminal region and the molecular 
weights of N-terminal fragments of two isoforms exclude the presence of amino acid sidechain 
modifications, it is postulated that these differences originate from a partial post-translational 
modification of a Lamino acid into a Damino acid. 
This chapter is the modified thesis version of: 
Comparative characterization of hyperglycemic neuropeptides from the lobster Homarus americanus. 
by: CP Tensen, KPC Janssen, D Soyez and F Van Неф. 
Published in: Peptides 12: 241-249 (1991) 
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INTRODUCTION 
Since the first description of a diabetogenic factor in the eyestalks of a crab [1], the 
Crustacean Hyperglycemic Hormone (CHH) is the biochemically and cytologically most 
studied metabolic hormone in crustaceans. CHH was shown to be a polymorphic neuropeptide 
synthesized by neurosecretory cell bodies in the eyestalk, grouped together in the so called X-
organ, and transported to axons endings which are clustered to form the neurohemal sinus 
gland. The X-Organ sinus gland complex is considered as a major neuroendocrine regulation 
center for several physiological processes. Apart from CHH, it also synthesizes other 
regulatory peptides such as Chromatophorotropins, the Molt-Inhibiting Hormone (MIH) and 
the Gonad (Vitellogenesis) Inhibiting Hormone (GIH or VIH) (For Reviews see 
[124;229;242]). 
The polymorphism of the CHH neuropeptides was demonstrated using High 
Performance Liquid Chromatography (HPLC), which allows efficient separation of 
biologically active peptides from the sinus glands of numerous crustacean species. In general, 
hyperglycemia in a given species is elicited by at least two closely related peptides with 
similar molecular weight and amino acid composition. These peptides can only be 
distinguished on the basis of their hydrophobicity or, occasionally, by their isoelectric point 
[118;162;199;212; Chapter 2]. 
The heterogeneity of CHH from the crayfish, Procambarus bouvieri, was studied in 
more detail [92,93]. After tryptic digestion and analysis of amino acid compositions of the 
fragments, it seemed that two bioactive isoforms differ only in the N-terminal octapeptide 
[92,93]. Both isoforms are also distinguishable in secondary structure, as determined by 
circular dichroism [94]. 
With respect to heterogeneity, CHH from the lobster, Homarus americanus, is 
remarkable: using different HPLC systems two groups of CHH neuropeptides, each containing 
two isoforms, could be characterized [199;217, Chapter 2]. Identification of the isoforms 
within each group is thus far only possible using HPLC systems that can resolve the peptides 
on the basis of their hydrophobicity. The differences between the two groups are more 
prominent and could be demonstrated at the level of electrophoretic mobilities [217], iso-
electric point and molecular masses [199]. 
Until now, the physiological significance of the four CHH peptides in the sinus gland 
of H. americanus is still speculative. With a heterologous bioassay using the crayfish, 
Orconectes limosus, it was demonstrated that both isoforms in one group and only one of the 
two isoforms from the other group have a hyperglycemic activity. In homologous bioassay it 
was shown that all four peptides were equally potent in raising the bloodsugar level in juvenile 
H. americanus [199]. 
The present investigations aim to study the two sets of CHH isoforms in H. 
americanus using several biochemical approaches such as determination of amino acid 
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compositions, peptide mapping and partial amino acid sequence determination. Furthermore, 
this study tries to resolve several problems probably common for CHH molecules in all 
decapod Crustacean species, in order to facilitate future comparative research on the primary 
structures of CHH and CHH-related peptides in general. 
MATERIALS AND METHODS 
Eyestalk material, extractions and purifications 
Sinus glands were obtained from lyophilized eyestalks from the lobster, H. 
americanus, originating from the coast of New Brunswick (Canada). Transport and 
maintenance of these eyestalks were as described previously [199]. Lyophilized eyestalks were 
briefly rehydrated in distilled water and the sinus glands were immediately dissected and kept 
on dry ice. Batches of pooled glands were homogenized in extraction solvent (0.1 M HCl) in a 
volume of 10 μΐ/gland, heated at 80 "С for 5 min and then directly frozen at -60 0C for 
cooling and storage. Each batch was centrifugea (10.000 g/10 min) before injection into the 
HPLC system. 
HPLC 
HPLC was carried out on the Gilson analytical system as described in Chapter 2. 
Purification of CHHs was achieved in two-steps: in the first step, the supernatant of the 
extract was separated on the TSK-SP-5PW cation exchanger column. In a second step, 
fractions from the elution zones of the ion exchanger column with CHH activity [See Chapter 
2], were further separated and desalted on the RP318 column. 
Enzymatic digestions 
In repeated experiments of reduction-alkylation, it appeared that denatured (reduced) 
peptides strongly interact with the CI8 matrix of the reverse phase column, leading to 
unacceptable losses of material. Therefore, all enzymatic digestions were carried out on 
native, purified peptide. After hydrolysis, peptide fragments were separated by RP-HPLC, 
using the RP-318 column and an acetonitrile/water/trifluoro acetic acid (TFA) eluant system 
(See legends under Figures). 
Pyroglutamate-aminopeptidase (PGAP) Cleavage was performed under 
conditions adapted from [189]. In a standard assay the purified peptide was dissolved in 90 /¿1 
digestion buffer (90 mM КНгРСУКзНРО^ pH =7.5 containing 20 mM EDTA) and 
equilibrated for 30 min at 30 0 C, then 250-1000 μg of PGAP (Boehringer) in 10 μ\ digestion 
buffer were added and the incubation was continued for 20-40 min at 30 "С. The reaction was 
stopped by adding 3 μΐ of 5.7 M HCl and 800 μΐ ice-cold HPLC buffer A (0.05% TFA in 
water). 
Endoproteinase-Lys-C (ELC) The peptides were digested in 250 μ\ digestion 
buffer (25 mM Tris-HCl pH 8.0, 1 mM EDTA and 5 mM dithiotreitol containing 0.5 μι ELC 
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(Boehringer, sequence grade) for 16 h at 37 "C under nitrogen vapor. The reaction was 
stopped with 3 μ\ 5.7 M HCl and 750 μ\ HPLC buffer A (0.10% TFA in water). 
Endoproteinase-Glu-C (EGC) Digestion of the purified peptides was carried out 
in 250 μΐ digestion buffer (25 mM NH4Ac, pH=4.0) with 10 μg EGC (Boehringer) for 16 hrs 
at 20 "C. The reaction was stopped with 750 μ\ HPLC buffer A (0.10% TFA in water). 
Analysis of amino acid composition 
For analysis of the amino acid composition, purified peptides were hydrolysed at 110 
°C in 5.7 M HCl + 3% thioglycolic acid (Merck) [143] for 24 hrs under reduced pressure. 
Hydrolysates were dried under vacuum and washed three times with 200 μ\ HPLC water and 
redried under vacuum. Quantification of the amino acids was performed according to the 
postcolumn derivatisation method with OPTA [65]. Amino acids were first separated on a 
cation exchanger column (Micropak column; 250x4 mm; Varian) using a Varian HPLC 
system, derivatised and then detected with a Varian fluorichrom fluorometer (Excitation: 340-
380 nm/ Emission: 430-480 nm). The data were correlated to a standard mixture of amino 
acids (Standard H, Pierce). The efficiency of recovery of tryptophan was tested by 
hydrolysing synthetic Red Pigment Concentrating Hormone (Peninsula Laboratories). 
Amino acid sequencing 
Automated Ed man degradation was performed with an Applied Biosystems Model 
470A Protein Sequencer, on-line equipped with a Model 120A PTH analyzer. Prior to 
sequencing, peptides or peptide fragments were spotted onto glassfiber filters and S-
pyridylethylated with 4-vinyl pyridine (Fluka) according to a vapor phase modification 
procedure [8], thus allowing positive identification of cysteine residues. 
Protein determination 
Protein content of crude sinus gland extract and purified fractions was determined by 
the micromethod using bicinchoninic acid [194]. The peptide content was related to the peak 
surface in the chromatograms, which permitted the approximate calculation of the amount of 
peptides or fragments obtained in the analyses. 
Mass spectrometry 
Two types of instruments were used for precise molecular weight determinations. 
Fast Atom Bombardment Mass Spectrometry (FAB/MS) FAB/MS of intact 
peptides was carried out on a ZAB-HF (VG-Analytical) apparatus and the spectra were 
processed on a VG 11-250 data system. Five to ten μg of purified peptides were dissolved in 5 
μΐ of 10% HAc and mixed with thioglycerol as a matrix. The approximate masses were first 
determined by a fast scan over a wide range (3.000 Da-12.000 Da). Narrow scans over a 
range of 8.200 to 9.200 Da permitted precise calculations of the masses of the [M+H]+ ions 
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from comparison with Csl external standards. 
Elecirospray Mass Spectrometry (ES/MS) ES/MS was performed on a VG 
Bio-Q quadrupole mass spectrometer. Data were aquired by operating the data system as a 
multichannel analyser. Peptide fragments were dissolved in 5% acetic acid in water and an 
equal volume of methanol was added. The solution (2 to 10 μΙ) was introduced into the ion 
source at a flow rate of 2 μΐ/min. Several scans over a range of 0 - 3000 Da were summed to 
obtain the molecular masses. Precise calculations of the masses were obtained from 
comparison with a biprotonated gramicidin internal standard. 
RESULTS 
Two-step HPLC purification 
The first two steps of purification were performed as described in Chapter 2 and 
resulted in four purified CHHs (not shown here. See Chapter 2). 
Enzymatic digestions and amino acid sequences 
N-terminal deblocking and amino acid sequencing Initial attempts to obtain N-
terminal amino acid sequences of the four CHH-forms failed, since no amino acids were 
released using automated Edman degradation. Successful cycles of analysis were obtained after 
incubation with PGAP, which is an indication for the presence of a pyroglutamine residue at 
the N-terminus of each of the four peptides. After digestion of the pure peptides (an equivalent 
of 100 sinus glands) with PGAP, the mixture was rechromatographed on the reversed phase 
column. This procedure allowed the desalting of the peptides as well as a control of the 
effectiveness of the enzyme treatment (Fig. 1A-F). Separation of the deblocked CHH I/II from 
the residual uncleaved peptides was achieved using the same elution conditions as in the 
second purification step. This approach gave easy identification of the digested, truncated 
forms which were more polar than the native peptides (Fig. 1B-C). In a similar way, CHH VI 
and VII were found to be susceptible to the PGAP treatment. Separation of the blocked and 
deblocked peptides was achieved by rechromatography on the reversed phase column under 
conditions used for separating CHH VI from CHH VII after the first purification step of crude 
sinus gland extract (Fig. 1D-F). It was noticed that the pGlu of CHH I and VI could be 
removed much easier than the pGlu of CHH II and VII: to deblock 40% of native CHH II 
twice the amount of enzyme was needed (500 μg, Fig. 1С) compared to CHH I (250 μg, Fig. 
IB). Fig. ID, E and F depict the same phenomena for deblocking CHH VI and CHH VII. 
The result of enzymatic treatment with 250 μg PGAP is shown for CHH VI and CHH VII 
(Fig. ID and E), demonstrating that under the same conditions more than 50% of CHH VI is 
deblocked compared to -10% of CHH VII. A four fold higher enzyme concentration (1000 
μg) in combination with a prolonged incubation time (40 min in stead of 20 min) is necessary, 
to get -70% deblocked CHH VII (Fig. IF). 
Automated Edman degradation was performed on —10 μg of CHH I, — 5 μg of CHH II, 
-10 μg of CHH VI and - 4 μ£ of CHH VII after deblocking, purification and S-
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pyridylethylation of the cysteine residues with 4-vinyl pyridine. From the results summarized 
in Fig. 2, it can be deduced that the first 19 amino acid residues of all four CHHs are 
identical. The asparagine on position 20 for CHH VI/VII is replaced by a aspartic acid in 
CHH I/II. During sequencing no signs of microheterogeneity were observed, however in all 
peptides the yield of lysine residues was rather low, which might be due to side chain 
modifications. 
005 
® 
oos 
® 
30 (0 
vr »I 
0 10 20 10 (0 
TIME IMINI 
о io 20 JO ;e 
Fig. 1. Removal of pyroglutamyl residues from purified CHH peptides. CHH I/II/VI and VII were 
digested with PGAP, acidified and rechromatographed on a Biogel Hipore RP-318 column. Elution 
was performed by mixing of Solvent A (0.05% TFA in water) with Solvent В (0.05% TFA in 50% 
aqueous acetonitril) and using a flow rate of 1 ml/min. 
Gradient: 10 min 0% В; from 0 to 67% В in 10 min; 30 min 67% В for Figures 1A-C. 
10 min 0% В; from 0 to 63% В in 10 min; 30 min 63% В for Figures 1D-F 
A. Control run of 250 μg PGAP in digestion buffer. 
B-C. Separation of digested CHH I (250 μg PGAP) and II (500 ¿tg PGAP) from undigested intact 
peptide material. 
D-Ε. Separation of cleaved CHH VI and VII after digestion under the applied standard conditions 
(250 μζ PGAP; 30 min). 
F. Purification of cleaved CHH VII after incubation with an increased enzyme concentration in 
combination with a prolonged incubation time (1000 μg PGAP/40 min). 
The truncated peptides are indicated with Γ, II', Г and VII' for CHH I, II, VI and VII 
respectively. Scales are represented at the left side of the chromatograms, absorbtion was measured 
at 215 nm. 
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CHH I PGlu-Vai-Phe-Asp-Gln-Ala-cys-Lys-Gly-Val-Tyr-Asp-Arg-Asn-Leu-Phe-Lys-Lys-Leu-Asp-
Arg-Va1-Cys-Glu-Asp-Cys-Tyr 
CHH I I PGlu-Val-Phe-Asp-Gln-Ala-cys-Lys-Gly-Val-Tyr-Asp-Arg-Asn-Leu-Phe-Lys-Lys-Leu-Asp-
Arg 
CHH VI pGlu-Val-Phe-Asp-Gln-Ala-cye-Lys-Gly-Val-Tyr-Asp-Arg-Asn-Leu-Phe-Lys-Lys-Leu-Asn-
Arg-Val-Cys-Glu-Asp-Cys-Tyr-Asn-Lau-Tyr-Arg-Lys-Pro 
CHH VII pGlu-Val-Phe-Asp-Gln-Ala-Cys-Lys-Gly-Val-Tyr-Asp-Arg-Asn-Leu-Phe-Lys-Lys-Leu-Asn-
Arg-Val-CyB-Glu-Asp-cys-Tyr-Asn-Leu-Tyr-Arg-Lys-Pro-Phe 
Fig 2 Partial N-terminal ammo acid sequence of CHH 1,11, VI an VII 
Peptide mapping 
Endoproteinase Endo-Lys-C (ELC) digestions 
Fractionation on the reversed phase column of the specific cleavage products generated 
by ELC digestion of the different CHH peptides is shown in Fig 3A-D Peaks not present m 
control runs of digestion buffer with enzyme only are numbered m order of elution 
Comparing the chromatograms indicates a high degree of homology (Fig 3A-D) All four 
peptides share the apparent identical fragments eluting at 42 mm and 45 mm (resp L12/L13, 
L21/L23, L62/L63 and L71/L73) Besides, CHH I and VI share a common fragment eluting 
at 39 mm (Lll and L61), which is absent in CHH II and VII On the other hand, a fragment 
common only for CHH II and VII (L22 and L72) elutes at 43 mm Identification of the 
fragments was achieved by sequence determination of L61, L62 and L63 (obtained after 
digestion of -12 μ.% of CHH VI) or precise molecular weight determination of Lll, L21, L12 
and L22 
Amino acid sequences of endo-Lys fragments 
The fragment L62 contained amino acid 9(Gly) to 17(Lys) with a small amount 
of 18(Lys), L63 gave the sequence from 19(Leu) to 32(Lys,See Fig 2), while no sequence 
could be obtained from L61 It was realized that if cleavage took place after the Lys at 
position 32, as suggested by the fact that L63 ends with a Lys, at least one other fragment 
should be present starting with a Pro Since reduced CHH strongly interacts with the reversed 
phase column, we supposed that the last fragment was retained on the column To test this 
hypothesis CHH VI and CHH VII were digested with 0 5 ¿¿g ELC and 75% of the material 
was sequenced directly The remaining 25% was resolved on the RP-HPLC column in order 
to check correct cleavage In both cases, sequence analysis gave a mixture of only two 
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sequences, 9-17 and 19-33 for CHH VI and 9-17 and 19-35 for CHH VII while no fragments 
starting with a Pro were found. This suggests that the Lys at position 32 is resistent to 
cleavage, which is probably due to the adjacent amino acids or a retained tertiairy structure. 
Fragment L61 was found to be N-terminal blocked; treatment of this peptide fragment with 
PGAP and rechromatography showed a conversion from L61 into a new peak of deblocked 
material eluting at 32 min. 
Masses of endo-Lys fragments 
Accurate molecular weights by means of ES/MS were obtained for the 
molecular ions of Lll and L22 (both 921.1 Da). The masses from L12, L21, determined from 
their biprotonated ions, were also identical: 1111.6 Da. These masses fully agree with the 
calculated masses of 921.04 Da for fragment 1-8 and 1111.20 Da for fragment 9-17. From the 
results of the mass determinations and amino acid sequences we concluded that the isoforms in 
both groups (CHH I/II and CHH VI/VII) differed in a N-terminally blocked octapeptidal 
fragment of 8 amino acids. 
Fig. 3. Comparative peptide maps of purified CHH I/II/VI and VII. After digestion with 
endoproteinase Lys-C, the samples were acidified and injected into the Biogel Hipore RP-318 
column. Elution was performed by mixing of Solvent A (0.1% TFA) with Solvent В (80% 
acetonitrile in water, containing 0.1 % TFA). After equilibration with 100% solvent A for 10 min, a 
linear gradient was performed from 0% solvent В to 80% solvent В in 80 min (dashed line in Figs. 
3B and D; flowrate 1 ml/min). 
Α-D. Fragments obtained from CHH I (Fig. A), II (Fig. B), VI (Fig. C) and VII (Fig. D) are 
numbered according to their order of elution. Bars with numbers between parentheses indicate 
putative remaining uncleaved material, which is partially degraded under the applied digestion 
conditions. UV scales (absorbance at 215 nm) are only represented on the left side of the 
chromatograms. 
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Endoproteinase Endo-Glu-C (EGC) digestions 
Figs. 4A-B demonstrates the chromatographic separation of the peptide fragments 
obtained after digestion of 12 μ% CHH I (Fig 4A) and CHH VI (Fig. 4B) with ELC. In both 
cases only two fragments were found, indicated as Gil and G12 for CHH I and G61 and G62 
for CHH VI. The peaks designated as EG indicates the endoproteinase, while remaining non-
digested peptide material is indicated with I and VI, respectively It is clear that both CHH 
forms have one peptide fragment with the same elution time (G11/G61) in common, while the 
other fragment is different and thus reflect the differences in elution of the intact peptides on 
the HPLC. Similarly, CHH II and CHH VII are cleaved into two fragments with one having 
the same elution properties as Gil and G61, the other being eluted like G12 (for CHH II) or 
G62 (for CHH VII; both not shown). Since all four fragments had the same amino acid 
composition it is expected that the sequence of these fragments is identical in the four 
peptides. 
Θ 
w 
en 
ι J 
10 20 10 10 SO 60 70 β 
ПНЕ I Mil) 
® 
.^_J-^ 
Fig. 4. Specific cleavage of purified CHH I and VI at glutamyl residues with endoproteinase Glu-
C. UV absorption (215 nm) profiles of digested CHH I (Fig A) and VI (Fig B) after HPLC 
separation on the Biogel RP 318 column Solvents A and В were as in Fig 3. A discontinuous 
linear gradient was employed (dashed line in B) from 0% В to 20% В in 10 mm and then to 40% 
В in 80 min. Flow rate 1 ml/min UV scale is represented on the left side of the chromatogram 
EG indicates the enzyme endoproteinase Glu-C which eiutes at 67 mm, I and VI are remaining 
uncleaved CHH I resp. CHH VI Fragments are numbered according to their elution order 
The sequences of Gil and G61 are indicated in Fig 5 No sequence could be determined 
from G12 or G62, probably due to the presence of a pGlu at the N-terminus. Therefore we 
Fragment Gil: (Glu)-Tyr-Val-Ser-Asn-Val-Gln-Met-Val-NH, 
Fragment G61: (Glu)-Tyr-Val-Ser-Asn-Val-Gln-Met 
Fig. 5. Amino acid sequences of fragments Gil and G61 obtained after cleavage of CHH I resp 
CHH VI with endoproteinase Glu-C. 
(Glu) indicates the putative position of the glutamic acid after which the native peptide was cleaved 
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concluded that Gi l , G21, G61 and G71 represent the C-terminal end of the four CHHs. The 
possible amidation of the last Val of Gil is based on the observation that during the last two 
sequencing steps both Val and a PTH amino acid with a slightly longer retention time as 
ValPTH were detected. Since this fragment was expected to represent the C-terminal end of 
the peptide (see also Discussion), in vivo amidation of the last amino acid would result in an 
extra NHj group, thus rendering it more hydrophobic. The mixture of Val and аІМНг could 
be the result of partial deamidation during the acidic conditions used for purification or 
enzymatic digestion. 
Amino acid compositions 
The given values in Table I are calculated on the assumption that all CHHs consists of 
72 residues, including six cysteines. Hydrolysis of synthetic Red Pigment Concentrating 
Hormone in the presence of thioglycolic acid, showed a recovery of approximately 70% of the 
tryptophan residues compared to 95 to 100% recovery of the other amino acids. Therefore it 
is likely that the amount of recovered tryptophan in CHH I and II accounts for at least one 
Table I. Amino acid compositions of CHH I, II, VI and VII from the lobster Homarus 
americanus '. 
Residue Peptide 
CHH I CHH II CHH VI CHH VII 
Asx 12.0 12.6 12.8 11.5 
Thr 2.0 1.8 1.5 2.0 
Ser 3.0 2.9 1.0 1.6 
GIx 7.8 7.5 8.0 6.7 
Pro 1.3 1.2 1.2 1.7 
Gly 1.6 1.7 1.6 2.0 
Ala 2.4 2.3 1.3 1.7 
Val 7.7 8.7 8.2 7.3 
Met 1.4 1.3 1.9 2.0 
He 1.1 0.9 2.7 2.6 
Leu 6.9 7.0 6.4 6.2 
Tyr 5.3 4.9 5.0 5.4 
Phe 4.0 3.9 3.8 3.4 
Lys 3.5 3.6 4.1 4.5 
Tip 0.4 0.6 0.0 0.0 
Arg 5.2 5.2 6.1 6.7 
* Cysteine contents were not determined, histidine was not detected in any of the samples. Values 
are given in mol/mol and are recalculated assuming 66 residues in each peptide (72 amino acids 
minus 6 cysteines, See also Discussion). 
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residue in these peptides. There are strong similarities between CHH I and II, as well as 
between CHH VI and VII. In contrast, prominent differences were found between the two 
sets; tryptophan is only present in CHH I/II and the relative amount of leucine/isoleucine is 7 
to 1 for CHH I/II in contrast to 6 to 3 for CHH VI/VII. The ratio of most of the other amino 
acids was approximately the same in all four peptides (maybe with the exception of Ser, Met, 
Ala and Arg), with high amounts of aspartic and glutamic acid. 
Determination of molecular masses of intact peptides 
Accurate determination of the molecular mass of CHH II (as representative for both 
CHH I/II) and CHH VII (as representative for both CHH VI/VII) was performed by means of 
Fast Atom Bombardment Mass Spectrometry (FAB/MS, Fig. 6). Analysis of CHH II in 
positive mode shows a [M + H]+ at m/z = 8578 Da, confirmed by the m/z signal of 4289 Da 
corresponding to half the value and representing the biprotonated molecular ion [M+2H]+ + . 
The CHH VII spectrum was more difficult to interpret since a low signal/noise ratio was 
obtained, probably due to an incomplete dissolvation of the sample in the matrix. 
Computerization of the signal indicates maximal values of 8630 Da and 8675 Da. The m/z 
signal at 4328 Da corresponds, when doubled, to an intermediate value (8656 Da). Therefore, 
the molecular mass of CHH VII can be estimated to be between 8630 and 8675 Da. 
Fig. 6. Fast-atom bombardment mass 
spectrometry (FAB/MS) of purified 
CHH II (10 /tg) and CHH VII (5 /tg). 
Reported values were calculated from a 
narrow (1000 Da) scan. 
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DISCUSSION 
The polymorphic nature of CHH has been described in a variety of cmstacean species 
and is thought to consist of two closely related isoforms. The situation in the lobster, H. 
americanus, however, seems to be remarkable, since the presence of three, or possibly four 
CHHs was described [199,217,225]. In the present study we have structurally characterized 
two sets of paired CHHs (CHH I and II, respectively CHH VI and VII) from the lobster sinus 
glands. 
The utilized two-step HPLC purification procedure, based on differences in charge, 
ionic strength and hydrophobicity of the peptides, proved to be a valuable tool in the complete 
separation of four CHHs from crude sinus gland extract (See Chapter 2). Further 
characterization of the purified peptides revealed several indications for the nature of the 
differences between the two groups of CHHs. From the amino acid compositions it could be 
deduced that at least one tryptophan is present in CHH I/II but is absent in CHH VI/VII. The 
ratio of isoleucine/leucine being 1:7 for CHH I/II is 3:6 for CHH VI/VII and additional 
differences in other amino acids (alanine, arginine, methionine and serine) are expected. The 
partial N-terminal amino acid sequences of the respective peptides indicate an additional 
difference: CHH I and II contain an Asp on position 20, while VI and VII contain an Asn on 
this position. 
Finally, the results of the molecular weight determination gave a Mw of 8578 Da for 
CHH II and a Mw of 8656 ± 25 Da for VII. In a previous study, using SDS/Urea/PAGE, the 
Mws of CHH I/II and VI/VII were estimated to be 6.5 kDa respectively 8.0 kDa (Chapter 2). 
Our more accurate values obtained by FAB/MS are in agreement with a very recently 
published study of Soyez et al., [199] on CHHs in the lobster, H. americanusihat describes 
two CHH-isoforms with an identical Mw of 8577 Da and two other CHH-isoforms with an 
identical Mw of 8633 Da. The differences between Mws determined by SDS/urea/PAGE and 
those obtained by FAB/MS might be due to differences in the (secondary or tertiairy) structure 
of the peptides that influence the electrophoretic mobility in SDS/urea/PAGE. As similar 
observations have been reported on CHH or CHH related peptides in other crustaceans 
[37; 110; and see Table I, Chapter 2) a réévaluation of published data on the estimated Mws 
using SDS/(urea)/PAGE, is highly desirable. 
The PGAP digestion- and peptide mapping-experiments gave more insight in the 
location of the differences between two isoforms and also demonstrated that these differences 
are identical for isoforms in each group. First, the N-terminal pyroglutamine residue is easily 
removed with PGAP from CHH I and VI, while CHH II and VII are less susceptible to PGAP 
treatment. These observed differences in rate of cleavage by PGAP can be explained by a 
difference in accessibility of the N-termini as a result of different overall conformation of the 
isoforms (i.e., the cysteine residue on position 7 and a second cysteine residue involved in a 
disulphide bridge can differ between the two isoforms). The N-terminal fragments of isoforms, 
however, elute at different positions as was deduced from the ELC digestions. It is therefore 
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more likely that CHH-isoforms do not differ in the overall conformation, but that the 
difference is associated within the first eight amino acids. A modification of the pGlu can be 
excluded: deblocked CHH-isoforms still display a difference in hydrophobicity (See Fig. 1) 
and deblocked fragments of isoforms do not elute at identical positions. We therefore 
concluded that the difference must be located within amino acid 2-8. Interesting in this respect 
are the results on the characterization of the two CHH isoforms from the crayfish, 
Procambarus bouvieri [92,93]. Comparative tryptic mapping in combination with reversed 
phase HPLC showed that both isoforms only differed in a N-terminal blocked octapeptide. 
Based on the identical amino acid composition of these fragments (which fits exactly with the 
sequence of the lobster CHHs) a reciprocal amidation-deamidation of two acidic residues was 
suspected (Glu to Gin, Asn to Asp). However in the lobster the different elution patterns of 
the octapeptides can't be explained by this presumed difference in amidation since all 
sequences are identical is this region (See Fig.2). The exact nature of the difference is unclear 
but the results of the Mw determinations of the peptide fragments exclude that amino acid 
sidechain modifications in this region might be responsible for the observed differences: the 
N-terminal fragments from CHH I and II have exactly the same molecular weight. Although 
speculative, the most plausible explanation for the existence of isoforms is a partial post-
translational modification of (a) L-amino acid residue(s) into (a) D-amino acid residue(s). Such 
a modification can change the secondary structure within the N-terminus of the peptides and 
thus: 
(i) might be responsible for the observed differences in elution patterns on HPLC of the 
isoformic peptide(fragment)s having an identical amino acid sequence and Mw 
(ii) can influence the accessibility of the pyroglutamine for the PGAP treatment. This type of 
post-translational modification is thus far only described for the peptides dermorphin and 
dermenkephalin, isolated from amphibian skins [133;173]. Interestingly, the D-amino acid 
forms of both dermorphin and dermenkephalin have affinity for another type of receptors 
compared to the L-amino acid containing peptides. This can, in the case of CHH VI and CHH 
VII, explain the difference in hyperglycemic activity observed in heterologous bioassays 
(Chapter 2). A difference in secondary structure between two CHH isoforms, was described 
for P. bouvieri, as determined by means of circular dichroism [94], although the exact 
location and nature of this difference is not verified yet. 
Comparison of the partial CHH sequences from H. americanus with the only reported 
sequence of a CHH from a crab, C. maenas [110], shows that all peptides contain a 
pyroglutamine residue at the N-terminal. Furthermore CHH VI/VII matches at 22 positions 
within the first 32 amino acids of the crab CHH sequence. The preserved positions of the 
cysteine residues at position 7, 23 and 26 indicate a high degree of conservation. Finally, it is 
interesting to mention the C-terminal end sequence of the crab CHH: Val-Gln-Met-Valamide. 
The amidation of the C-terminal Val was difficult to determine but indeed confirmed by 
peptide chemistry [110] and cDNA cloning [243]. Its presence strengthens the hypothesis of 
the presumed amidation of the lobster CHHs. The Mw of this 72 amino acid long peptide was 
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calculated to be 8524 Da and it seems therefore reasonable (also refering to the similar C-
terminal sequence of CHH I/II/VI and VII) to assume that the lobster CHHs also consist of 72 
amino acids. 
In view of a role in the molting process, the isolation of a 8 kDa peptide, containing 
tryptophan, from H. americanus sinus glands with molt-inhibiting activity is of great interest 
[37]. Especially, since the presented amino acid composition of this peptide is similar to those 
of CHH I/II and the amino acid composition of a MIH fragment is in perfect agreement with 
the C-terminal end sequence of the CHHs. This suggests that CHH I/II might have a 
bifunctional role in controlling molting as well as glycogen metabolism. 
The establishment of the complete primary and/or secondary structure of the CHH 
isoforms as well as the identification of the specific targets within the organism is now 
required to study efficiently the specificity of the different CHH isoforms and their relation to 
other physiological processes mediated by peptides from the X-organ sinus gland complex. 
51 
52 
CHAPTER 4 
HYPERGLYCEMIC NEUROPEPTIDES FROM THE SINUS 
GLAND OF THE CRAYFISH, ORCONECTES LIMOSUS: 
PURIFICATION, PHYSIOLOGICAL SPECIFICITY AND 
BIOCHEMICAL CHARACTERIZATION 
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ABSTRACT 
A two-step HPLC purification procedure was used in order to isolate Crustacean 
Hyperglycemic Hormones (CHHs) from sinus glands of the crayfish, Orconectes limosus. The 
purification steps were monitored with an ELISA method using an antiserum raised against 
CHH from Astacus leptodactylus. This approach allowed the isolation of at least four 
immunopositive CHH peptides. Three of these peptides were indeed hyperglycemic; they were 
designated as Orl-CHH 1,11, and VI. Orl-CHH I and II were identified as two closely related 
isoforms exhibiting the same structural features as the CHH isoforms from the lobster, 
Homarus americanus, when analyzed by peptide mapping and precise molecular weight 
determination. The most abundant isoform (Orl-CHH I) was further characterized by 
determination of the amino acid composition and partial N-terminal amino acid sequence. 
Concise analysis of Orl-CHH VI demonstrated that this peptide is structurally related to CHH 
I and II, albeit differing slightly in mass. The relation between the immunopositive Orl-CHH 
VII and the other three hyperglycemic CHHs is as yet unclear, however, its molecular weight 
suggests that this peptide may well be a CHH-precursor protein. 
Parts of this chapter are incorporated in the manuscript: 
Amino acid sequence of the crustacean hyperglycemic hormone (CHH) from the crayfish, 
Orconectes limosus. By: G Kegel, В Reichwein, CP Tensen and R Keller. 
Accepted for publication in Peptides 
Other parts will be used for a manuscript entitled: 
Comparative characterization and structural aspects of Crustacean Hyperglycemic Hormones from 
the crayfish, Orconectes limosus. By: CP Tensen, KPC Janssen, D Soyez, and F Van Herp 
(in preparation for submission to Gen Comp Endocrinol) 
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INTRODUCTION 
The first application of High Performance Liquid Chromatography (HPLC) in order to 
isolate neuropeptides from crustacean sinus glands was on the purification of the rather small 
octapeptidal, Red Pigment Concentrating Hormone (RPCH) from the lobster Homarus 
americanus [97]. With the successful isolation of several Crustacean Hyperglycemic Hormones 
(CHHs) from sinus glands of a number of different species [118;160;212], it was realized that 
the strength of HPLC separation was not only limited to the separation of small neuropeptides, 
but also applicable to study the molecular polymorphism of CHH. 
In previous chapters, we described a two-step HPLC system which allowed the 
complete separation of four CHHs from the lobster, H. americanus. The peptides could be 
characterization by peptide mapping, partial amino acid sequencing and precise molecular 
mass determination. The main objective of the present study is to extend our knowledge on the 
molecular polymorphism of CHHs by a comparative study on these neuropeptides in another 
crustacean species, the freshwater Astacidean, Orconectes limosus. Some properties of purified 
hyperglycemic peptides, obtained by peptide mapping, amino acid sequence analysis and 
molecular mass determination, are compared with structural features of the CHH isoforms 
isolated from sinus glands of H. americanus. 
MATERIALS AND METHODS 
AnimaL· 
Specimen of the crayfish, O. limosus, were obtained from local fishermen from the 
river Meuse. The animals were kept in the laboratory in running tap water (13-15 °C) on a 12 
h light/12 h dark regime and fed with fish once a week. 
HPLC 
HPLC was carried out on a Gilson analytical system as described in Chapter 2. Two 
columns (Biorad) were used: a cation exchanger column (Biogel TSK-SP-5PW; 75x7.5 mm; 
particle size 10 дт) and a reversed phase(RP) column (Hipore, RP-318; 250x4.6 mm). Both 
columns were equipped with a guard column. 
Extractions and purifications 
Sinus glands were dissected from ablated fresh eyestalks and kept on dry ice. Batches 
of pooled glands were homogenized in extraction solvent (0.1 M HCl) in a volume of 10 
μΐ/gland, heated at 80 "C for 5 min and then directly frozen at -60 e C until use. Each thawed 
preparation was centrifiiged (10.000 g/10 min) before injection into the HPLC system. In the 
first step the supernatant of the extract was separated on the TSK-SP-5PW cation exchanger 
column. After the first separation step, CHH was localized using the ELISA detection system 
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as outlined in Chapter 2. Fractions from the elution zones of the ion exchanger column 
containing CHH immuno-reactivity, were further separated and desalted on the reversed phase 
column. 
Assay of hyperglycemic activity 
In this study a homologous CHH bioassay, using O. limosus as test animal, was 
performed as is described in Chapter 2. Glycemia is expressed in mg glucose/100 ml 
hemolymph. The possible dose dependency was tested by injection of different peptide 
concentrations. The significance of the differences between the mean of groups (test samples 
versus controls) was evaluated by the Student's /-test. 
Electrophoresis and Western blotting. 
Sodium Dodecyl Sulphate-Urea-Polyacrylamide gel electrophoresis (SDS-Urea-PAGE), 
silverstaining and Western blotting were identical to the procedures described in Chapter 2. 
Enzymatic digestions. 
Enzymatic digestions were carried out on native peptides which were purified by the 
two-step HPLC system. After hydrolysis peptide fragments were separated by RP-HPLC, 
using the RP-318 column and an acetonitrile/water/trifluoro acetic acid (TFA) eluent system 
(See legends under Figures). 
Pyroglutamate-aminopeptidase (PGAP). Cleavage was performed under conditions 
adapted from [189] and are identical to the procedure as described in Chapter 3. Briefly, in a 
standard assay the purified peptide was dissolved in 90 μ\ digestion buffer (90 mM 
KH2P04/K2HP04 buffer pH 7.5 containing 20 mM EDTA) and equilibrated for 30 min at 30 
"C, then 500 /ig of crude PGAP in 10 μΐ digestion buffer was added and the incubation was 
continued for 20 min at 30 0C. The reaction was stopped by adding 3 μΙ of 5.7 M HCl and 
800 /il ice-cold HPLC buffer A (0.05% TFA in water). 
Endoproteinase-Lys-C (ELC). Peptides were digested in 250 /il digestion buffer (25 
mM Tris-HCl (pH=8.0), 1 mM EDTA and 5 mM dithiotreitol) for 16 h at 37 °C under 
nitrogen vapor with 0.5 μg ELC (Boehringer, sequence grade). The reaction was stopped with 
3 μΐ 5.7 M HCl and 750 μΐ HPLC buffer A (0.10% TFA in water). 
Analysis of amino acid composition. 
For analysis of the amino acid composition, purified peptide material was hydrolysed 
at ПО 0C in 5.7 M HCl+3% thioglycolic acid (Merck) [143] for 24 hrs under reduced 
pressure. Hydrolysates were dried under vacuum and washed three times with 200 μΐ HPLC 
water and redried under vacuum. Quantification of the amino acids was performed as 
described in Chapter 3. 
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Amino acid sequencing. 
Automated Edman degradation was performed with an Applied Biosystems Model 
470A Protein Sequencer, on-line equipped with a Model 120A PTH analyzer. Prior to 
sequencing, peptides or peptide fragments were spotted onto glassfiber filters and modified for 
the identification of cysteine residues as described in Chapter 3. 
Protein determination. 
Protein contents of crude sinus gland extract and purified Orl-CHH I were determined 
by the micromethod of Smith et al. [194]. Subsequently, the peptide content was related to the 
peak surface on the chromatogram, which permitted the approximate calculation of Orl-CHH 
II, VI and VII. 
Mass spectrometry. 
Two methods were used for precise molecular weight determination. 
Fast atom bombardment mass spectrometry (FAB/MS). This was carried out as 
described in Chapter 3. Five μg of purified Orl-CHH II was dissolved in 5 μΐ of 10% HAc 
and mixed with thioglycerol as matrix. The approximate masses were first determined by a 
fast scan over a wide range (3.000-12.000 Da). Narrow scans over a range of 8.000 to 9.000 
Da permitted precise calculations of the masses of the [M + H]+ ions from comparison with 
Csl external standards. 
Electrospray Mass Spectrometry (ES/MS). This was performed as described in Chapter 
3. Ten μg of Orl-CHH I, 5 μg of Orl-CHH II and 1 ^g of PGAP treated Orl-CHH VI were 
dissolved in 5% acetic acid, mixed with an equal amount of methanol and introduced into the 
ion source at a flow rate of 2 μΐ/min. Several scans over a range of 4.000-10.000 Da were 
summed and precise masses were calculated from comparison with internal standards. 
RESULTS 
Two-step HPLC purification. 
A typical chromatogram of an extract of 100 sinus glands from O. limosus (containing 
1 mg of protein) separated on the cation exchanger is shown in Fig. 1A,. CHH 
immunoreactivity was determined for each fraction by means of the ELISA detection system. 
These results are illustrated by the bar graph in Fig. 1A2. The immunoreaction of a dilution 
serie of crude sinus gland extract is depicted on the left site of the bar graph. 
Immunoreactivity appeared in two regions and the corresponding peptides are designated Orl-
CHHs in accordance with the nomenclature proposed by Raina and Gade [168]. The 
numbering with roman capitals is according to the order of elution and the numbering of 
lobster CHHs (Chapters 3 and 4). Desalting and separation of Orl-CHH I from Orl-CHH II 
was achieved by passing the fractions ft 56, 57 and 58 from the first immunopositive region in 
three consecutive runs on the reversed phase column using a linear gradient followed by 
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Fig 1. Two-step purification of hyperglycemic peptides from sinus glands of Orconectes 
limosus. 
A. HPLC on a TSK-SP-5PW ion exchanger column. 
Sample: Hot hydrochloric extract of 100 sinus glands. 
Solutions: A: 0.02 M sodium phosphate pH 3.0/acetonitrile 7:3 
B: 0.75 M sodium phosphate pH 3.0/acetonitrile 7:3 
Gradient: linear from 100% A to 100% В in 90 minutes 
(Flow rate 1.0 ml/min; Fraction size 1.0 ml). 
Aj. Representation of the corresponding immunoreactivity after the first purification step 
using an ELISA with a polyclonal anti-CHH antiserum. On the left side of the bargraph are 
the ELISA values measured in a serial dilution of crude sinus gland extract (BL=blanc, 
(control)) 
isocratic elution (Fig. ΙΒ,-Bj). The recovery after the two steps of separation was calculated to 
be 153 ng of Orl-CHH I per sinus gland. Purification of Orl-CHH II without contaminating 
Orl-CHH I was difficult to achieve, since Orl-CHH I and II eluted at approximately the same 
positions. Residual Orl-CHH I in the Orl-CHH II preparations could therefore not be 
excluded. The amount of Orl-CHH II per sinus gland was estimated to be -60 ng. 
Purification of the immunoreactive zone Orl-CHH VI/VII was obtained by 
rechromatography of fractions 66+67+68, 69+70 and 71 in three subsequent runs on the 
reversed phase column using a gradient elution (Fig. IC.-Cj). Several peaks were identified by 
their immunoreactivity in the ELISA, however, only two appeared consistently in all sinus 
gland preparations and were designated Orl-CHH VI and Orl-CHH VII. Additional 
immunoreactivity was found in the peaks indicated with asterisks in the chromatograms, but 
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the relative amount of these peaks in successive extractions was very dissimilar; therefore, we 
did not characterize these components in more detail. Estimation of the quantities of Orl-CHH 
VI and VII gave 20 ng for Orl-CHH VI and 10 ng for Orl-CHH VII per sinus gland. 
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Samples: 
Solutions: 
Gradient: 
Reversed phase HPLC separation on a Biogel Hipore RP-318 column. 
Fractions # 56 (Fig. B,), # 57 (Fig. B2) # 58 (Fig. B,) 
A: 0.05% Trifluoroacetic acid (TFA) in water. 
B: 0.05% TFA in 50% aqueous acetonitrile. 
10 min 0% В; from 0% В to 67% В in 10 min; 30 min 67% В. 
Fig. IC,.,. Reversed phase HPLC separation on a Biogel Hipore RP-318 column. 
Samples: Fractions # 6 6 + 67 + 68 (Fig C,), # 6 9 + 70 (Fig. Q,) and # 71 (Fig. C3) 
from the first column. Solutions A and В as in Fig. IB. 
Gradient: 10 min 0% В; from 0% В to 100% В in 60 min; 
For clearness, the applied gradients are only indicated in the bottom chromatograms (dashed 
line). Absorbance was measureed at 215 nm. 
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SDS-urea-PAGE and Western blotting. 
SDS-urea-PAGE of Orl-CHHs I, II, VI and VII, followed by silver staining or 
immunoblotting, was carried out to determine their approximate molecular weights. The 
results are shown in Fig. 2A-B. According to the migration distance of the markers, Orl-CHH 
I, II and VI have a similar molecular weight of ~6200 Da. Additionally, the Western blot 
shows that these three peptides are recognized by the anti-CHH antibody. In contrast, Orl-
CHH VII has a Mw between 12-14 IcDa and is not recognized by the antibody in the Western 
blot. 
X ПИШГ M M 'Sn УЕЛ I 
® ® 
Fig. 2A-B. SDS-urea-PAGE and Western blotting of purified Orl-CHH I, II, VI and VII 
(indicated by I, II, VI and VII resp.). 
A: Result of electrophoresis and visualization of peptides by silverstaining. B: Result of 
Western blot, using the polyclonal anti-CHH antiserum. 
Markers (M; prestained Mw protein standards from BRL): 1: ovalbumine (43 kDa); 2: a-
chymotrypsinogen (25 kDa); 3: /3-lactoglobulin (18 kDa); 4: lysozyme (15 kDa); 5: Bovine 
trypsin inhibitor (6.2 kDa). Arrows indicate the position of Orl-CHH I, II and VI. 
Hyperglycemic bioactivity 
Crude sinus gland extract as well as purified Orl-CHHs I, 11, VI and VII were tested at in a 
homologous bioassay. In order to investigate the possible dose-depency in recipient animals 
after injection, several concentrations were tested. The obtained hyperglycemic responses upon 
injection of crude sinus gland extract are summarized in Fig. 3. From the results of this serial 
dilution it was concluded that 0.05 sinus gland equivalent was the minimal effective dose and 
that a maximal increase in blood glucose content (100 mg/ml) was achieved after injection of 
0.33 sinus gland equivalents. Injection of purified peptides indicated that Orl-CHH 1,11 and VI 
are hyperglycemic (Fig. 4). They are, however, individually less potent than crude extract 
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Fig. 3. Hyperglycemia in recipient animals obtained after injection of crude sinus gland 
extract. A hydrochloric acid extract was lyophilized, washed with HPLC water once and 
redissolved in physiological saline [Van Harrevelt, 1936J. A serial dilution was injected in O. 
limosus. Values are represented as mean +/- SEM obtained from 5 animals. Significant 
differences compared to physiological saline injected animals were determined by means of 
the Student Mest. No differences were found for 0.001, 0.005, or 0.01 SG; 0.05 SG was 
significantly different from the control at p<0.02, while 0.1, 0.33, 1 and 3 SG differed 
significantly from the control at ρ < 0.001. 
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Fig. 4. Hyperglycemia in recipient animals obtained after injection of HPLC purified CHHs 
I, II or VI. 
Values are represented as mean +/- SEM obtained from 5 animals, except for controls 
(physiological saline injected animals): n=8 and Orl-CHH VI 1 SG equivalent: n=10. 
Significant differences, determined by means of the Student r-test, are indicated by asterisks: 
* ρ < 0.05, ** ρ < 0.01 (compared to values from controls) 
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(i.e., 3 sinus gland equivalents of CHH I gave in increase of 50 mg glucose/100 ml 
hemolymph). No increase in glucose levels was observed with any tested concentration of Orl-
CHH VII; even injections of 1 or 3 sinus gland equivalents remained negative (not shown). 
Additional characterization of Orl-CHH I and II 
Enzymatic digestions 
Endoproteinase Endo-Lys-C (ELC) cleavage. The fractionation on the reversed phase 
column of the specific cleavage products generated by ELC digestion of Orl-CHH I or Orl-
CHH II with 0.5 /tg of enzyme is shown in Fig. 5A-B. Peaks related to the obtained 
fragments are numbered in order of elution. The unlabelled peaks were also present in control 
runs of digestion buffer with enzyme only. Fig. 5A shows the results after cleavage of pure 
Orl-CHH I (10 /¿g). Three fragments were obtained: OLII, OL12 and OL13. Amino acid 
sequence analysis revealed that OLII was N-terminally blocked since no amino sequence 
could be obtained. 
The outcome of cleavage of Orl-CHH II (10 ¿ig) is depicted in Fig. 5B. We deduced 
that the peak designated OLII was the N-terminal fragment of residual Orl-CHH I in this 
sample. Therefore the other peaks, OL12/OL22 and OL13/OL23, are likely to be a mixture of 
fragments arising from cleavage of Orl-CHH I and II. Only one fragment, OL21, is 
characteristic for Orl-CHH II. 
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Fig. 5. Comparative peptide maps of Orl-CHH I and II. After digestion with endoproteinase 
Lys-C, the samples were acidified and injected into the Biogel Hipore RP-318 column. 
Solvent A: 0.1 % TFA in water 
Solvent B: 0.1% TFA in 80% aquoues acetonitrile 
Gradient: 100% A for 10 min; 0% В to 80% В in 80 min (dashed line in Fig. 5B) flowrate 1 
ml/min). 
Α-B. Fragments obtained from Orl-CHH I (A) and II (B) are numbered according to their 
order of elution (OL 11, 12 and 13 for CHH I; OL 21, 22 and 23 for CHH II). UV scale 
(absorbance at 215 nm) is only represented on the left side of the chromatogram. 
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N-terminal deblocking. Initial attempts to obtain a N-terminal amino acid sequence of 
the most abundant Orl-CHH I failed, since no amino acids were released during automated 
Edman degradation. In analogy to all lobster CHHs (Chapter 3), the presence of a 
pyroglumate as N-terminal residue was therefore expected. Treatment with pyroglutamate 
aminopeptidase demonstrated that Orl-CHH I was indeed susceptible to enzymatic cleavage. 
Rechromatography on the reversed phase column of the Orl-CHH/enzyme mixture under the 
conditions used for separation of Orl-CHH I from II, resulted in a new peak representing the 
digested form, which became more polar and eluted at 34-36 mm It was noticed that the 
pyroglumatamine residue from Orl-CHH I was easily removed 85% deblocked Orl-CHH I 
was recovered after incubation of 15 ^g Orl-CHH I with 500 μg PGAP for 20 min (not 
shown). 
Amino acid composition 
The values in Table I are calculated assuming the presence of 72 residues, including 
six cysteines Hydrolysis of Orl-CHH I was done in the presence of thioglycolic acid in order 
to improve the recovery of tryptophane residues. From the results it was concluded that Orl-
CHH I does not contain tryptophane residues 
Table I Amino acid composition of Orl-CHH I 
Residue amount 
Asx 10 3 
Thr 2 6 
Ser 2 8 
Glx 7 2 
Pro 1 5 
Gly 3 4 
Ala 4 9 
Val 5 9 
Met 0 9 
He 2 4 
Leu 7 1 
Tyr 4 9 
Phe 2 7 
His 0 8 
Lys 3 8 
Trp 0 0 
Arg 4 7 
Cysteine contents were not determined. Values are given in mol/mol and are recalculated 
assuming 66 residues in the peptide (72 amino acids minus б cysteines. See also Discussion 
section). 
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Amino acid sequencing 
Automated Edman degradation was performed on 10 μg of Orl-CHH I after 
deblocking, purification and S-pyridylethylation of the cysteine residues with 4-vinyl pyridine. 
This yielded an amino acid sequence of 37 residues, which is summarized in Fig. 6. The 
sequence of the last 4 residues should be interpreted with care since the sequence was difficult 
to determine in this region. Sequence analysis of two endo-lys fragments, OL12 and OL13 
(see above), confirmed the sequence from residue 9 to 32. The fragment OL12 consists of 9 
amino acids (Gly-IIe-Tyr-Asp-Arg-AIa-Ile-Phe-Lys), while OL13 represents a fragment of 14 
amino acids (Leu-Asp-Arg-Val-Cys-Glu-Asp-Cys-Tyr-Asn-Leu-Tyr-Arg-Lys). During 
sequencing no signs of microheterogeneity were observed in none of the samples, however the 
yield of lysine residues was rather low. 
1 10 20 
Orl-CHH I : pGlu-Val-Ph«-Asp-cln-Al«-Cy»-Ly«-Gly-I le-Tyr-Jtóp-Arij-Ala-I l«-Ph«-Lys-Ly»-L«u-A»p-
21 30 17 
АГ9- «1-Су»-01и-Аяр-сув-Туг-»вп-Ьви-Туг-Хгд-Ьу«-І>го-(Туг)-( а1)-(А1а)-(ТІіг) 
Fig. 6. Partial N-terminal amino acid sequence of Orl-CHH I, obtained by automated Edman 
degradation. 
Determination of molecular masses ofOrl-CHHs. 
An accurate determination of the molecular mass, performed by Fast Atom 
Bombardment Mass Spectrometry (FAB/MS) in the positive mode, was obtained for Orl-CHH 
II. One clear signal was found for a ÍM+H]+ at m/z = 8402 Da, which was confirmed by the 
m/z signals of 4201 Da and 2801 Da corresponding to half and one third of the value and 
representing the bi- resp triprotonated molecular ions [M-I-2H)++ and [M + 3H]+ + + (Fig. 7.). 
In contrast, no clear signals were observed in the FAB/MS analysis of Orl-CHH I and VI (not 
shown). Therefore we tried to obtain information on the masses of Orl-CHH I, II and VI by 
ES/MS analysis (results not shown). By this technique the molecular weight obtained through 
FAB/MS for Orl-CHH II was confirmed and found to be 8401 Da. In addition the accurate 
mass of Orl-CHH I could be determined as 8401 Da. The mass spectrum of Orl-CHH VI was 
very complicated, probably due to remaining salts in the preparation. Analysis of 
computerized data gave the Mw of at least one peptide (8413 Da) but the presence of 
additional peptides could not be excluded. 
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[M + 3Η]+ + + 
2801 І М + 2 Н Г 
Orl-CHH II 
4201 
3000 6000 
mlz 
9000 
Fig. 7. Fast-atom bombardment mass spectrometry (FAB/MS) of purified Orl-CHH II (5 
fig). The reported values were calculated from a narrow (1000 Da) scans. 
DISCUSSION 
The present study deals with the purification, biochemical characterization and 
structural comparison of hyperglycemic neuropeptides from the crayfish O. limosus. For this 
purpose we employed a two-step HPLC purification procedure, previously demonstrated to be 
a helpful instrument in the separation and characterization of hyperglycemic peptides from 
sinus glands of H. americanus [217;221; Chapter 2 and 3]. Screening of HPLC fractions, 
using an апй-Astacus CHH serum in an ELISA system, revealed the presence of 4 major 
immunoreactive peptides. They were designated as Orl-CHH I, II, VI and VII, and appeared 
consistently in the sinus gland preparations. The applied homologous bioassay demonstrated 
that Orl-CHH 1,11 and VI were able to induce a significant increase in blood sugar levels in 
the hemolymph upon injection into recipient animals, but no hyperglycemic effect could be 
assigned to Orl-CHH VII. 
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Two СЫН isoforms, Orl-CHH I and II, have a clear biological hyperglycemic activity 
and are strongly structurally related. The similarity of these peptides is illustrated by the 
elution behaviour on both HPLC systems. They appear as one peak on the ion exchanger 
column and even with the applied isocratic elution in the second purification step, it was 
difficult to separate Orl-CHH II completely from Orl-CHH I. The similarity is also noticed in 
their migration behaviour on SDS-urea-PAGE, suggesting a common molecular weight of 
approximately 6 kDa. Precise molecular weight determination revealed a nearly identical Mw 
for both Orl-CHHs, being 8401 Da for Orl-CHH I and 8401/8402 Da for Orl-CHH II. 
A difference between Orl-CHH I and II was observed following digestion after the 
lysine residues and subsequent fractionation on a reversed phased column of the derived 
peptide fragments. This approach resulted in nearly identical peptide maps, with the exception 
of one fragment. Since, in general, the difference between CHH isoforms is located at the N-
terminus [92 ;93 ¡Chapter 3] we concluded that OL21 represents the N-terminal fragment of 
Orl-CHH II and that OLII is the N-terminal fragment of Orl-CHH I. 
Amino acid sequence analysis of deblocked Orl-CHH I allowed the unambiguous 
elucidation of the first 33 residues. Parts of this sequence were confirmed by the sequence 
data obtained from the peptide fragments generated by ELC cleavage. Overall, the sequence 
shows a great resemblance with the amino acid sequences of lobster CHHs (Chapter 3) and 
has to a lesser extend also homologies with CHH from the crab Carcinus maenas [110]. The 
similarity with lobster CHHs is also found in the their amino acid compositions. 
Orl-CHH VI might be structurally related to Orl-CHH I and II, since it shares the 
immunopositive reaction to anti-CHH. In contrast, the hyperglycemic respons of Orl-CHH VI 
does not increase in proportion to the amount of SG equivalents tested and makes its biological 
importance in the control of glycogen metabolism rather questionairy. The elution behaviour 
during the HPLC purification indicates an additional difference with Orl-CHH I and II. 
Unfortunately, we cannot be sure, at this moment, of the authentic Mw of Orl-CHH VI since 
the mass of Orl-CHH VI was determined after PGAP incubation. The obtained minimal Mw 
of 8413 Da demonstrated that this peptide is clearly different from CHH I and II. 
Comparison of the chromatograms and biochemical properties of the Orl-CHHs I, II 
and VI from O. limosus, with the two sets of CHH isoforms from the lobster, H. americanus, 
[217;221; Chapters 2 and 3) suggests a mutual relation between Orl-CHH I/II and lobster 
CHH I/II. Their elution profiles on HPLC and their electrophoretic behaviour on SDS-Urea 
PAGE are similar and the amino acid sequence identity is slightly higher for lobster CHH I/II. 
Some difference between lobster CHH I/II and Orl-CHH I/II were also noticed: in lobster 
sinus glands CHH II is present in larger amounts than CHH 1, while crayfish sinus glands 
always contain more of CHH I. Furthermore, it is clear that the CHH isoforms of the lobster 
are less structurally related, since they appear as a doublet peak on the ion exchange column 
while only one peak is observed for crayfish CHH. Finally, the N-terminal fragments of 
lobster CHH I and II elute at 38 resp 45 min while the N-terminal fragments of Orl-CHH I 
and II elute at 39 resp. 43 min under identical conditions. Refering to the putative post-
66 
Purification and characterization of crayfish CHHs 
translational modification responsible for the existence of CHH isoforms in lobster sinus 
glands Camino acid(s) to D-amino acid(s); Chapter 3) it might well be that in Orl-CHH I and 
II this type of modification occurs for another amino acid(s) as is the case for the H. 
americanus CHHs. This can explain the different elution profiles found for the N-terminal 
fragments of Orl-CHH I and II compared to the N-terminal fragments (with identical 
sequences) of H. americanus CHHs. 
The relation of Orl-CHH VI with lobster CHH VI and VII is less obvious. The lobster 
CHH VI or VII appear as 8 kDa peptides after SDS-urea-PAGE and are less hydrophobic 
compared to lobster CHH I and II. In contrast, no differences in migration behaviour on SDS-
urea-PAGE were observed between the Orl-CHH I, II and VI while Orl-CHH VI is more 
apolar than Orl-CHH I and II. 
Until now we cannot rule out that the hyperglycemic effect of Orl-CHH VI is only a side 
effect and in this respect it is worthwhile to note that the preliminary biochemical 
characteristics of this peptide are similar to those of a molt inhibiting peptide isolated from the 
crayfish, Procambarus bouvieri [94]. More detailed physiological studies might demonstrate 
the role of this peptide in crustacean neurohormonal regulation. 
Finally, we think that Orl-CHH VII represents an uncleaved CHH precursor molecule. 
This idea explains the immunoreactivity with the antiserum in the ELISA. Besides, the 
deduced Mw from SDS-Urea PAGE (12-14 kDa) fits very well with the reported Mws of the 
CHH-precursor from the land crab, Cardisoma carnifex (14 kDa [212]) and the shore crab С 
maenas (13.3 kDa [243]. 
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ISOLATION AND AMINO ACID SEQUENCE OF 
CRUSTACEAN HYPERGLYCEMIC HORMONE 
PRECURSOR-RELATED PEPTIDES 
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ABSTRACT 
The Crustacean Hyperglycemic Hormone (CHH) is synthesized as part of a larger 
preprohormone in which the sequence of CHH is N-terminally flanked by a peptide for which 
the name CPRP (CHH Precursor-Related Peptide) is proposed. Both CHH and CPRP are 
present in the sinus gland, the neurohaemal organ of neurosecretory cells located in the 
eyestalk of decapod crustaceans. This chapter describes the isolation and sequence analysis of 
CPRPs isolated from sinus glands of the crayfish, Orconectes limosus and the lobster, 
Homarus americanus. 
The published sequence of "peptide H" isolated from the land crab, Cardisoma carnifex has 
now been recognized as a CPRP in this species. Amino acid sequence comparison, also 
including the peptide sequence of CPRP from the shore crab, Carcinus maenas (Cam-CPRP), 
reveals a high level of identity for the N-terminal region (residues 1-13) between all four 
peptides. Identity in the C-terminal domain is high between lobster and crayfish CPRP on the 
one hand, and between both crab species on the other hand. Conserved N-terminal residues 
include a putative monobasic processing site at position 11, which suggests that CPRP may be 
a biosynthetic intermediate, from which a potentially bioactive decapeptide can be derived. 
This chapter is the altered thesis version of a manuscript entitled: 
Isolation and sequence analysis of crustacean hyperglycemic hormone precursor-related peptides. 
By: CP Tensen, AH Verhoeven, KPC Janssen, G Gaus, R Keller and F Van Неф. 
Accepted for publication in Peptides 
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INTRODUCTION 
In decapod crustaceans, the X-Organ Sinus Gland (XO-SG) neurosecretory system, 
located in the eyestalks, is considered to be the most important neuroendocrine regulation and 
integration center of the animal. The SG acts as a neurohemal organ and storage pool for 
neuropeptides synthesized by neurosecretory cells, which are grouped together to form the 
XO. A large number of neurohormonal activities, such as control of pigment migration, gonad 
development, molting and glycogen metabolism have been attributed to peptides originating 
from this system [162;228;229;242]. 
The Crustacean Hyperglycemic Hormone (CHH) regulates glycogen metabolism and, 
putatively, release of digestive enzymes [122]. This hormone is a member of a family of 
closely related neuropeptides (size ~8 kDa) produced by the XO perikarya. Based on 
biosynthesis experiments with the land crab, Cardisoma carnifex, it was postulated that a 14 
kDa precursor, pro-CHH, gives rise to one CHH, which is posttranslationally modified to 
yield three different CHHs, and one peptide of 4.5 kDa designated peptide H [212]. 
Peptide H was previously isolated from SGs and a nearly complete amino acid 
sequence has been determined [160;161;162]. A cDNA sequence encoding the complete 
prepro-CHH from the shore crab, Carcinus maenas, [243] demonstrated that CHH is indeed 
synthesized as part of a 13.3 kDa precursor protein, with a so-called C-peptide flanking CHH 
N-terminally within the prohormone. Peptide H and the C-peptide show 50% sequence 
identity. 
Until now biological functions for both peptide H and the C-peptide have not been 
established. It has been suggested that peptide H might be a biosynthetic intermediate which 
could give rise to three smaller, potentially bioactive, peptides by proteolytic cleavage at two 
internal sites [161]. These observations prompted us to investigate whether conservation of 
these peptides has occurred during crustacean evolution, hence sustaining the functional 
significance of conserved regions, e.g., putative monobasic processing sites. 
The C-peptide and peptide H counterparts from the crayfish, Orconectes limosus, and 
the lobster, Homarus americanus, were isolated and characterized. The crayfish species was 
chosen since several cytophysiological and morphological aspects of its CHH-producing X-
organ cells have been intensively studied in our laboratory [73;75;218;229]. Besides, 
molecular cloning of CHH precursor(s) from this crayfish species is one of the topics of our 
current research. Lobster sinus glands were chosen since in this species the presence of two 
structurally different CHHs, each consisting of two isoforms, was established 
[199;217;219;221; Chapters 2, 3 and 6 of this thesis]. If both CHHs are synthesized as parts 
of different precursors, two different flanking peptides might excist. 
This chapter describes the isolation and sequence analysis of these neuropeptides, for 
which we propose the acronym CPRP (Crustacean hyperglycemic hormone Precursor-Related 
Peptide) analogous to APRP (Adipo kinetic hormone Precursor-Related Peptide [86]). The 
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purified peptides are designated Orl-CPRP and Hoa-CPRPl/Hoa-CPRP2 for O. limosus 
respectively H. americanus, (using the terminology in [168]) and are compared with the 
sequence of peptide H [161] and the sequence of the C-peptide as determined by means of 
protein sequence analysis (refered to as Cam-CPRP [68;222]). Finally, possible proteolytic 
processing sites based on the primary and (theoretical) secondary structures of the peptides are 
discussed. 
MATERIALS AND METHODS 
Animals 
H. americanus : As source for CPRP isolation from H. americanus, sinus glands were 
dissected from lyophilized eyestalks of animals, which originated from the coast of New 
Brunswick (Canada). Transport and maintenance of the eyestalks are extensively described 
[Chapter 3]. Since with respect to CHH isolation no differences in the separation 
chromatograms, localization of bioactivity and peptide maps could be observed between sinus 
gland extracts of fresh and lyophilized eyestalks [217;221], we considered these freeze dried 
eyestalks valid starting material for isolation of lobster CPRPs. 
O. limosus : Specimens of the crayfish were obtained from local fishermen from the 
river Meuse (The Netherlands). The animals were kept in the laboratory in running tap water 
(13-15 0C) on a 12 h light/12 h dark cycle and fed with fish once a week. Sinus glands were 
dissected immediately after ablation of the eyestalks and kept on dry ice. Batches of pooled 
glands were homogenized in a volume of 10 μ\ 0.1 M HCl/gland, heated at 80 °C for 5 min 
and then directly frozen at -60 "С until use. Each thawed preparation was centrifuged (10.000 
g/10 min) before injection into the HPLC system. 
HPLC 
All chemicals used for HPLC were HPLC grade (Baker); HPLC water was obtained 
by passing demineralized, double distilled water through a Norganic column (Waters). 
HPLC was carried out on a Gilson analytical system described in Chapter 2. Two columns 
were used (both obtained from Bio-Rad and equipped with a guard column): a cation 
exchanger column (Biogel TSK SP-5PW; 75x7.5 mm; particle size 10 μπι) and a reversed 
phase column (Hipore, RP-318; 250x4.6 mm). Initial purification was obtained by passing an 
extract of 100 SGs on the cation exchanger column applying a gradient as is shown in Figs 1A 
and 2A (solvent A: 0.02 M sodium phosphate, pH=3.0/acetonitrile 7:3; solvent B: 0.75 M 
sodium phosphate pH=3.0/acetonitnle 7:3; flow rate 1.0 ml/min; fraction size 1.0 ml). In a 
second step, selected fractions (# 38+39 for H. americanus, ff 35+36 for O. limosus) from 
the cation exchanger column were pooled and rechromatographed on the reversed phase 
column for further purification and desalting of the peptide material. The same elutions 
conditions were employed for both separations (Solvent A: 0.05% TFA in water; Solvent B: 
0.05% TFA in 50% aqueous acetonitrile; flow rate: 1 ml/min; fraction size 1 ml) with a 
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gradient as indicated in Figs IB and 2B. 
Analysis of amino acid composition 
An Applied Biosystems amino acid analyzer, consisting of a Model 420A 
hydrolysis/PTC-derivatization unit, a Model 130A separation system and a Model 920A data 
analysis module was used to determine the amino acid composition and the quantity of Hoa-
CPRPl. 
Amino Acid Sequencing 
The primary structures of Hoa-CPRP2 and Orl-CPRP were determined by automated 
Edman degradation using an Applied Biosystems Model 473A pulse-liquid protein-peptide 
sequencer, on-line connected to a Model 120A PTH analyzer (Applied Biosystems). 
Manual Edman degradation the N-terminal of native Hoa-CPRP2 was performed using 
the DABITC/PITC double coupling method [39]. 
Mass spectrometry 
Electrospray mass spectrometry (ES/MS) was performed on a VG Bio-Q quadrupole 
mass spectrometer (VG Analytical, UK). Peptides were first dissolved in 5% acetic acid in 
water and then an equal amount of methanol was added. This solution was introduced into the 
ion source and the electrospray was emitted at 3200V. Masses were calculated from internal 
standards. 
RESULTS 
Isolation and purification of CPRPs 
An elution profile of an extract of 100 sinus glands from H. americanus separated on 
the cation exchanger is shown in Fig. 1A. In addition to the multiple CHH isoforms, 
designated Hoa-CHH (I, H, VI, VII), which were recently extensively characterized 
[3;30;Chapters 2 and 3], SG extracts contain a prominent peak (indicated as Hoa-CPRP in the 
chromatogram). The relative amounts of this peak and CHHs were consistently found to be 
the same. Desalting and further purification of this peptide material was achieved by passing 
fractions 38+39 onto the reversed phase column. The Hoa-CPRP obtained after the first 
purification step contained two major products (called Hoa-CPRPl and Hoa-CPRP2 in order 
of elution) and approximately eight minor products (Fig. IB). 
The UV absorption profile resulting from passing an extract of 100 sinus glands from 
the crayfish, O. limosus, on the cation exchanger column is shown in Fig. 2A. The material 
designated Orl-CPRP (fractions 35+36) was found to be present in relative amounts compared 
to CHH and therefore subjected to further purification on the reversed-phase column (See Fig. 
2B). This revealed the presence of only one apparently pure peptide having the same retention 
time as Hoa-CPRPl. 
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io 50 
TIME (MIN) 
Fig. ] Α-B. Two-step purification of CPRPs from sinus glands of Homarus amerlcanus. 
A. Ion exchange HPLC on a TSK-SP-5PW ion exchanger column of a hot hydrochloric 
extract of 100 sinus glands. Gradient (dashed line): linear from 100% A to 100% В in 90 
minutes. Fractions #38 + 39 were used for further purification. 
B. Reversed phase HPLC separation on a Biogel Hipore RP-318 column of fraction #38 + 39 
from the cation exchanger column. Gradient (dashed line): discontinuous, 18 min 0% В, 10 
min 0 - 50% В, 30 min 50% В, 30 min 50 - 60 %, 10 min 60% В. 
From the peak designated Hoa-CPRPl the amino acid composition was analyzed. Hoa-
CPRP2 was subjected to manual and automated amino acid sequencing. 
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Fig. 2A-B. Two-step purification of CPRP from sinus glands of Orconectes limosus. 
A. Ion exchange HPLC on a TSK-SP-5PW ion exchanger column of a hot hydrochloric 
extract of 100 sinus glands. Gradient (dashed line) was as in Fig IA. Fractions # 35+36 
were used for further purification. 
B. Reversed phase HPLC separation on a Biogel Hipore RP-318 column of fraction # 3 5 + 36 
from the cation exchanger column. Gradient (dashed line) as in Fig. IB. The peak designated 
Orl-CPRP was subjected to automated amino acid sequencing. 
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Structure determination of CPRPs 
Hoa-CPRPs 
An aliquot of purified Hoa-CPRP2, equal to 40 sinus gland equivalents (800 pmol), 
was used for sequence determination by automated Edman degradation. The recovery of the 
first two amino acids was low, while high repetitive yields were obtained starting from the Val 
on position 3. From this residue on, the sample could easily be sequenced without signs of 
interfering sequences. The results obtained during sequencing (Fig. 3) clearly demonstrated 
the presence of an Asn on position 33, followed by a drastic decrease of the signal in cycle 
34. The sequence of the N-terminal of Hoa-CPRP2 (residues 1 to 10) was confirmed by 
manual Edman degradation of 2 nmol of purified peptide. The ES/MS analysis demonstrated 
that the peak denoted as Hoa-CPRP2 consists of a mixture of two peptides with molecular 
weights of 3546 Da and 3563 Da (not shown). The mass of 3546 Da fully agrees with the 
peptide sequence of Hoa-CPRP2 presented in Fig. 3. 
1 10 20 
Hoa-CPRP2: N H 2 ~ * r 9 " S e r - v a l - G l u - G l y - V a l - s e r - A r g - H e t - G l u - L y e - L e u - L e u - S e r - S e r - I l e - s e r - P r o - S e r - S e r -
21 30 3} 
Thr-Pro-Leu-Gly-Phe-Leu-Ser-Cln-Aep-Hie-SQr-Val-Aen-COOH 
1 10 20 
Orl-CPRP : NH2-Arg-Ser-Val -Glu-Gly-Ser-Ser-Arg-Ket -Glu-Arg-Leu-Leu-Ser-Ser-Gly-Ser-Ser-Ser-Ser-
21 30 33 
Glu-Pro-Leu-Ser-Phe-Leu-Ser-Gln-Asp-Gln-Ser-Val-Asn-COOH 
(Ser-COOH)' 
Fig. 3. Amino acid sequences of Hoa-CPRP2 and Orl-CPRP as obtained by Edman 
degradation of HPLC purified peptides. Asterisk indicates the carboxyl-terminal Ser of a 
second Orl-CPRP, found in minor amounts compared to the CPRP having an Asn as a 
terminal amino acid. 
The characterization of Hoa-CPRPl was limited to the determination of the amino acid 
composition. About 100 pmol of Hoa-CPRPl were hydrolyzed, derivatized and the 
composition of the peptide was analyzed. The obtained results, presented in Table I, 
demonstrate a great resemblance with the amino acid content of Hoa-CPRP2. The main 
differences are found in the contents of Ser and Ala, being 3, resp. 2, in Hoa-CPRPl, and 6 
resp. 0, in Hoa-CPRP2. 
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Table I. Amino acid composition of Hoa-CPRPl * 
Amino acid Amount (pmol) Number of residues 
Asx 
Thr 
Ser 
Glx 
Pro 
Gly 
Ala 
Val 
Met 
Leu 
Phe 
His 
Lys 
Arg 
154.75 
65.40 
196.36 
186.80 
86.93 
155.82 
127.03 
190.56 
100.06 
377.50 
104.09 
67.35 
70.75 
167.04 
2-3 
1 
3 
1 
3 
2-3 
2 
3 
1-2 
6 
1-2 
1 
1 
2-3 
* Ile and Туг were not detected; Cys and Trp were not determined. 
Orl-CPRP 
Peptide material isolated from 100 sinus glands (3 nmol) was used for automated 
Edman degradation. During the first two cycles the recovery of Arg and Ser was very low, 
with an improved recovery and high repetitive yields starting from cycle 3 (Val). The results 
of the sequence analysis are summarized in Fig. 3. The carboxy-terminal end could not 
unambiguously be established by sequence determination since cycle 33 indicated the presence 
of Asn as well as Ser. Therefore both are included in the sequence. The results from ES/MS 
indicate also that Orl-CPRP is in fact a mixture of two peptides with molecular weights of 
3517 Da and 3545 Da (data not shown). The lower mass fits exactly with the peptide sequence 
containing a Ser as last amino acid, while the higher mass agrees fully with the sequence 
having a terminal Asn. 
DISCUSSION 
Isolation and purification of CPRPs 
This chapter describes the isolation and amino acid sequence of three similar 
neuropeptides from SGs of two decapod crustacean species. In view of the rather high 
sequence identity between these peptides, the sequence of peptide H from С carnifex [161] 
and the predicted sequence of the C-peptide from C. maenas [243] (and the established peptide 
sequence Cam-CPRP [68]) it is likely that these peptides all belong to a novel family of 
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neuropeptides. These peptides are synthesized as part of the CHH precursor and are therefore 
referred to as CHH Precursor-Related Peptides (CPRPs). 
Automated Edman degradation of Hoa-CPRP2 revealed one peptide sequence with a 
calculated Mw of 3546 Da. In contrast, the ES/MS analysis gave two Mws of 3546 and 3563 
Da respectively. We did not observe any heterogeneity during sequencing, but at this stage we 
cannot preclude the presence of an additional, closely related peptide. Alternatively, the two 
different Mws might also be the result of an amino acid side chain modification of a fraction 
of the peptide material. 
Hoa-CPRPl was characterized by analysis of the amino acid composition. These 
results suggest the presence of least two Ala residues, which might be in agreement with the 
large amounts of Ala found in Cam-CPRP and peptide H of the crabs. The elution 
characteristics of Hoa-CPRPl in both HPLC systems also strongly suggest that this peptide 
represents a distinct CPRP in lobster SGs. This observation strengthens the hypothesis of the 
occurrence of at least two different genes encoding two sets of two CHH isoforms in the 
lobster [219;221 ¡Chapter 6 of this thesis]. We think that molecular cloning of the CHH-
precursor encoding (c)DNAs from H. americanus is the most appropriate approach for the 
determination of the sequence of Hoa-CPRPl. This strategy will also establish whether Hoa-
CPRPl is synthesized as part of the CHH A (encoding CHH 1/11) precursor or CHH В 
(encoding CHH VI/VII) precursor [219;Chapter 6] and might demonstrate the presence of 
additional CPRPs. Until the correct relation between Hoa-CPRPs and Hoa-CHHs is 
established, we prefer to designate the Hoa-CPRPs, Hoa-CPRPs 1 and 2 to avoid confusing 
and suggestive numbering with capitals or roman numerals. 
The peptide sequence analysis of Orl-CPRP demonstrated the presence of two nearly 
identical peptides, which differed in the COOH-terminal residue. It can be calculated that the 
peptide with Asn as last residue has a Mw of 3545 Da and the Orl-CPRP with Ser has a Mw 
of 3517 Da. These Mws fully agree with the data obtained from the ES/MS analysis. The 
amino acid sequence is also identical with the recently cloned cDNAs encoding O. limosus 
CHH precursors, predicting the existence of at least two different mRNAs encoding an Asn or 
a Ser at position 33 (Chapter 7). 
Comparison of CPRP sequences 
Alignment and comparison of the CPRP sequences, including the amino acid sequence 
of peptide H of C. carnifex [161] and the sequence of the C-peptide of C. maenas as 
determined by protein purification and sequence analysis (Cam-CPRP [68;222] shows a 
number of interesting features (Fig. 4). The highest sequence conservation among all four 
CPRPs is present in the N-terminal regions (residues 1-13) which suggests a low acceptance 
of mutational changes in this part of the peptides. In contrast, the C-terminal region is only 
conserved among the two crab species on the one hand and the lobster and crayfish on the 
other hand. Additionally, the differences in length between the CPRPs from the four species 
indicates the biological insignificancy of the C-terminal end. Interestingly, the differences in 
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Cam-CPRP 
Peptide H 
Hoa-CPRP2 
Orl-CPRP 
R S 
R S 
R S 
R S 
Τ Q 
λ D 
V E 
V E 
Y G 
F G 
V S 
S S 
R И 
R И 
R M 
R M 
D R I 
E S L 
Ε К L 
E R L 
A A L Κ Τ 
Τ S L R G 
S S I S Ρ 
S S G S S 
Ρ M Ε Ρ S A A 
A - E S Ρ A A 
S - Τ Ρ L G F 
S - Ε Ρ L S F 
A V Q H G T T H P L E 
G - E A S A A H P L E 
S Q D H 5 V N 
S Q D Q S V N(S)' 
Fig. 4. Comparison of the sequences Cam-CPRP [68;222], Peptide H [161], Hoa-CPRP2 and 
Orl-CPRP. Gaps were introduced [193] to improve sequence alignment. Boxes indicate 
conserved residues in all four peptides. Amino acids are given in the standard one-letter 
code. Arrow indicates a putative processing site. Asterisk indicates the carboxyl-terminal Ser 
of a second Orl-CPRP, found in minor amounts compared to the CPRP having an Asn as 
terminal amino acid. 
sequence conservation seem to reflect the diverged evolution pattern of the four decapod 
crustacean species. Nowadays, crabs (Brachyura) and lobster/crayfish (Astacidea) are 
classified into two different infra-orders: the lobster, H. americanus, and the crayfish, O. 
limosus, belong to one family (Astacidae), while the terrestrial, C. carnifex, and the shore 
crab, C. maenas, are grouped into two separate superfamilies (Grapsidoidea resp. 
Portunoidea). The astacidean-palinuran lineage can be traced back to a common ancestor 250 
million ago, while the Brachyura have evolved from the palinuran line 130 million years ago 
[182]. Calculations of the overall sequence identity and similarity (summarized in Fig. 5) 
indeed show a stronger resemblance between lobster and crayfish CPRPs compared to the 
CPRP sequence conservation between both crab species. 
Fig. 5. Sequence identity (upper, right side of the 
diagonal) and sequence similarity (lower, left side of 
diagonal) among the four CPRPs. Values are given 
in percentages and are calculated according to [193] 
using the alignment in Fig. 4. (Asn was taken as last 
amino acid for Orl-CPRP). 
\ ID 
S I M \ 
Cam-
CPRP 
Pepude 
H 
Hoa-
CPRP2 
Ort-
CPRP 
Cam-
CPRP 
\ 
72.2 
57.6 
54.5 
Peptide 
H 
47.2 
\ 
59.4 
56.3 
Hoa-
CPRP2 
30.3 
37.5 
87.9 
Orl-
CPRP 
33.3 
40.6 
78.6 
\ 
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Possible functions ofCPRPs in relation to CHH biosynthesis 
CHH of C. maenas is synthesized as part of a precursor protein, which contains a 
putative signal peptide followed by the C-peptide (Cam-CPRP), a dibasic (Lys-Arg) processing 
site and finally, at the C-terminal end of the prohormone, CHH [243]. The same 
preprohormone structure has recently been established in our laboratory for the CHH-
precursors of two crayfish species, Orconectes limosus (Chapter 7) and Procambarus clarkii 
(manuscript in preparation; DPV de Kleijn pers. comm.) and seems, therefore, to be the 
ubiquitous mode of CHH biosynthesis in Crustacea. These conserved structures of the CHH-
precursors suggest a role for CPRPs in CHH-biosynthesis in two ways: (i) to ensure the 
correct folding of the prohormone, thus exposing the appropriate cleavage sites to processing 
enzymes, (ii) to assure the proper assignment of cysteine bridges within CHH. In both cases 
the CPRPs are likely to be colocalized with CHH throughout the secretory pathway, which 
can be studied at the electronmicroscopic level using antibodies raised against CPRPs and 
CHH. On the other hand, such studies may reveal that CHH and CPRP become sorted and 
packaged into distinct vesicles. Recently, such sorting processes were described for 
neuropeptides emerging from the N-terminal and C-terminal site of a common precursor 
protein [63;195;232]. 
At present no biological activity of CPRP is known. Such activity could be assigned to 
intact CPRPs or, alternatively, the CPRPs could act as biosynthetic intermediates, from which 
smaller peptides could be derived. This view is exemplified below. 
CHH-precursor processing to CPRP and CPRP-derived peptides 
Slow cleavage of peptide H, the CPRP counterpart in the crab C. carni/ex, has been 
demonstrated to occur at the single Ser" and the single Arg17 [161;162]. The elucidation of 
CPRP sequences from evolutionary distinct decapod crustaceans, as presented in this chapter, 
gives the opportunity to determine whether these proposed processing sites are conserved. 
Such a conservation might consequently imply a potential physiological role for smaller end 
products resulting from cleavage at these sites. In general, endoproteolytic cleavage of 
(neuro)peptide precursors can occur at monobasic sites, although this process is very slow 
compared to the more common proteolytic processing at dibasic sites [184]. The actual use of 
both mono- and dibasic sites for cleavage is not only depending on the presence of processing 
enzymes within elementary granules but also on other parameters such as the type of the 
surrounding amino acids [21;85;184] or secondary structural features [14;1741 of the 
precursor protein to be processed. With this in mind we have analyzed the CPRP sequences to 
see whether the primary or secundary structure may give an indication for putative processing 
sites. We used the Chou-Fassman (CF; [44]) and Garnier-Osguthorpe-Robson (GOR; [67]) 
rules for prediction of α-helices, /î-sheets and reverse turns and the algorithm of Век and 
Berry [14] for Ω loop prediction [14]. 
All CPRPs have only one monobasic site (Arg8) in common. The only structural 
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indication for putative processing at this position might be the presence of a CF-turn in close 
proximity of this Arg in the case of peptide H, Cam-CPRP and Orl-CPRP but not for Hoa-
CPRP2. The preponderance of prohormone cleavage sites near reverse turns was demonstrated 
by [174]. However, Arg' is apparently not used since no cleavage at this position was 
observed for peptide H [162]. 
Another potential cleavage site is at position 11. Despite the presence of an 
unconventional processing site (Ser) at this position in peptide H, the actual cleavage at this 
residue was established [162]. The primary structures of Cam-and Orl-CPRP and Hoa-CPRP2 
give additional evidence for putative processing of CPRPs at this site for the following 
reasons, (i) It is proposed that monobasic amino acids (mostly Arg and occasionally Lys) 
involved in cleavage of prohormones are located in a region rich in Ala and He or Leu and are 
preceded by an Arg at 3, 5 or 7 amino acids before this cleavage site [21]. The Arg at 
positions 11 in Cam- and Orl-CPRP and the Lys in Hoa-CPRP2 all meet these criteria, (ii) 
Dibasic prohormone processing sites appear to consist of at least five to seven amino acids 
including the doublet of basic amino acids preceded N-terminally by a strongly polar and/or 
monobasic residue [85]. This "consensus" fits remarkably well as to the use of residue 11 as 
monobasic processing site, with an Asp10 in the case of Cam-CPRP, a Glu10 for peptide H, 
Hoa-CPRP2 and Orl-CPRP and the monobasic Arg8 in all four peptides. Secondary structure 
prediction shows only for Orl-CPRP that the Arg" is situated in a GOR-reverse turn and 
adjacent to a CF-reverse turn, while no turns in the near region are predicted for Cam-CPRP, 
Hoa-CPRP2 or peptide H. Application of the Ω loop prediction program [14] demonstrates 
that residue 11 of Orl-and Hoa-CPRP2 can be assigned to the neck of a Ω loop [136], which 
consists of residues 15 to 22. Although the proposed relation between prohormone cleavage 
sites and neck regions of Ω loops has thusfar only been reported for dibasic sites [14], it might 
also be valid for Orl-CPRP and Hoa-CPRP2. We think, however, that the total absence of Ω 
loops in peptide Η and Cam-CPRP argues against the importance of loop structures for 
processing of CPRPs, since conservation of this loop structure during evolution would have 
been required. 
A further putative internal processing site is at position 17, consisting of an Arg in 
peptide H, a Lys in Cam-CPRP and Ser in Orl-CPRP and Hoa-CPRP2. Although cleavage at 
this site has been reported [161] and the presence of a CF-reverse turn can be predicted for 
peptide H, we found no additional indications for processing at this site based on structural 
characteristics of the other CPRPs. Therefore it seems unlikely that the CPRPs are cleaved at 
this site. 
Finally, analysis of the secondary structures of the CHH precursors (assuming the 
presence of Lys-Arg between Homarus CPRP and CHH) demonstrates a significant correlation 
of GOR-reverse turns with this Lys-Arg for the CHH prohormones of C. maenas, H. 
americanus and O. limosus. This supports the significance of the presence of reverse turns at 
dibasic processing sites [174]. Interestingly, the conservation of strongly polar 
(Glu/Asp/Ser/Gln) residues near the C-terminal end of all CPRPs (and peptide H) might 
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indicate their importance as part of a processing recognition site [85]. 
In conclusion, we think that all CPRPs and peptide H are biosynthetic intermediates 
which can be processed at amino acid residue 11. Añer cleavage, and subsequent Arg or Lys 
removal, this results in a decapeptide with a high overall sequence identity among all four 
decapod crustacean species. We are aware of the fact that monobasic cleavages are very slow, 
but there is substantial evidence for long time storage of neuropeptides in SGs, thus enabling 
such cleavage reactions to occur. The complete turnover of the SG peptide pool of С 
camifex, on the basis of in vitro biosynthesis studies appears to require months [162]. 
Furthermore, the maximum observed in vivo release of CHH in O. limosus is limited to 
approximately 500 fmol/ SG [120] which comprises only 1-2% of the stored amount of CHH 
in SGs. Finally, electronmicroscopical studies demonstrated only limited degradation of CHH-
granules in axon terminals (JL Kallen, pers. comm.)· We therefore postulate that even slow 
processing events can yield enough mature peptide material to be released simultaneously with 
CHH, allowing the two neuropeptides to mediate distinct physiological responses. 
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CLONING AND SEQUENCE ANALYSIS OF cDNAs 
ENCODING TWO CRUSTACEAN HYPERGLYCEMIC 
HORMONES FROM THE LOBSTER, 
HOMARUS AMERICANOS 
Chapter б 
ABSTRACT 
Using the Polymerase Chain Reaction with degenerated oligonucleotides derived from amino 
acid sequences, we have isolated cDNA clones that encode two structurally different (92% 
identity) Crustacean Hyperglycemic Hormones (CHHs) from the lobster Homarus americanus. 
The deduced amino acid sequences fully agree with previously published partial amino acid 
sequences, amino acid compositions and molecular masses of hyperglycemic peptides in the 
lobster. A comparative analysis between the deduced primary structure of the two lobster 
CHHs and the crab CHH sequence reveals a phylogenetic relationship and allows the 
prediction of biologically important regions within the structures of this novel family of 
neuropeptides. 
This chapter is the extended thesis version of a manuscript entitled: 
Cloning and sequence analysis of cDNAs encoding two crustacean hyperglycemic hormones from 
the lobster Homarus americanus By: 
CP Tensen, DPV de Kleijn and F Van Негр 
Eur J Biochem (1991) in press 
Part of this chapter is also presented in the form of an abstract entitled: 
Primary structure of cnistacean hyperglycemic hormone (CHH) and related peptides in the lobster 
by amino acid sequencing and cDNA analysis. By: 
CP Tensen, F Van Негр, DPV de Kleijn and JL Kallen. 
Gen Comp Endocrinol (1991) 82: 284 
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INTRODUCTION 
Various physiological processes in decapod Crustacea are regulated and modulated by 
the X-organ sinus gland complex. This neuroendocrine system is situated in the optic ganglia 
of the eyestalk and consists of neurosecretory cell somata with clustered axon endings that 
form a neurohaemal organ, the sinus gland (SG). Two classes of small neuropeptides 
controlling color change by dispersing or concentrating chromatophores have been isolated 
from SGs of numerous crustacean species and their amino acid sequences have been 
determined (see [71; 172] for Reviews). 
The Crustacean Hyperglycemic Hormone (CHH), involved in the regulation of blood 
sugar levels and glycogen metabolism [122], belongs to a third class of intensively studied 
crustacean neuropeptides. This hormone was shown to be polymorphic and is generally found 
as two closely related isoforms of 6 - 8 kDa [93;124;162]. Despite the presence of high 
amounts of CHH in SGs, until now only the amino acid sequence and the partial cDNA 
sequence encoding its polypeptide precursor of the most abundant form of CHH from the crab 
Carcinus maenas have been elucidated [110;243]. Recently, a first report has been published 
on the amino acid sequence of a crustacean Molt Inhibiting Hormone (MIH), a hormone 
which retards molting in the lobster, Homarus americanus [38]. This neuropeptide however, 
has also a significant hyperglycemic activity and is therefore expected to belong to the family 
of hyperglycemic hormones in Crustacea. 
Using peptide mapping. Fast Atom Bombardment/ Mass Spectrometry (FAB/MS) and 
partial amino acid sequencing, we and others characterized two sets of two CHH isoforms in 
SGs from the lobster H. americanus [199;217;221]. Although structurally related, differences 
in the amino acid sequences are present between the two sets of isoforms. One of these 
differences could be detected by direct amino acid sequencing, whereas others were expected 
on the basis of amino acid compositions, iso-electric points and molecular masses. 
In this chapter, we used sets of degenerated oligonucleotide primers based on partial 
amino acid sequences for amplification of lobster CHH encoding cDNAs by the Polymerase 
Chain Reaction (PCR). The cloned cDNAs encode the complete sequences of two structurally 
different hyperglycemic neuropeptides. The deduced peptide sequences are compared with the 
sequence of crab CHH [110;243] and their relationship with the lobster MIH is discussed. 
MATERIALS AND METHODS 
ChemicaL· Guanidinium thiocyate was from Fluka. CsCl and LMP agarose were from 
Gibco-BRL. Restriction endonucleases were obtained from Gibco-BRL or Pharmacia. All 
general (A.R. grade) and other biochemicals were, unless otherwise stated, from Merck or 
Boehringer Mannheim. 
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Animals Specimens of the lobster H. americanus were purchased from a commercial 
importer and originated from the east coast of Canada. Lobsters were kept in the laboratory in 
aerated artificial seawater at about 5 "C and were sacrificed within two days after arrival. 
RNA isolation Total RNA of whole eyestalks was prepared by the guanidinium 
thiocynate/CsCl procedure [42]. Briefly, batches of 10 eyestalks, dissected from animals 
immediately after sacrifice, were ground to a fine powder in liquid nitrogen using a pre-cooled 
mortar and pestle. One g of powder was homogenized in 10 ml guanidinium thiocyanate 
solution (4 M guanidinium thiocyanate, 12.5 mM EDTA, 12.5 mM Tris-HCl, pH=7.6, 0.5% 
sarcosyl, 0.1 M 2-mercaptoethanol) and centrifuged to remove particulate material. The 
supernatant was then layered over 3.5 ml of 5.7 M CsCl and 100 mM EDTA in 14 χ 89 mm 
Beekman polyallomer ultracentrifuge tubes and centrifuged overnight (20 hr) in a Beekman 
SW 40 Ti rotor at 135.000 g (32.000 rpm) at 20 "C. Total RNA was recovered from the 
bottom of the tubes, resuspended in 400 μΐ STE (STE=10 mM Tris-HCl pH 7.5, 5 mM 
EDTA, 0.1% sarcosyl), extracted with an equal volume of phenol to remove remaining retinal 
pigments and precipitated with ethanol. Precipitated RNA was dissolved in bidest and the 
concentration was determined by absorbance at 260 nm, whereby Λ,«^! corresponds to 40 
μg/ml. One eyestalk yielded approximately 20 ^g of total RNA. 
Synthesis of oligodeoxynucleotide primers Mixed oligonucleotides based on partial 
amino acid sequences which are identical between all four CHHs, were synthesized with a 
DNA synthesizer (Applied Biosystems Inc., model 381 A) and purified on Sep-Рак C-18 
cartridges (Waters) [177]. The sequences of the primers are shown in Fig. 1. 
cDNA synthesis. Twenty μg of total eyestalk RNA was dissolved in 10 μΐ 2x Reverse 
Transcriptase (RT)-buffer (lOxRT-buffer is 500 mM Tris-HCl, pH 8.3 at 22 "C, 750 mM 
KCl, 30 mM MgCy containing 20 pmol of primer 3. This sample was heated for 3 min at 65 
0 C, and slowly cooled to 37 0C over 1 h. cDNA synthesis was accomplished by using 200 
Units cloned Moloney murine leukemia virus reverse transcriptase (M-MLV RT, Gibco-BRL) 
in a final reaction volume of 20 μΐ RT-buffer containing 500 μΜ of each dNTP, 35 Units 
RNAsin (Promega) and 10 mM DTT. After incubation for 1 hr at 37 "C the cDNA was 
diluted to 500 μΐ with bidest and stored at -20 CC until use. 
Amplifications. Two amplification protocols (A and B) were followed, depending on 
the primers used. This two-step approach was chosen, since primer 3 (used for starting the 
cDNA synthesis) was rather short (17-mer) to optimalize specific RNA priming. For this 
reason, production of large amounts of nonspecific PCR products was expected, if this primer 
was used in combination with primer 1. 
(A) Amplification between primers 1 and 2 was done in 100 μΐ of 1 χ Taq-buffer (10 χ Taq-
buffer is 500mM KCl, ІООтМ Tris-HCl, pH 8.4 at 22 "C, 30 mM MgClj, 2mM dNTP and 1 
mg/ml gelatine) containing 10 μΐ of the diluted cDNA pool, 100 pmol of each primer 1 and 2 
and 1.5 Units of Taq polymerase (Amplitaq, Perkin-Elmer/Cetus). The mixture was overlaid 
with 50 μΐ mineral oil and forty cycles of PCR in a Perkin-Elmer/Cetus DNA cycler were 
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Protein 
Sequence A 
(Priser 1) 
Protein 
Sequence В 
(Priser 2) 
Protein 
Sequence С 
(Priser 3) 
1 
pGlu 
S'-CGGAATT 
(rcoR 
22 
Val eye 
Э'-CAN ACR 
Aon Val 
l'-TTR CAM 
.SAR 
I) 
Glu 
CTY 
Gin 
GTY 
Val Phe Asp Gin 
GTN TTY GAY CAR 
Asp Суе Туг Авп 
CTR ACR ATR TTR 
end 
Met Val (aside) 
TAC CAN CC-5' 
β 
Ala cya Lye 
GCN TGY AA-3' 
29 
Leu 
RA ÇÇTAÇÇCC-5 
(ВаяН I) 
Fig. 1. Sequences of three peptide fragments conserved among all CHH isoforms of the 
lobster Homarus americanus. Each fragment was backtranslated to all possible DNA 
sequences that could potentially encode the stretch of amino acids. The oligonucleotide 
primers and there respective codes within parenthesis are presented below the peptide 
sequences. 
In fragment A, spanning amino acids 1-8, the pyroGlu in the mature neuropeptide is thought 
to be the result of an enzymatic modification of Gin present in the precursor protein; 
therefore the sequence CAR was included in the oligonucleotide. In fragment C, expected to 
be the carboxy terminal end of the amino acid sequence, the presumed presence of the amide 
group is thought to be donated by a Gly in the prohormone; therefore CC was included at the 
5' end of the oligonucleotide. The nucleotide sequences are presented with the following 
codes: Y, either deoxythymidine (T) or deoxycytidine (C); R, either deoxyadenosine (A) or 
deoxyguanosine (G); N, either A, G, С or T. 
carried out: denaturation at 94 "C, 30 sec; annealing at 60 °C, 2 min; extension at 72 °C, 3 
min; final extension for 10 min at 72 "C. 
(B) Amplification between primers 1 and 3 was performed as described in A, except that 
primer 2 was replaced by primer 3 (100 pmol) and the annealing took place at 45 "C. 
Cloning strategy and DNA sequencing. Amplified cDNA, synthesized by protocol A 
was phenol extracted, cut with EcóR I and ВшлН I, and size selected on Low Melting Point 
agarose. A 100-bp band was extracted from the gel using the freeze/squeeze method [215] and 
cloned into M13mpl8 or M13mpl9 [244]. Recombinants were transformed to and propagated 
in E. coli (JM 101) and the nucleotide sequences were determined with the dideoxy 
sequencing method [177] using modified T7 and Taq polymerase (Promega). Twenty μΙ of the 
amplified cDNA from protocol В was first size selected on an agarose gel, denatured, 
transferred to nitrocellulose [177] and hybridized with a labeled 100-bp cDNA synthesized in 
first amplification protocol. DNA fragments were labelled and detected using the 
digoxigenine-[ll]-dUTP labelling and detection kit (Boehringer Mannheim). Hybridization was 
performed exactly as described in [125]. Bands that hybridized were isolated from the 
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remaining amplification mixture in a similar way as described above. After phenol extraction 
the amplified cDNAs were cleaved with EcoR I, size selected on and extracted from LMP 
agarose and cloned into EcoR I/ Sma I-cleaved M13 mpl8 or 19. Single stranded DNA from 
recombinants was hybridized with the aforementioned 100 bp cDNA fragment and hybridizing 
clones were sequenced as described. 
RESULTS AND DISCUSSION 
Generation and characterization ofcDNA clones encoding two hyperglycemic hormones. 
The use of the PCR with degenerated oligonucleotide primers, derived from partial 
amino acid sequences has been shown to be a successful technique for the amplification of 
specific cDNAs [79;135;213]. We used this technique in a two-step approach to obtain the 
complete sequences of two cDNAs encoding two different, yet related, CHHs from the lobster 
Homarus americanus. We have shown in a previous paper [221; Chapter 3] that sinus glands 
from the lobster contain four CHH isoforms, designated as CHH I, II, VI and VII. These 
peptides could be divided into two groups of two closely related peptides (1,11 and VI,VII). No 
differences were found in amino acid composition or sequence between peptide I and II 
respectively VI and VII. Between both groups discrimination was possible on the basis of the 
amino acid sequences (an Asp on pos 20 for I/II and an Asn on pos 20 for VI/VII) and amino 
acid composition, indicating additional differences between the two groups. Apart from 
determining the N-terminal amino acid sequence, we were also able to establish the C-terminal 
end sequences which were identical in the four CHH isoforms. For this reason we choose to 
use the PCR in combination with degenerated oligonucleotides for specific amplification of 
cDNAs encoding the complete primary structure four CHH isoforms. 
Total eyestalk RNA was converted into cDNA by priming with primer 3 and 
amplifications were performed between primer 1 (encoding amino acids 1-8) and primer 2 
(anti-sense to amino acids 22-29) stretches of amino acids identical in all CHH isoforms. The 
PCR reaction yielded one expected product of 100 bps (not shown). Sequence analysis of 
eleven recombinants, containing this 100 bps PCR product, revealed the presence of two 
different CHH encoding cDNAs. The two cDNAs differed in that seven clones predicted an 
Asn on position 20, while from four other clones an Asp in this position could be deduced. 
These cDNA sequences fully agreed with the amino acid sequences obtained after automated 
Edman degradation [Chapter 3] indicating successful priming of the cDNA by primer 3. 
Moreover, the insert of one of these clones could be used to screen the PCR products obtained 
after amplification between primers 1 and 3. Of the approximately 6 bands, ranging from 75-
500 bp, two bands hybridized (220 bps and 380 bps). The obtained sequences from the 220 bp 
cDNAs, which are summarized in Fig. 2, encode the complete structures of two different 
CHHs. Fourteen hybridizing clones were sequenced, from which 9 coded for the CHH A 
form, while the remaining five clones encoded the CHH В form. Between recombinants, one-
base differences outside the primer regions were occasionally found. However, these 
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χ 60 
Ргітег-І • . . . . 
CHH В 5' a— 
CHH A 5' car gtn tty gay car gen tgy aag ggc gtg tat gac cgc aac etc ttc aag aag ctg gac 
CHH A Gin Val Phe Asp Gin Ala Cys Lys Gly Val Туг Asp Arg Asn Leu Phe Lys Lye Leu Asp 20 
CHH В a * * * * » * * * « » * * · * * * * * Asn 
120 
4 Priner-2 . . . . 
CHH В а 1 
CHH A egt gtg tgt gag gac tgt tac aac etc tac cgc aaa cet ttc gtc gee acc acc tgc agg 
CHH A Arg Val Cys Glu Asp Cys Туг Asn Leu Tyr Arg Lys Pro Phe Val Ala Thr Thr Cys Arg 40 
CHH В * * * * · * # * * * * * * * Ile Val * * * * 
180 
CHH В —с с-а а 1-
CHH A gag aac tgc tac agt aat tgg gtg ttc cgt caá tgt etc gac gac eta etc ttg agt gat 
CHH A Glu Asn Cys Туг Ser Asn Trp Val Phe Arg Gin Cys Leu Asp Asp Leu Leu Leu Ser Asp 60 
CHH В * * * * * * Arg * * * * * * * * * * Met Ile * 
218 
•« Ргіпег-З 
CHH В — -3' 
CHH A gtg atc gac gag tao gte tec aay gtn car atg gtn ce -3' 
CHH A Val Ile Asp Glu Tyr Val Ser Asn Val Gin Met Val(Gly) 73 
CHH В * * * * * * * * * * * * * 
Fig. 2. Nucleotide sequences of the coding strands of PCR produced cDNAs encoding two 
different CHHs (A,B) and the deduced amino acid sequences. Dashed lines and asterisks 
represent identical nucleotides and amino acid residues, respectively. Arrows above 
nucleotides 1-23, 64-86 and 202-218 show the positions of the oligonucleotide primers and 
their direction. Nucleotides in the regions of primers 1 and 3 are represented according to the 
codes as in Fig. 1, since no preference for a certain sequence was observed. 
substitutions were never at the same position and are considered to be errors introduced by the 
Taq polymerase rather than that they indicate the occurrence of additional CHH or CHH-
related peptides. 
From the two deduced peptide sequences, assuming that the Gin on position 1 is 
enzymatically modified to a pyroGlu and that the Gly at position 73 can result in an amide in 
the mature peptide, it can be calculated that the CHH A cDNA encodes a peptide of 8583 Da 
and CHH В cDNA a peptide of 8638 Da. In Chapter 3 we determined by FAB/MS a 
molecular mass of 8578 Da for CHH II and of 8656 +/- 25 Da for CHH VII. Recently, 
Soyez et al. [199] determined by FAB/MS a molecular mass of 8577 Da for two acidic 
isoforms and of 8633 Da for two other more basic isoforms of hyperglycemic neuropeptides in 
the lobster H. americanus. We therefore conclude that our cDNA sequences encode the 
complete amino acid sequences of two CHHs. Talcing into account the reliability of the mass 
determination (± 0.5 Da), the difference of 5 or 6 Da can be the result of the formation of 
three disulphide bridges in the mature peptides. Comparison of the calculated ¡so-electric 
points of the two forms, assuming blocked N-and C-termini, predicts CHH A (pi = 4.7) to be 
more acidic than CHH В (pi = 6.3). 
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Each of the lobster CHHs appears to have an isoform with an identical amino acid 
sequence [221]. Our data suggest the presence of only two different cDNAs. The two isoforms 
could occur as a result of a posttranslational modification (not detectable with the FAB/MS 
method e.g., a L-amino acid to a D-amino acid) or because of different peptide folding 
resulting from a different arrangement of the disulphide bridges. 
Preliminary sequence analysis of the larger hybridizing PCR products (380 bps) 
suggests that this product results from partially or unspliced CHH-B encoding pre-mRNAs and 
is therefore designated CHH B-R(etained)I(ntron). Its sequence as deduced from two clones 
with an identical sequence, is presented in Fig 3. This PCR product does not arise from 
contaminating DNA in the RNA/cDNA preparation since amplification of Hin dill digested 
genomic DNA with primer combination 1/3, under the conditions of protocol (B), yields one 
hybridizing fragment of approximately 1600 bps, while no products of 400 bps were found 
(not shown). The retained intron sequence carries two stop codons that preclude translation of 
the final open reading frame which is not shifted by the 159 bps intronic sequence. In this way 
the addition of an extra protein domain to the corresponding CHHs is prevented. In contrast, 
the translation of the CHH-B preceding sequence, which might encode a CPRP (See Chapter 
5), could give rise to one or more (if duplicated and subsequently mutated) additional CPRPs. 
The retained intron might be created by base substitutions at the bounderies of the exon/intron 
and intron/exon junctions resulting in the incorporation of the intron sequence [28]. 
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cgt 
caç 
gaa 
tta 
gtg 
aay 
gtn 
gtg 
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ctg 
agt 
ttc 
gtn 
tty 
tgt 
tgt 
ttc 
gat 
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car 
gay 
gag 
ttt 
ctt 
egg 
caa 
atg 
car gen tgy aag 
gac tgt tac aac 
gag ggc gac аса 
200 
gag ttc agg gta 
agg gga gga gga 
tgt etc gac gac 
377 
gtn cc -3' 
ggc 
etc 
ttc 
tag 
agg 
eta 
gtg 
tac 
сед 
ate 
tgt 
etc 
tat 
cgc 
agg 
aag 
аса 
atg 
gac 
aaa 
tgt 
ggg 
ада 
att 
cgc aac etc 
100 
cet ttc ate 
gtg atg gac 
tag act cac 
tgg gag aac 
gat gtg ate 
ttc 
gtc 
ctt 
act 
tgc 
gac 
aag 
ace 
gga 
caa 
tac 
gag 
aag 
ace 
ctt 
gtc 
agt 
tac 
ctg 
tgc 
gac 
tct 
aac 
gtc 
gac 
agg 
ctg 
ace 
300 
cga 
tec 
Fig. 3. Nucleotide sequences of the coding strand of PCR produced cDNAs of 377 bps 
(CHH B-RI). Arrows above nucleotide 1-23, and 361-377 show the positions of the 
oligonucleotide primers and their direction. Nucleotides in the regions of primers 1 and 3 are 
represented according to the codes as in Fig. 1. Italics indicate the inserted sequence, stops 
are underlined. 
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Amino acid comparison of lobster CHHs with other members of the CHH family. 
The amino acid sequence of Homarus MIH has recently been determined from a 
doublet of closely related peptides with both molt inhibiting and hyperglycemic activities [38]. 
The striking resemblance between the deduced amino acid sequence of CHH A and the 
sequence of MIH suggests that our cDNA CHH A sequence encodes MIH (Fig. 4). The only 
difference in structure concerns the replacement of Asn-60 in MIH by Asp-60 in CHH A, 
while MIH consists of 71 amino acids and the CHH A sequence predicts 72 amino acids with 
an additional amidated Val at the C-terminus. We propose that Met-71 might not be the actual 
C-terminus of Homarus MIH for the following reasons. Firstly, the reported amino acid 
composition of a peptide fragment from Homarus MIH, fully agrees with our carboxyterminal 
end of CHH A over residues 66 to 72 (Asx 1, Ser 1, Glx 1, Met 1 and Val 3) [37]. Secondly, 
in the crab С maenas, the C-terminus of CHH was initially thought to be Met-71 using the 
same method as employed for the determination of the carboxylterminal end of MIH. 
Subsequently, however, on the basis of additional peptide analysis and cDNA information, the 
С-terminal end of crab CHH turned out to be an amidated Val [110;243]. Up to now we 
prefer to continue to call our HPLC-purified isoforms CHH since the hyperglycemic activity is 
associated with both well separated isoforms. Moreover, the functional role in molt-inhibition 
by the MIH, described by Chang and co-workers [37] was not established with purified 
isoforms and the molt inhibiting effect may even be attributed to other coeluting peptide(s) 
because these authors assayed the peptides after a single purification step. 
C. maenas CHH : 
H. amencanus CHH A : 
ƒƒ. a m e n c a n u s CHH В : 
H. amencanus MIH : 
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L F 
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N D 
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D R 
N R 
D R 
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V С 
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D С Y N L Y R 
D С Y N L Y R 
D С Y N L Y R 
D С Y N L Y R 
32 
Τ S Y 
Κ Ρ F 
72 
V A 
V A 
S A 
Τ Τ 
Κ Ρ F I V Τ Τ 
κ ρ F I V Α Ι Τ Τ 
С R 
С R 
С R 
С R 
N С Y S Ν 
N С Y S Ν 
N С Y S Ν 
N С Y S Ν 
V F R Q С 
V F R Q С 
V F R Q С 
V F R Q С 
D D L L MM 
D D L L I T S 
D D L L МІІ 
E F 
V I 
V I 
D D L L L S N V I 
A R K 
V S N 
V S N 
V S N 
V Q M V NH2 
V Q M V NH2 
V Q M V NH2 
V Q M f 
Fig. 4. Comparison of the deduced peptide sequences of lobster CHH (A,B) with the peptide 
sequence of a CHH from the crab, C. maenas [110] and MIH from the lobster [38]. Boxed 
amino acids indicate residues conserved between the CHH from the crab and one of the 
CHHs or MIH from the lobster. Cysteine residues are indicated by asterisks. 
91 
Chapter 6 
Comparison of the deduced amino acid sequences of CHH A and В from the lobster 
H. americanus with the sequence of CHH from the crab С maenas reveals a high degree of 
similarity (Fig. 4). Although the phylogenetic distance is about 140 million years since the last 
common ancestor [182], CHH of C. maenas matches with CHH A at 46 positions and with 
CHH В at 45 positions out of 72 residues, while all cysteine residues are at identical positions 
within the hormone structures. Despite the conserved nature of these hormones, their 
biological activity is different as cross injections with purified CHH have shown that the 
diabetogenic effect is not achieved with lobster CHH in crabs or with crab CHH in lobsters 
[137]. Closer inspection of the sequences reveals that the most pronounced structural 
differences between lobster and crab CHHs are located in three regions, namely amino acid 
residues 17 - 21, 32 - 37 and 61 - 68. In view of the difference in biological activity the 
charged amino acids within the 17 - 21 region, being part of a larger charged domain, may 
play an essential role in receptor interaction. In the crab CHH, this region contains more 
negatively charged amino acids than lobster CHHs. 
With regard to the secondary structure it may well be that the amino-terminal part of 
lobster CHH up to amino acid 52, which contains all cysteine residues of the molecule, adopts 
a globular structure, as is indeed established for crab CHH [110]. The hydrophobic C-terminal 
tail can, according to the Chou-Fasman rules [44], potentially form an α-helix and 
consequently will not be buried within the globule. This implicates that, after release into the 
hemolymph, this hydrophobic tail may interact with other proteins (carriers), of which 
hemocyanin is a likely candidate [108], or it may enable the formation of CHH 
(hetero)dimers. In addition, this domain might be important for receptor binding. 
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CLONING AND CHARACTERIZATION OF mRNAs ENCODING 
CRUSTACEAN HYPERGLYCEMIC HORMONE (CHII) PRECURSORS 
IN THE CRAYFISH, ORCONECTES LIMOSUS 
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ABSTRACT 
Polymerase Chain Reaction (PCR) experiments and sequence analysis of cloned PCR products 
were carried out in order to determine the primary structure of a precursor of the Crustacean 
Hyperglycemic Hormone (CHH). First, access was gained into a transcript encoding CHH in 
the crayfish, Orconectes limosus, by means of PCR using degenerated oligonucleotides derived 
from a CHH amino acid sequence. Next, specific oligonucleotide primers were used to obtain 
additional sequence information in the 5' and 3' direction of the CHH-encoding mRNAs. The 
PCR approach revealed the existence of at least two distinct, yet related, mRNAs encoding 
CHH-precursor proteins. Both preprohormones can upon proteolytic cleavage, in addition to 
CHH, give rise to two closely related peptides formerly already isolated from crayfish sinus 
glands. RNA transfer blot analysis indicated the sizes of the mRNA transcripts and 
demonstrated that the mRNA encoding the CHH precursor is present in the eyestalk and not in 
the hepatopancreas or green gland. 
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INTRODUCTION 
The Crustacean Hyperglycemic Hormone (CHH) is one of the neuropeptides released from the 
sinus gland (SG), the neurohemal organ of neuroendocrine X-organ (XO) cells located in the 
eyestalks of decapod crustaceans. This XO-SG system is the most prominent neuroendocrine 
regulation and integration center controlling a diversity of physiological important processes, 
such as color change, reproduction, molting and ion balance, by converting internal and 
external stimuli into adequate neurohormonal responses [229]. CHH is involved in the 
regulation of many processes: it plays an important role in glycogen metabolism, but also 
stimulates release of digestive enzymes, affects molting, is involved in the regulation of oocyte 
development and is associated with stress conditions induced by oxygen depletion and 
crowding [124;229;242]. These multifunctional properties and the availability of a convenient 
bioassay (the hyperglycemic response) led to many investigations pointing to the isolation and 
biochemical characterization of this neuropeptide from a large number of crustacean species 
[126;128]. 
With the introduction of HPLC techniques, it turned out that CHH exhibits molecular 
polymorphism. In most of the investigated species, SGs contain one or two sets of two closely 
related CHH isoforms [92;93;160; Chapters 2, 3 and 4 of this thesis]. Despite the recognized 
heterogeneity of CHH, little is known of its biochemical properties and the genetic 
mechanisms underlaying this polymorphism. To date only the amino acid sequence of the most 
abundant CHH isoform from the crayfish, Orconeaes limosas [111], the crab, Carcinus 
maenas [110] and a corresponding partial cDNA sequence encoding the crab CHH-precursor 
[243] are elucidated. In addition, the partial amino acid sequences of four CHH isoforms 
[221 ¡Chapter 3] and two different cDNAs encoding the complete CHH sequences 
[219;Chapter 6], from the lobster, Homarus americanus have been published. This chapter 
describes the cloning, sequence analysis and additional characterization of at least two distinct, 
yet related, mRNAs encoding CHH-precursors in the crayfish, O. limosus. 
MATERIALS AND METHODS 
AnimaL· 
Specimen of the crayfish, O. limosus, were obtained from local fishermen and were 
collected in the river Meuse (The Netherlands). The animals were kept in the laboratory in 
running tap water (13-15 0C) on a 12 hr light/12 hr dark cycle and were fed with fish once a 
week. 
RNA extraction 
Total RNA of dissected medullae terminales, containing the CHH-cell perikarya, 
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hepatopancreas, tail muscle and green gland were isolated with the AGPC method [43] (see 
also Chapter 9). Medulla terminalis RNA was isolated in batches of 10 medullae each and 
—100 mg (wet weight) was used of the other tissues. 
Genomic DNA extraction 
Genomic DNA was extracted from tail muscle tissue as described in [51]. Briefly, the 
tissue was immediately excisized after sacrifying the animals, minced with scissors and frozen 
in liquid nitrogen. Individual tails were ground with a mortar and pestle and the powdered 
tissue ( - 1 gram) was suspended in 15 ml digestion buffer (100 mM sodium chloride; 10 mM 
Tris-HCl, pH = 8.0; 25 mM EDTA; 0.5% SDS; 0.1 mg/ml Proteinase K) and incubated for 
16 h at 50 "C in tightly capped tubes (Greiner). Samples were thoroughly extracted with an 
equal volume of phenol/chloroform, centrifuged and the aqueous phase was transferred to 
another tube. DNA was recovered by adding 1/2 vol of 7.5 M ammonium acetate and two vol 
of 100% ethanol, winded on a glass rod, washed with 70% ethanol, dried and resuspended in 
bidest. The DNA concentration was determined by absorbance at 260 nm, whereby А
гба
 = 1 
corresponds to 50 μg/ml. One tail muscle yielded — 1 mg of genomic DNA. 
Oligonucleotides 
Mixed and unique oligonucleotides based on the partial amino acid sequence resp. 
cDNA sequences of O. limosus CHH, were synthesized on an Applied Biosystems Model 
381A DNA synthesizer and purified on Waters Sep-рак C-18 cartridges [177]. The sequences 
of oligonucleotide primers are shown in Table I. Their position on an idealized CHH cDNA 
sequence is shown in Fig. 1. SI and S2 were designed according to sequences obtained by 
amplification between two degenerated primers derived from the amino acid sequence. S3 and 
S4 were based on sequences obtained in the course of this studv. 
TABLE I. Sequences of oligonucleotide primers used in this study* 
oligo sequence 
nucleotide 5' -> 3' 
RoRi(dT17) 
Ro 
Ri 
Ml 
M2 
SI 
S2 
S3 
S4 
ATCGATGGTCGACGCATGCGGATCCAAAGCTTGAATTCGAGCTCTTTTTTTTTTTTTTTTT 
ATCGATGGTCGACGCATGCGGATCC 
GGATCCAAAGCTTGAATTCGAGCTCT 
GGGAATTCARGTNTTYGAYCARGCNTGYAA 
CCGGATCCARRTTRTARCARTCYTCRCANAC 
GTCAAGCTTCTTGAAGATGGCTCTG 
GGGAATTCAAAGGAATATACGACAGAGCCATCTT 
GGGAATTCCTCTCTCAGGACTCTCTAGACCT 
CCGGATCCTTGTTAGCTAACGCTCCACCACTAG 
* The nucleotide sequences are presented according to the IUPAC-IUB standard nomenclature [50]. 
The location of these primers on an idealized CHH-transcript is shown in Fig. 1. 
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0 M1 ?r^M2 
• M 2 1 ·» PCR 
• 51 2nd PCR 
Fig. 1. Schematic representation of the CHH-precursor and the PCR strategy. 
A. From left to right the diagram shows: the 5' untranslated region, the region coding for the 
signal peptide (hatched box), the mature CPRP (dotted box), the doublet Lys-Arg (black 
box), the mature CHH (open box) and the 3' untranslated region. 
B. Position of primers Ml and M2, both derived from the partial amino acid sequence of 
CHH. 
C. 5' Amplifications. Total RNA was primed with M2, reverse transcribed into cDNA and 
tailed with dATP. In a first step, CHH-encoding sequences were amplified using PCR in 
combination with primers M2, RoRi(dT17) and Ro. In a second step 2% of the synthesized 
PCR product was reamplified using primer Ri and SI. 
D. 3' Amplifications. Total RNA was primed with RoRid(T)17 and reverse transcribed into 
cDNA. CHH sequences were amplified using either primer combination S2/Ro or S3/Ro. 
E. Amplification of the total CHH encoding region. cDNA, as obtained under D, was 
amplified using primer combination S3/S4 and a 1500 bp PCR product was synthesized. 
Dotted line indicates the putative position of an insertionai sequence not obtained under the 
PCR conditions of D. 
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Generation ofcDNA clones encoding preproCHH 
cDNA synthesis and amplifications between mixed oligonucleotide primers.See Fig. 1 
for the scheme. Twenty ßg of total eyestalk RNA was dissolved in 10 μΐ bidest, heated at 65 
"C for 3 min and quenched on ice. The poly(A)+ mRNA content was preferentially reverse 
transcribed into cDNA by priming with 100 ng oligo d(15)T (PL Biochemicals) and using 200 
Units cloned Moloney murine reverse transcriptase (Gibco-BRL) in a final reaction volume of 
20 μΐ containing 1 χ Reverse Transcriptase (RT)-buffer (10 χ RT-buffer is 500 mM Tris-HCl, 
pH 8.3 at 22 "C, 750 mM KCl, 30 mM MgCl2), 500 μΜ of each dNTP, 35 Units RNAsin 
(Promega) and 10 mM dithiothreitol (DTT). After incubation for 1 hr at 37 "С the cDNA was 
diluted to 500 μΐ with bidest and stored at -20 "С until use. The CHH sequence encoding 
amino acids 1 to 29 was specifically amplified in the polymerase chain reaction (PCR) using 
the prepared cDNA pool and two mixed oligonucleotide primers: M 1 (sense to amino acids 1-
8) and M 2 (anti-sense to amino acids 22-29). Since the amino acid sequences of crayfish 
CHH and lobster CHHs are identical in this regions, we used the same mixtures of 
oligonucleotides, formerly also successful for the amplification of lobster CHH encoding 
cDNA sequences [Chapter 6]. Amplification was done in 100 μΙ of 1 χ Taq-buffer (10 χ Taq-
buffer is SOOmM KCl, lOOmM Tris-HCl, pH 8.4 at 22 °C , 30 mM MgCl2, 2 mM of each 
dNTP and 1 mg/ml gelatin) containing 10 μΐ of the diluted cDNA pool, 100 pmol of each 
primer and 1.5 Units of Taq polymerase (Perkin-Elmer/Cetus). The mixture was overlaid with 
50 μΐ mineral oil and forty cycles of PCR in a Perkin-Elmer/Cetus DNA cycler were carried 
out: denaturation at 94 "C, 30 s; annealing at 60 "C, 2 min; extension at 72 °C, 3 min; final 
extension for 10 min at 72 "C. The amplification mixture was phenol extracted, cut with EcoR 
I and BamH I and size selected on Low Melting Point agarose (Gibco, BRL). The expected 
100 bp product was recovered from the agarose [215], cloned into pBluescript KS-I-
(Stratagene), transformed to and propagated in E. coli and sequenced. 
cDNA synthesis and 5' amplifications. See Fig. 1. This was performed as described by 
Frohman et al.[64]. Briefly, ten μg of total MT-RNA was dissolved in 10 μΐ 2 χ RT-buffer, 
containing 10 pmol of primer M2. This sample was heated for 3 min at 65 0C, and slowly 
cooled to 37 0C over 1 h. cDNA synthesis was accomplished by using 200 Units M-MLV 
RT, in a final reaction volume of 20 μΐ RT-buffer containing 500 μΜ of each dNTP, 20 μΟ 
[α-32] dATP (Amersham), 35 Units RNAsin (Promega) and 10 mM DTT. After incubation for 
1 h at 37 e C the cDNA was passed through a Biogel A 50 M column made up in a Pasteurs 
pipet. This 1.5 ml column was first equilibrated with 0.05 χ TE (1 χ TE = 10 mM Tris, pH 
8.0, 1 mM EDTA) and one drop fractions were collected. Fraction -3 to +4 relative to the 
first drop containing radioactivity were pooled and dried down to 23 μΐ in a centrifugal dryer 
(Speed Vac). Six μΐ of 5 χ Tailing buffer (BRL), 1 μ! of 6 mM dATP and 10 Units Terminal 
Deoxynucleotidyl Transferase (BRL) were added and the sample was incubated for 5 min at 
37 °C, 5 min at 65 "C and then diluted to 200 μΐ with bidest. A first round of amplification 
was performed in 100 μΐ of 1 χ Taq-buffer containing 10 μΙ of the diluted cDNA pool, 100 
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pmol of primer Ml, 10 pmol of primer dtRiRo, 25 pmol of primer Ro and 2.5 Units of Taq 
polymerase (Amplitaq, Perkin-Elmer/Cetus). The mixture was overlaid with 50 μ\ mineral oil 
and 40 cycles of PCR were carried out: denaturation at 94 °C, 40 s; annealing at 60 0 C, 2 
min; extension at 72 0 C, 3 min; final extension for 10 min at 72 "C. Then 2% of this PCR 
product was reamplified using 25 pmol of primer Ri and SI under identical conditions as 
above, except that the annealing temperature was raised to 70 "C and only 32 cycles of PCR 
were performed. 
cDNA synthesis and 3' amplifications. See Fig. 1. Total RNA was dissolved in 10 μΐ 
bidest, heated at 90 "C for 30 s and quenched on ice. The poly(A)+ mRNA content was 
preferentially reverse transcribed into cDNA by priming with 10 pmol RoRi(dT17) primer 
using 200 Units of Superscript reverse transcriptase (BRL) in a final reaction volume of 20 μΙ 
containing 1 χ RT-buffer, 500 μΜ of each dNTP, 35 Units RNAsin (Promega) and 10 mM 
DTT. After incubation for 1 h at 42 0C and 1 h at 52 °C, the cDNA was diluted to 200 μΐ 
with bidest. All amplifications were done in 100 μΐ of 1 χ Taq-buffer containing 10 μΐ of the 
diluted cDNA pool, 25 pmol of primers (see Results) and 2.5 Units of Taq polymerase. In all 
cases thirty-two cycles of PCR were carried out: denaturation at 94 °C, 40 s; annealing at 70 
"C, 2 min; extension at 72 "C, 3 min; final extension for 10 min at 72 "С. 
Genomic DNA amplifications 
Genomic DNA (10 μg) was cleaved with EcoRl in 50 μΐ, heated at 65 °C for 10 min 
and diluted to 100 ng/ml with bidest. Amplification was done in 100 μΐ of 1 χ Taq-buffer 
containing 100 ng of genomic DNA and 25 pmol each of a defined set of primers. After 10 
min at 94 CC, 2.5 Units of Taq polymerase were added and 32 cycles of PCR were carried 
out: denaturation at 94 e C, 40 s; annealing at 70 "C, 2 min; extension at 72 "С, 3 min; final 
extension for 10 min at 72 "C. 
Cloning and sequence analysis of PCR products 
Obtained PCR products were extracted with phenol/chloroform, cut with the 
appropriate restriction endonucleases (Pharmacia or Boehringer) and size selected on TBE-
agarose gels. After purification with glassmilk (Gene Clean; Bio 101), selected fragments were 
cloned into M13mpl8 or 19. Sequence analysis was performed on single stranded or double 
stranded DNA using the dideoxy-chain termination method [177a] with the use of either 
universal sequencing primers or oligonucleotides S1-S2 as internal sequencing primers in 
combination with a modified T7 sequencing kit (Pharmacia). 
Northern blot analysis 
The poly(A)+ mRNA content of medulla terminalis tissue, was isolated using oligo 
(dT)-cellulose (Sigma) in the following manner: 10 mg of cellulose was equilibrated with 1 ml 
of diethyl pyrocarbonate (DEPC) treated binding buffer (=5 χ SSPE /0.1 % SDS (20 χ SSPE 
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= 3.6 M sodium chloride; 0.2 M sodium phosphate, pH = 7.0; 2 mM EDTA). The RNA 
sample was preincubated at 65 °C for 5 min, snap cooled on ice and mixed with 200 μΐ of the 
oligo (dT) cellulose slurry in an eppendorf tube and incubated for 1 h at 22 °C. The cellulose 
was washed twice with 1 ml binding buffer and the bound poly (A)+ mRNA was eluted in 200 
μ\ elution buffer (1% SDS/1% Sarcosyl in bidest) at 60 e C. After a second elution with 200 
/il, the mRNA was precipitated with 1/10 vol 4 M lithium chloride, 5 μ% yeast tRNA and 2.5 
vol 100% ethanol. For Northern blotting, RNA (total or polyadenylated) was separated by 
electrophoresis on denaturing formaldehyde agarose gels (1.2%) in MOPS buffer [7;51]. 
Digoxigenine labelled synthetic RNA markers (1418 and 679 bases) were run along site the 
samples. Northern blot transfers to Hybond N (Amersham) were performed essentially as 
described by Thomas [223]. RNA was fixed by baking for 2 h at 80 °C and a strip containing 
the markers was stained with an anti-digoxigenine antiserum (Boehringer) in order to check 
the efficiency of the Northern blot procedure and to estimate the molecular weights of 
hybridizing transcripts. 
Probe synthesis andprehybridization/hybridization techniques 
DNA probes were synthesized by primer extension from single stranded M13 DNA 
templates (2 μg) using 3 Units modified T7 DNA polymerase (Pharmacia), 30 /iCi [a 
"P]dATP (Amersham) and 1 mM of dCTP, dGTP and dTTP in T7 DNA polymerase buffer 
(Pharmacia). After an incubation of 20 min at 37 "С, the template/probe DNA was separated 
from non-incorporated nucleotides with glassmilk purification and boiled for 5 min before 
addition to the hybridization mixture. 
High specific single stranded RNA probes were synthesized as run-off transcripts from 
linearized recombinant pBluescript KS+ (Stratagene). This recombinant plasmid contained a 
Hin dill fragment of 200 bp derived from the 750 bps cDNA generated by PCR between 
primers S3 and Ro (Fig 1). Labelling was performed in a final volume of 10 μΙ containing 1 χ 
optimized transcription buffer (Promega), 500 μΜ concentrations of rATP, rCTP, and rGTP, 
75 μΟί [a-32P]rUTP (800 Ci/mM; Amersham), 15 Units RNasin (Promega) and 5 Units T3 
RNA polymerase. After synthesis the probes were loaded on a 7 M urea-5% Polyacrylamide 
gel to separate the synthesized RNA from its DNA template and free nucleotides. After 
identifying the position of the cRNA probe on an autoradiogram, the probe was recovered by 
elution into 2.5 M ammonium acetate for 2.5 h at 56 °C followed by an ethanol precipitation 
in the presence of 10 μg yeast tRNA (Gibco-BRL). The precipitate was redissolved in 
hybridization buffer. Northern blots were prehybridized in 5 χ SSPE/0.1 % SDS/ 100 μg acid-
alkali cleaved heterologous DNA and hybridized in the same solution containing 5% dextran 
sulphate. Hybridizations (for 16 h) were followed by stringent washes at increasing 
temperatures (see legends under Figures). 
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RESULTS 
Generation and characterization ofcDNA clones encoding the N-terminal sequence ofCHH 
The nucleotide sequences of fifteen individual recombinant clones, containing the 
selected 100 bp PCR products obtained after amplification of O. limosus cDNA between the 
two oligonucleotide mixtures (Ml and M2), were determined. Nine clones contained identical 
sequences between the mixed primers, all encoding the partial sequence of O. limosus CHH as 
was determined by automated Edman degradation [Chapter 4]. 
Generation and characterization ofcDNA clones encoding the 5' end of the CHH-precursors 
Reamplified PCR products were size selected on 1.8% agarose gel and a smear of 
fragments ranging from 200 - 400 bps was cloned into M13. Eleven recombinants, containing 
the largest inserts, were sequenced. Eight clones contained an open reading frame encoding a 
signal peptide of 26 amino acids, followed by a Crustacean hyperglycemic hormone Precursor 
Related Peptide (CPRP) of 33 amino acids with a C-terminal Ser, a Lys-Arg and the first 20 
amino acids of a CHH. Three clones differed only at four positions resulting in an open 
reading frame encoding three different amino acids: a substitution of Leu10 and Gly" in the 
signal peptide by Val10 and Ala" and a CPRP with a C-terminal Asn (See Fig. 2). 
Occasionally additional differences in nucleotide sequences were found, but since they were 
never at the same position we considered these as errors introduced by the Taq-polymerase or 
due to molecular polymorphism between individual animals. 
One of these clones (encoding the C-terminal Ser in the CPRP) was used as single stranded 
DNA template for the synthesis of an anti-sense CHH-specific probe, which was subsequently 
used for the Northern hybridization (Fig. 3). This allowed an estimation of the length of the 
transcripts to be expected from the 3' region amplification. 
Generation and characterization of cDNA clones encoding 3' sequences of the CHH-
precursors 
Initial attempts to amplify the 3' regions, using the primer combination S2/Ro and 
RoRi(dT17) primed cDNA (See Fig. 1), yielded two PCR products of 450 resp. 350 bps (not 
shown). Cloning and sequence analysis (10 recombinants for each product) demonstrated that 
the larger cDNA encoded a CHH-like peptide of 75 amino acids, while the smaller product 
contained the same sequence with a 98 bp deletion (nts 303 -401 in Fig. 5). Similar results 
were obtained using a newly designed primer (S3), sense to a region in the 5' untranslated 
area for which the sequence was derived from the 5' CHH-precursor encoding cDNAs. PCR 
with primer combination S3/Ro, gave two products of 750 and 650 bps (See Fig. 6). Cloning 
and sequence analysis of the 750 bp fragment (4 recombinants) gave in all cases the same 5' 
sequences (encoding the CPRP with a C-terminal Ser) followed by the 3' sequence encoding a 
CHH-like peptide of 75 amino acids (see Fig. 5). A Hin dill fragment of -200 bps 
(corresponding to nts 236 - 438 in Fig. 5), was excisized from a recombinant carrying the 
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-105 -80 
Orconoctoa limosas PrePro CHH A: 5' 
Orconectes limosus PrePro CHH B: 5' ACACACCATTCCAGCGTCCAGTCCCT 
A -1 
CTCTCAGGACTCTCTAGACCTCCGAGGCAGTCTTCGTGGTGCTGGTCTGTGTCGTTCAGAGACTCGTCCCCCTCCAGCA 
1 60 
G С 
ATG GTT TCC TTC AGA ACG ATG TGG TCG TTG GTG GTG GTA GTG GTG GTG GCG AGT CTG GGC 
Met Val Ser Phe Arg Thr Met Tro Ser Leu Val Val Val Val Val Val Ala Ser Leu Glv 
Val Ala 
( SIGNAL PEPTIDE -» 
120 
TCG TCT GGT GTC CAA GGA CGG TCC GTA GAA GGG TCG TCG AGG ATG GAG CGA CTG TTG TCG 
Ser Ser Gly Val Gin Gly Arg Ser Val Glu Gly Ser Ser Arg Met Glu Arg Leu Leu Ser 
] ( CPRP -» 
A 180 
TCT GGG TCG TCA TCT TCG GAA CCT CTC AGC TTC CTC TCC CAA GAC CAG AGC GTC AGC AAA 
Ser Gly Ser Ser Ser Ser Glu Pro Leu Ser Phe Leu Ser Gin Aap Gin Ser Val Ser Lys 
Asn] 
240 
CGA CAG GTG TTC GAC CAG GCT TGT AAA GGA ATA TAC GAC AGA GCC АТС TTC AAG AAG CTT 
Arg Gin Val Phe Aap Gin Ala Cys Lya Gly Ile Tyr Asp Arg Ala Ile Phe Lye Lye Leu 
[ CHH -» < S-l 
Fig. 2. Nucleotide sequences (and the deduced amino acid sequences) of the coding strands 
of PCR produced cDNAs encoding the 5' end of two different CHH precursors (A,B)· For 
the CHH precursor A only non-homologous nucleotides and amino acids are given. The 
hydrophobic core sequences of the signal peptides are underlined. 
750-bps cDNA, cloned into pBluescript KS-l- and used for the generation of a cRNA probe. 
Northern blot analysis using this cRNA probe demonstrated only hybridization with a 
transcript of —1600 nts (Fig. 4). Even upon longer exposure, no hybridization signals were 
found with transcripts of 650 or 750 nts (not shown). This strongly suggested that either the 
mRNAs corresponding to the sequenced cDNAs are present at a very low level, or that the 
cloned cDNAs are PCR artifacts, lacking a 800 bps sequence. The presence of low levels of 
mRNA was checked with an RNase protection assay (under conditions as described in Chapter 
9), using the same cRNA probe as used for the Northern hybridization. No protection of 200 
nts long mRNA was found (not shown) and it was therefore concluded that the isolated 
cDNAs did not represent the entire CHH-encoding mRNA. 
A new primer (S4) was synthesized antisense to a region just preceding the poly (A) tail of all 
obtained 3' sequences. cDNA amplifications using the primer combination S3/S4 yielded three 
PCR products of different length: 1500, 750 and 650 bps (Fig. 6). Preliminary sequence 
analysis and restriction mapping experiments, suggest that the 1500 bps cDNA indeed encodes 
a complete CHH preprohormone sequence. The complete characterization is currently being 
carried out. 
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Fig. 3. RNA transfer blot analysis. Thirty μg 
of total RNA from the medullae terminal is (15 
animal equivalents; lane 2), medulla terminaiis 
poly (A)+ RNA (15 animals; lane 3) and 20 
μg of total RNA from the green gland and 
hepatopancreas (lane 4-5 respectively 6-7) 
were hybridized with a primer-extension probe 
(Specific activity: ~ 3 χ 107 cpm/^g) 
encoding the 5' region of the CHH-precursor 
(See text; lane I is empty). Hybridization was 
performed at 45 CC for 16 h and the filter was 
washed until 0.25 χ SSPE at 56 0 C. Exposure 
time was 96 h using two intensifying screens. 
Digoxigenine-labelled synthetic RNA were 
used as markers (shown in nucleotides); the 
actual size of these markers is ~ 10% longer 
as a consequence of the digoxigenine 
labelling. 
Fig. 4. RNA transfer blot analysis. Medullae 
terminales poly (A)+ RNA (15 animal 
equivalents; lane 1), 25 /tg of total RNA from 
the hepatopancreas (lane 2 and 5), 30 μg of 
total RNA from the medullae terminales (15 
animals; lane 4) and 20 μg of total RNA from 
the green gland (lane 3 and 6) were hybridized 
with a (a-32P]rUTP labelled cRNA probe 
(Specific activity: ~ 1 χ 108 cpm^g) 
containing a sequence encoding a part of the 
3' region of the CHH-precursor (See text; lane 
7 is empty). Hybridization was performed at 
50 "С for 16 h and the filter was washed until 
0.25 χ SSPE at 56 0 C. Exposure time was 24 
h with a single intensifying screen. 
Digoxigenine-labelled synthetic RNA were 
used as markers (shown in nucleotides); the 
actual size of these markers is -10% longer 
as a consequence of the digoxigenine 
labelling. 
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Orconectes Іілюаиэ РгеРго CKH (В): 
-1 
S-3 >TCCGAGGCAGTCTTCGTGGTGCTGGTCTGTGTCGTTCAGAGACTCGTCCCCCTCCAGCA 
1 
ATG GTT TCC TTC AGA ACG ATG TGG TCG TTG GTG GTG GTA GTG GTG GTG GCG AGT CTG CGC 
Met Val Ser Phe Arg Thr Met Trp Ser Leu Val Val Val Val Val Val Ala Ser Leu Gly 
20 
100 
TCG TCT GGT GTC CAA GGA CGC TCC GTA GAA GGG TCG TCG AGG ATG GAG CGA CTG TTG TCG 
Ser Ser Gly Val Gin Gly Arg Ser Val Glu Gly Ser Ser Arg Met Glu Arg Leu Leu Ser 
40 
TCT GGG TCG TCA TCT TCG GAA CCT CTC AGC TTC CTC TCC CAA GAC CAG AGC GTC AGC AAA 
Ser Gly Ser Ser Ser Ser Glu Pro Leu Ser Phe Leu Ser Gin Asp Gin Ser Val Ser Lys 
60 
200 
CGA CAG GTG TTC GAC CAG GCT TGT AAA GGA ATA TAC GAC AGA GCC АТС TTC AAG AAG CTT 
Arg Gin Val Phe ABP Gin Ala Cvs Lvs Gly Ile Tvr Азр Arg Ala Ile Phe Lvs Lva Leu 
80 
300 
GAC CGA GTG TGT GAA GAT TGT TAC AAC TTG TAC CGT AAA CCC TAC GTC GCC ACC ACC TGC 
ABP Aro Val С в Glu Авр Сув Туг Авп Leu Tvr Arg Lys Pro Туг Val Ala Thr Thr CvB 
100 
AGA CAA AAC TGC TAT GCC AAT TCC GTC TTT CGT CAA TGC CTT GAT GAC CTT CTC TTG ATA 
Ara Gin Аап С в Tvr Ala Авп Ser Val Phe Arg Gly Cvs Leu Aap Aap Leu Leu Leu Ile 
120 
399 
GAC GTT CTT GAC GAG TAC АТС TCC GGC GTC CAA ACT GTC 
ABP Val Leu Авр Glu Tvr Ile Ser Gly Val Gin Thr Val 
133 
400 
GATTTCAGTTAATACGTTGGACCGTCTTGGGAGATGAAAGCTTCTCTGGCAACAATGTTTACTTGTGCAGTCTTGGCAA 
500 
CACTGCTTACCTGTCTTTTGCAAGCATTACTGAACCTCATTTTGTATACCAAAGATTAATGTAATGAGACAGACAGACA 
600 
GACAGACAGACGGGAAATACGACAGACAAGCTTACTAGTGGTGGAGCGTTAGCTATCAACACCTCTGTGATTGTGGGAA 
TAAAACTGCATTA (n) 
Fig. 5. Nucleotide sequences (and the deduced amino acid sequences) of the coding strand of 
PCR produced cDNA encoding the 5' and 3' end of а СЫН precursor. Dots indicate the 
putative position of an insertional sequence (see Discussion section). The CHH sequence as 
well as a putative polyadenylation signal are underlined. 
Genomic DNA amplifications 
Two types of genomic DNA amplification were performed. PCR with primer 
combination S3/S1 was employed in order to generate clones encoding the two different 5' 
regions of the CHH-precursor. Starting with DNA from an individual animal only one product 
of — 300 bps was generated. Sequence analysis of 25 recombinants, containing this PCR 
product, revealed the presence of two different sequences which fully agreed with the two 
sequences obtained from the 5' cDNA clones. 
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Only two major products of approximately 1500 and 750 bps were synthesized by genomic 
DNA amplification between primers S3 and S4 (Fig. 6). From the absence of the 650 bps 
band we concluded that this product most likely was an artifact in the cDNA preparation 
which might be due a loop structure which was not copied correctly by the reverse 
transcriptase during cDNA synthesis. 
1 2 3 4 5 
I—I I—{ H I — I J-H 
Fig. 6. Detail of a 1% agarose gel stained with 
ethidium bromide showing the results of 
amplifications of (c)DNA between primer S3 and 
S4/Ro/Ri. Lane 1, DNA size marker (given in 
nucleotides, lambda DNA digested with Pstl). 
Lane 2, cDNA amplification between primers S3 
and S4. Lane 3, cDNA amplification between 
primers S3 and Ri. Lane 4, cDNA amplification 
between primer S3 and Ro. Lane 5, DNA 
amplification between primers S3 and S4 
DISCUSSION 
This chapter describes the generation, cloning and initial characterization of cDNAs 
for two mRNAs encoding CHH-precursors in the crayfish, O. limosus. The CHH amino acid 
sequence information in combination with the PCR technique, using mixed oligonucleotide 
primers, was used for the generation of specific cDNA sequences encoding the partial amino 
acid sequence of CHH from this crayfish species. This sequence information was used for the 
design of oligonucleotides primers that were used in additional PCR experiments in order to 
obtain the 5' and 3' flanking sequences of mRNAs encoding CHH. 
The 5' sequences were obtained using one gene specific and one degenerated primer in 
combination with a modified version of the original 'RACE' protocol [64]. This approach 
revealed the presence of two different cDNAs, hybridizing to mRNA transcripts of -1600 
nts. The translation initiation site of both cDNA sequences, is assigned to the methionine 
1 0 9 3 
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codon at position 1-3 (in Figs 2 and 5), not only because position -3 to +4 (GCAATGG) is in 
agreement with the consensus sequence for eukaryotic translation initiator sites 
(A/GNNATGG, whereby N is mostly а С [131;132]), but also since translation of the 
resulting open reading frame gives a (partial)CHH-precursor protein with a high overall 
homology with the crab CHH-precursor [243]. This homology includes the presence of a 26 
amino acid long signal peptide at the N-terminal, which displays well-known features of such 
sequences, including the presence of a strongly positively charged amino acid (Arg5) preceding 
a hydrophobic core sequence (residue 8-20) [235;236]. The signal cleavage site at position 26 
fully agrees with the rules proposed by Von Heijne [234]. Moreover, cleavage at this position 
is consistent with the structures of two CPRPs, peptides flanking CHH at the N-terminal in the 
precursor protein. The predicted sequences of the CPRPs fully agree with the sequences of O. 
limosus CPRPs as we have determined by protein sequencing methods [Chapter 5]. 
The corresponding 3' sequences were more difficult to obtain. Initial attempts to 
amplify and clone 1500 bps cDNAs were unsuccessful. This was probably due to strong loop 
structures within the CHH encoding DNA and mRNA sequence. However, when employing 
the "classical" RACE protocol using one (internal) gene specific primer in combination with 
an aspecific primer, some of the 3' sequence of a CHH encoding mRNA was obtained. This 
sequence information allowed the design of a new (speci Гіс)ргітег which was used in the PCR 
to generate cDNAs which will probably encode the complete CHH precursor(s). 
Although not complete, the sequence of the mature CHH encoded by the 750-bp 
cDNA agrees well with the results obtained by protein sequencing ([111]; see Fig. 8). The 
residue Gin62 in the prohormone structure apparently results in a mature pyroGlu when the 
precursor is proteolytically cleaved at the adjacent dibasic processing site. However, we 
expected a Gly-Lys-Arg encoding sequence next to the Val1" encoding triplet, since this 
sequence is the common signal for processing and subsequent amidation [27]. This C-terminal 
amidation of CHH was demonstrated by peptide chemistry [111] and seems to be a common 
feature for all CHHs thus far characterized [Chapter 3 and 6; 110]. This suggests that the 
additional 800 nts sequence is located next to the Val1" encoding triplet. 
Comparison of the CHH sequence from O. limosus, deduced from its mRNA sequence 
and amino acid sequence analysis [111], with CHH A and В from the lobster, H. americanus 
and a CHH from the crab, C. maenas, clearly demonstrates that the crayfish CHH is more 
similar to the lobster CHHs than to the crab CHH (Fig. 7.). This is not surprising, since both 
this lobster and crayfish species belong to the family of Astacidea, while C. maenas is thought 
to have evolved from a separate linage 140 million years ago [182]. This similarity between 
lobster and crayfish CHHs was also deduced from bioassays, demonstrating that three of the 
four CHH isoforms from H. americanus are bioactive in O. limosus [Chapter 2]. 
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O. limosus 
H. americanas 
H.americanus 
C.maenas 
CHH : 
CHH A : 
CHH В : 
CHH : 
1 
p E V F D Q A C K G 
p E V F D Q A C K G 
p E V F D Q A C K G 
p E I Y D T S C K G 
30 
Y D R A I 
Y D R 
Y D R 
N L 
N L 
F K K L D R V C E D C Y N L Y 
F K K L D R V C E D C Y N L Y 
F К К L NlR V C E D C Y N L Y 
Y D R A ] L FIN DIL E HIV C [ D ] D С Y N L Y 
31 
R Κ Ρ 
R Κ Ρ 
R Κ Ρ 
R T S 
Y V A 
F V A 
F I V 
Y V A 
* 
Τ Τ С R 
Τ Τ С R 
Τ Τ С R 
S A | C R 
72 
N С Y 
N С Y 
N С Y 
N С Y 
V F R Q C L D D L L L I D V 
V F R Q C L D D L L L T J D V 
V F R Q C L D D L L I D V 
V F R Q C [ M 1 D D L L M M | D | E F 2 ] θ | _ Υ A R К 
D E Y 
D E Y 
D E Y 
V Q 
V Q 
V Q 
V Q 
VNH2 
VNH2 
VNH2 
VNH2 
Fig. 7. Comparison of the sequence of 0. limosus CHH (obtained by amino acid sequence 
analysis [111]), with H. americanus CHH A and В [Chapter 6] and C. maenas CHH [110]. 
Amino acids identical in O. limosus CHH and one of the other CHHs are boxed. Cysteine 
residues are indicated with asterisks. 
As noted before, the organization of these preproCHH sequences has a remarkably 
similarity with the CHH-prohormone from the crab, С maenas [243]. This includes the 
presence of a 26 amino acid long signal peptide, a CPRP (of 38 amino acids) and a 72 amino 
acids long CHH. The size of the cDNA clone from which this sequence was derived (1800 
bps, W Weidemann pers. comm.), matches the presumed length of crayfish CHH mRNAs. 
This latter phenomena might emphasize the importance of such a long non-translated trailer 
sequence e.g., the stability of the mRNA [24;169;175]. 
In the near future, sequence analyses of the 1500 bps cDNAs can eventually demonstrate the 
presence of a Gly encoding triplet, thus confirming the C-terminal amidation of CHH. In 
addition, elucidation of the sequences might demonstrate further differences between the two 
precursor molecules. Such differences might be very useful to discriminate both messengers in 
Northern blot and in situ hybridization experiments in order to study the expression of both 
messengers under different physiological conditions. 
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DETECTION OF mRNA ENCODING CRUSTACEAN 
HYPERGLYCEMIC HORMONE (CHH) IN THE EYESTALK 
OF CRAYFISH AND LOBSTER USING NON-RADIOACTIVE 
IN SITU HYBRIDIZATION 
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ABSTRACT 
This chapter describes a non-radioactive in situ hybridization procedure for the localization of 
mRNA encoding the Crustacean Hyperglycemic Hormone (CHH) in the eyestalk of crayfish 
and lobster. Localization of the mRNA in the CHH cellsomata of the crayfish, Orconectes 
limosus was obtained with a digoxigenin-labelled complementary RNA (cRNA) probe on 
Bouin fixed eyestalks which were pre-treated with pepsin/HCl. Combination with an 
immunocytochemical staining on alternate sections, using a polyclonal antibody against CHH, 
confirmed the specificity of the reaction. Based on these experiences, specific localization of 
CHH-encoding mRNA in the lobster, Homarus americanas , was achieved with lobster CHH-
specific digoxigenin labelled cRNA probes on identically processed eyestalk tissue. In both 
cases, the mRNA encoding CHH is only detectable in the CHH-cell somata, which is the 
expected site of CHH gene transcription. The absence of hybridization signals when using the 
crayfish-specific probe on lobster eyestalk tissue sustains the specificity of the applied in situ 
hybridization procedure. 
This chapter is the modified thesis version of a manuscript entitled: 
Detection of mRNA encoding Crustacean Hyperglycemic Hormone (CHH) in the eyestalk of the 
crayfish Orconectes limosus using non-radioactive in situ hybridization. By: 
CP Tensen, Τ Coenen and F van Неф. 
Published in Neurosci Lett 124: 178-182 (1991) 
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INTRODUCTION 
The metabolic Crustacean Hyperglycemic Hormone (CHH) is produced by 
neuroendocrine cells belonging to the X-organ sinus gland complex in the eyestalks of decapod 
Crustacea. This hormone is involved in the regulation of glucose levels in the hemolymph and 
its participation in other physiological processes is anticipated [122; 124]. Due to its 
antigenicity, production of polyclonal antibodies against purified CHH of several species could 
easily be accomplished allowing immunocytochemical and morphological identification of the 
CHH-producing cell system in numerous crustaceans [73;74;101;145;217]. 
During the last decade data obtained from bioassays, immunocytochemistry and 
morphometry have led to insight in the physiology of the CHH-producing cells in crayfish, 
especially with respect to synthesis, storage and release of CHH. This approach revealed that 
the system has a circadian rhythm: as CHH is released at the onset of the dark period, an 
increase in synthetic activity occurs two hours before the liberation of CHH [75;76]. 
Regulation of CHH synthesis/release occurs through synaptic input on CHH-axon 
ramifications in the medulla terminalis [77]. It is postulated that biogenic amines, especially 
serotonin, are involved in the regulation of CHH release (For Review See [229]). 
Our current interest is focussed on the study of the regulation of CHH synthesis in 
crayfish with special reference to environmental and internal stimuli influencing the expression 
of the gene(s) encoding CHH. For this reason we have developed an in situ hybridization 
technique, which allows detection of mRNA in individual cells. 
Until now no reports are available on the application of the in situ hybridization 
technique in crustacean eyestalks. Therefore, the first aim of this study was to establish 
suitable conditions in terms of fixation and pretreatment of the eyestalk tissue for detection of 
the CHH-encoding mRNA in combination with immunocytochemical staining for CHH. 
Secondly, we show that the use of single stranded RNA probes allows non-radioactive 
visualization of target mRNAs within the CHH-producing cells of the X-organ of O. limosus. 
Finally, we demonstrate that this approach is also applicable for the specific detection of 
mRNA encoding CHH in the lobster, H. americanas. 
MATERIALS AND METHODS 
AnimaL· 
Specimen of the crayfish, O. limosus, were obtained from local fishermen from the 
river Meuse (The Netherlands). The animals were kept in the laboratory in running tap water 
(13-15 °C) on a 12 h light/12 h dark cycle and were fed with fish once a week. 
Specimen of the lobster H. americanus were obtained from a commercial importer and 
originated from the east coast of Canada. The animals were kept in the laboratory in artificial 
seawater at about 5 eC for a maximum of one week after arrival. 
I l l 
Chapter 8 
Probes (labelling procedures and detection) 
Specific crayfish CHH probes were synthesized as run-off transcripts from a recombinant 
clone which consisted of pBluescript KS + , containing a 100-bp PCR product (See Chapter 7). 
This clone contained a CHH-specific cDNA sequence of 44 bases, starting with the triplet 
encoding amino acid 8 (Lys) and ending with the first two bases of the triplet encoding amino 
acid 22 (Val); this region is flanked on each site by one of the primer sequences used in the 
PCR. This recombinant plasmid is called pBSCHH-ORL. 
To produce specific lobster CHH probes, a by means of PCR generated cDNA encoding CHH 
В from H. americanus (See Chapter 6) was recloned from M13 into pBluescript KS-K This 
recombinant is called pBSCHH-B-HOA. 
Both recombinant plasmids were CsCl purified [177] and subsequently linearized before usage 
as template for in vitro transcription. Labelling was performed in a final volume of 20 /il 
containing 1 mM concentrations of гАТР, rCTP, and rGTP, 650 μΜ rUTP, and 350 μΜ 
digoxigenine-U-UTP (Boehringer-Mannheim), 1 χ optimalized transcription buffer (Promega) 
and 10 units T7 or T3 polymerase (Promega or Pharmacia) [88]. After 2 h at 37 "C the 
synthesized RNA was alcohol precipitated. The amount and integrity of the RNA probes was 
checked by electrophoresis on a 4% poly-acrylamide gel [177]. The efficiency of labelling was 
verified by spotting the probes directly on nitrocellulose or by hybridization to target 
sequences immobilized on nitrocellulose; detection of digoxigenine was performed as in [125], 
with an alkaline-phosphatase conjugated anti-digoxigenin antibody. 
Tissue processing 
Eyestalks from O. limosas were dissected 3 hrs before the onset of the dark period. Eyestalks 
from H. americanus were dissected within one week after arrival of the animals in the 
laboratory. In both cases the ablated eyestalks were immediately fixed en bloc in Bouin's 
fixative (71% picric acid, 24% formaldehyde, 5% acetic acid) for 16 hrs. After the classical 
(de)hydration treatment, fixed eyestalks were embedded in paraffin and 5 μπι sections were 
alternately collected on slides coated with 0.01% poly-L-lysine (Sigma). To improve 
adherence of the sections to the glass surface, slides were baked for 1 h at 50 °C. Mounted 
sections were deparaffinized in xylene (twice for 5 min each), hydrated and used for the m 
situ hybridization or immunocytochemical staining. 
In situ hybridization 
To improve penetration, sections were pretreated with 0.1% pepsin (Boehringer-Mannheim) in 
0.2 N HCl at 37 "С for 20 min and shortly washed in bidest. As described in [56], sections 
were post-fixed in 2% formaldehyde (freshly prepared from PFA) in PBS (PBS = 10 mM 
sodium phosphate pH 7.4, 0.1% KCl, 0.8% NaCl) for 4 min, rinsed in 1% 
hydroxylammonium chloride in PBS for 15 min and finally rinsed in PBS (5 min) and 
dehydrated. RNA probes were dissolved in hybridization buffer, containing 50% deionized 
formamide, 4xSSC (lxSSC=0.15 M sodium chloride, 0.015 M sodium citrate), 10% dextran 
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sulphate, 0.196 polyvinylpyrrolidone, 0.1% Bovine Serum Albumin, 0.1% Ficoll 400, 200 
/ig/ml acid-alkali cleaved salmon sperm DNA and 25 mM sodiumphosphate buffer pH 7.0. 
The hybridization mix was heated at 70 °C for 5 min before applying to the sections. Per 
section 150 μΐ of hybridization mix, containing the RNA probe at a concentration of 2 ng/μΐ, 
was used. The mix was overlaid with a coverslip and the edges of the coverslip were sealed 
with melted paraffin. Hybridization was performed at 45-50 "C in a moist chamber for 16 h. 
After hybridization, slides were rinsed three times in 2xSSC at 22 0 C, followed by stringent 
washes at 37 e C with 1 χ SSC (3 times for 20 min), 0.5 χ SSC (twice for 20 min) and 0.2 χ 
SSC (twice for 20 min). Visualization of the probes was performed using an alkaline-
phosphatase conjugated anti-digoxigenin antiserum (1 : 500) [125]. Bidest, SSC and the 
sodiumphosphate buffers used for the ш situ hybridization were all treated with 0.1% diethyl 
pyrocarbonate (DEPC, Sigma) and autoclaved. Glassware (including ethanol cleaned slides) 
was baked for at least 16 h at 250 ° С 
Immunocytochermstry 
Two polyclonal antisera raised against CHH were used for the immunocytochemical detection 
of CHH on alternate, non-pepsin treated sections. The crayfish sections were incubated with a 
rabbit anti-serum against CHH of the crayfish, Astacus leptodactylus (anti-AslCHH; for details 
about this antiserum see [73]), while the sectioned lobster eyestalks were incubated with a 
guinea pig anti-senim against HPLC purified CHH from H. americanas (anti-HoaCHH-5; for 
details about this antiserum see [154]). Slides were pre-incubated for 10 min with 20% normal 
rabbit serum in PBS, followed by a 16 h incubation at 4 °C with the antisera (1 : 500 dilution 
in PBS for anti-AslCHH or 1: 200 dilution for anti-HoaCHH-5). After rinsing in PBS the 
slides were subsequently incubated at room temperature with a horse-radish peroxidase 
conjugated anti-rabbit serum or anti-guinea pig serum (Nordic; 1 : 100 dilution in PBS; 1 h) 
and PAP complex (Nordic; 1 : 500 dilution in PBS; 1 h), of which the peroxidase activity was 
visualized using diamine benzidine/ammonium nickelsulphate (50 mg diamine benzidine, 0.5 
gr ammonium nickel sulphate, 0.01% H A /100 ml Tris-HCl pH 7.4). 
RESULTS 
With the anti-sense RNA probes specific localization was possible of the 
neuroendocrine cells expressing CHH in the eyestalks of both decapod crustaceans. This is 
demonstrated by Fig. 1 for O. limosus and Fig. 2 for H. americanus. By using alternate 
sections for immunochemical staining and in situ hybridization it was revealed that the same 
cells react with the respective anti-CHH antisera (Fig. 1A-D resp. 2A-B). The CHH peptide is 
present in large amounts in the CHH perikarya of the X-organ, the axon branches of the X-
organ sinus gland tract and the sinus gland itself (Fig. 1A-B resp. 2B and 2F). In contrast to 
this wide spread occurrence, the mRNA encoding CHH is only detectable in the cell somata, 
which is the expected site of CHH gene transcription (Fig. 1C-D resp. 2A and 2E). We did 
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Fig. 1. A: Longitudinal section of the eyestalk of O. limosus, showing the immunocytochemical localization of CHH in the CHH-cells (arrow 
in X), branches of the tract (arrows in MT) and the sinus gland (SG). Other abbreviations: ME, medulla externa; MI, medulla interna; MT, 
medulla terminalis. B: Detail of the immunopositive CHH-cells. C: Longitudinal section of the eyestalk, adjacent to the section in Fig. A, 
showing the in situ hybridization of mRNA encoding CHH at the level of the perikarya (arrow). D: Detail of the hybridizing cells. E: No 
hybridization in the adjacent section to Fig. B. after using the control probe. Bar is 135 μια for A and С and 45 μτα for B, D and E. •* 
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MT 
Fig. 2. Non-radioactive in situ hybridization and immunocytochemical localization at 
alternate sections of CHH expressing neurosecretory cells in the eyestalk of the lobster, 
Homarus americamis. A: Hybridization of the dig-labelled anti-sense RNA probe at the level 
of the cell bodies and absence of hybridization in the X-organ sinus gland tract [see arrow in 
MT (= medulla terminalis)]. B: Immunocytochemical localization of CHH in the CHH-
producing cells and branches of the X-organ sinus gland tract (see arrow). C-D: Absence of 
hybridization with Dig-labelled sense RNA (С) or Dig-labelled anti-sense RNA specific for 
O. limosus CHH-encoding mRNA (D). E: Absence of hybridization with the anti-sense RNA 
probe in the neurohemal area of the CHH cells, the sinus gland. F: Immunocytochemical 
staining of CHH in the sinus gland. Bar is 50 μιτι for Α-D and 30 μιτι for E-F. 
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not observe any reaction in the CHH cells with the sense control probes (Fig. IE resp. 2C). 
Moreover, the specificity of the in situ hybridization reaction is emphasized by the absence of 
any reaction when the lobster eyestalks were hybridized with the crayfish specific anti-sense 
probe (Fig. 2D). When sections were pre-treated with RNase before hybridization with the 
anti-sense RNA probe, no reaction occurred (not shown) thus also confirming the specificity 
of the hybridization reaction. 
Both the anti-sense and sense probes displayed a reaction with the cuticle which could be 
caused by endogenous phosphatase activity. Alternatively, it can be the result of aspecific 
binding of the RNA probes or of the antibody used for detection of these RNA probes. 
DISCUSSION 
The availability of amino acid sequence information in combination with the PCR 
technique using mixed oligonucleotide primers, allows the generation of cDNA sequences. 
This technique is thus far mainly used for creating probes for screening of (c)DNA libraries 
[79;135]. We used this approach previously with success to generate cDNA clones encoding 
the complete structure of two CHHs from the lobster, H. americanus or the partial sequence 
of CHH in the crayfish O. limosus (Chapter 6 and Chapter 7 of this thesis). In this chapter we 
show that the obtained cDNA sequence information is sufficient for the in situ detection of 
mRNA encoding CHH in CHH-synthesizing neuroendocrine cells. We choose to use a non­
radioactive labelling procedure as non-radioactively labelled probes have the advantage of 
speed of detection and, as compared to radioactively labelled probes, can be stored for a long 
time without loosing their specific activity. These properties have helped to optimize the in 
situ hybridization procedure, using the crayfish eyestalks as model study, in terms of finding 
the proper conditions for fixation and pretreatment of the tissue. 
The described method of Bouin fixation gave the best results for visualization of 
mRNA by the in situ hybridization procedure in one section and detection of the CHH peptide 
by immunocytochemistry in the alternate section. Other fixation procedures e.g., modified 
Carnoy's (73% ethanol, 25 % acetic acid, 2% formaldehyde), ethanol/acetic acid (3:1) 
produced less satisfactory results. Tissue pretreatment with pepsin/HCI was needed for the 
detection of target mRNAs using the non-radioactive in situ hybridization procedure and it 
appeared superior to other methods involving the use of Triton, Proteinase К and Pronase. 
This increased sensitivity after pepsin/HCI treatment in non-radioactive m situ hybridization 
has also been reported for other tissues [31;56]. The different fixation and pretreatment 
conditions were not evaluated for the detection of CHH mRNA in lobster eyestalks, since we 
did not expect any variation between lobster and crayfish eyestalk tissue with respect to the 
sensitivity of the hybridization conditions. 
Concerning the employed technique of labelling it should be mentioned that the use of 
single-stranded RNA probes is probably required to detect the mRNA encoding CHH in 
crustacean eyestalks. Aside from the greater specificity of single-stranded RNA probes in 
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general, the applied labelling method has the advantage of incorporation of relatively large 
amounts of digoxigenine label. Non-radioactive probes of such length, containing 5-6 (for 
crayfish probes) or 10-12 (for lobster probes) digoxigenine UTP molecules on average, are 
presumably necessary for detection of CHH mRNA; there was no reaction in the CHH cells of 
the crayfish when a random primed dig-labelled 95 bp double stranded DNA fragment or a 
dig-tailed 25-mer crayfish specific anti-sense oligonucleotide was used. 
In conclusion, we developed a technique for the detection of mRNA encoding CHH in 
individual X-organ cells from the crayfish, 0. limosus and the lobster, H. americanus. This 
mRNA is only detectable in the CHH cell somata, which are the expected sites of CHH gene 
transcription. We will use this in situ hybridization technique to study the cellular dynamics of 
the CHH-producing cell system in crayfish and lobster under a variety of physiological 
conditions. 
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TISSUE DISTRIBUTION AND REGULATION OF LEVELS 
OF mRNAs ENCODING CRUSTACEAN HYPERGLYCEMIC 
HORMONES 
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ABSTRACT 
The amount and distribution of mRNAs encoding Crustacean Hyperglycemic Hormones 
(CHHs) in two crustacean species were studied with a RNase protection assay. First, the 
sensitivity of this assay was tested with RNA extracted from crayfish medullae terminales 
containing the CHH-synthesizing perikarya from the X-organ. These data indicated that the 
assay was sensitive enough for CHH mRNA detection in two medullae terminales, 
corresponding to one individual animal. Based on these experiences, the protection assay was 
used to study the occurrence and distribution of mRNAs encoding CHH in the eyestalk and 
several other tissues from the crayfish Orconectes limosus and the lobster Homarus 
amencanus. It turned out that the CHH gene(s) is also expressed in cerebral, thoracic and 
abdominal ganglia but not in the tail muscle, green gland or tissues belonging to the digestive 
system. These observations were confirmed, in the case of the crayfish, by Polymerase Chain 
Reaction (PCR) analysis using two CHH-specific oligonucleotide primers. Finally, the 
nuclease protection assay was also used to determine the level of CHH mRNA in medullae 
terminales from individual crayfish during a day/night period. Highest levels of CHH mRNA 
were found in the middle of the day and this level decreased to significant lower amounts 
around the transition from the light to the dark period. 
Parts of this chapter are presented during the Jacques Monod Conference on "Molecular aspects of 
invertebrate hormones", Roscoff (France), 15-19 October 1990, and will appear in abstractform 
entitled: Comparative study on the structure of hyperglycemic neurohormones in Crustacea: a 
chemical and molecular biological approach. By F Van Негр and CP Tensen. New Biologist (1991) 
in press. 
Other parts will be included in a manuscript entitled: 
Distribution of mRNAs encoding Crustacean Hyperglycemic Hormones in the lobster Homarus 
amencanus. By: CP Tensen, DPV de Kleijn, J Berkeljon, Τ Coenen and F Van Неф (in 
preparation). 
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INTRODUCTION 
Circadian rhythms influence many behavioural and physiological processes and it has 
been demonstrated that synthesis and release of the Crustacean Hyperglycemic Hormone 
(CHH) in decapod crustaceans are also subject to circadian rhythmicity [80; 108]. The CHH 
neuropeptides are produced by the neurosecretory X-organ Sinus Gland (XO-SG) complex 
located in the eyestalk and are involved in the regulation of a diversity of physiological 
processes [229]. The role of CHH in the regulation of carbohydrate metabolism was shown 
already 45 years ago, with the observation that injection of eyestalk extract results in an 
increase of blood glucose concentrations [1]. Hamann [80] was the first to demonstrate that 
hemolymph glucose levels in crayfish show a circadian rhythmicity, with a rise in blood 
glucose during the night. Using the crayfish, Orconectes limosus, he established that SG 
extirpation caused a decrease in average blood glucose concentrations and, in addition, also 
abolishes the nocturnal glucose peak. From these experiments it was concluded that CHH is 
not only responsible for the maintenance of resting levels of glucose, but also plays an 
essential role in the instant elevation of blood sugar levels, possibly related to physiological 
needs [122;124]. One aspect of Hamann's experiments is thusfar overlooked: removal of the 
SG did not result in complete absence of glucose in the hemolymph. Therefore, it is entirely 
possible that, besides the XO-SG system, other neuroendocrine centers are present that are 
capable of producing and releasing CHH. Studies on these alternative sites for CHH synthesis 
and release are scarce and to our knowledge only one report has described the presence of 
CHH immunoreactive material in tissue other than the XO-SG system, i.e., the pericardial 
organs of the crab, Carcinus maenas [124]. Furthermore, another paper mentioned the 
presence of CHH in the hemolymph of destalked animals [120]. 
The dynamics of the CHH-producing cells in the eyestalk, especially in the case of the 
crayfish, Astacus leptodactylus, have been studied intensively. These studies revealed that 
these cells show a daily rhythmicity, with CHH released at the onset of the dark period, which 
is preceded by an increase in synthetic activity [75;76;99;105]. The regulation of CHH 
synthesis and release is mediated by synaptic input on CHH-axon ramifications in the medulla 
terminalis, involving dopamine and serotonin [229]. 
One of our goals is to investigate the role of external and internal stimuli influencing 
the expression of gene(s) encoding CHH. In order to gain insight into the transcription and 
translation processes that are involved in regulating the expressing of the CHH gene(s), we 
have set up a method allowing the monitoring of changes in CHH-encoding mRNA levels. 
This paper describes a solution hybridization method, the RNase protection assay [152; 177], 
which was used to quantify circadian rhythmicity in CHH mRNA levels. Furthermore, this 
method was used to detect low amounts of CHH-encoding transcripts in tissues other than the 
eyestalk. In addition, the presence or absence of CHH mRNA in several tissues of the 
crayfish, was verified by a qualitative detection method, the Polymerase Chain Reaction. 
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MATERIALS AND METHODS 
ChemicaL· 
Guanidinium thiocyanate was from Fluka. Restriction endonucleases and RNA 
polymerases were obtained from Gibco-BRL or Pharmacia. Formamide was from Janssen 
Biochemica. All other biochemicais were, unless otherwise stated, from Merck or Boehringer 
Mannheim. 
AnimaL· 
Specimen of the crayfish, Orconectes limosus, were obtained from local fishermen and 
were collected in the river Meuse (The Netherlands). The animals were kept in the laboratory 
in running tap water (13-15 eC) on a 12 hr light/12 hr dark cycle and were fed with fish once 
a week. The animals used for measuring RNA levels during a day/night cycle were starved for 
one week to avoid possible effects of food on CHH release. For these experiments male 
specimens were selected that had a similar thorax length (40 mm +/- 2 mm) and were in the 
same phase of the molting cycle (C-stage). During the dark period animals were collected 
from the animal stocking system using a red light. 
Specimen of the lobster, Homarus americanus, were obtained from a commercial 
importer and originated from the east coast of Canada. The animals were kept in the 
laboratory in artificial seawater at 4 CC for a maximum of one week after arrival. 
RNA isolation 
All glasware was heated at 250 °C for a minimum of 4 h and solutions were prepared 
with diethyl pyrocarbonate treated water. Total RNA was isolated according to the method of 
Chomczinski and Sacchi [43] using acid-guanidinium-thiocyanate-phenol-chloroform 
extraction. Briefly, tissue was homogenized in an all glass homogenizer containing 500 μ\ 
guanidinium thiocyanate solution (4 M guanidinium thiocyanate; 25 mM sodium citrate, pH 7; 
0.5% sarcosyl, 0.1 M 2-mercaptoethanol) and transfered to microcentrifuge tubes. 
Sequentially, 50 μΐ of 2 M sodium acetate (pH = 4), 500 μΐ phenol (water saturated) and 200 
μΐ chloroform-isoamylalcohol were added and the sample was mixed vigorously. RNA was 
recovered as supernatant after centrifugation (10.000 g/20 min), precipitated with ethanol and 
dissolved in bidest. The concentration was determined by measuring the absorbance at 260 
nm, whereby -4260=1 corresponds to 40 /xg/ml. Crayfish RNA was extracted in batches of 10 
medullae terminales or 10 animal equivalents of cerebral, thoracic and abdominal ganglia. For 
other tissues a maximum of approximately 100 mg wet weight was used. When measuring 
RNA levels during a day/night cycle, 10 ßg tRNA was added after the acid phenol extraction 
as a carrier in order to precipate all RNA in a quantitative way. Lobster RNA was extracted 
from dissected parts of the eyestalk in batches of four eyestalk equivalents; RNA from total 
cerebral, thoracic and abdominal ganglia was isolated from individual animals. 
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cRNA probe synthesis 
Anti-sense RNA probes were synthesized as run-off transcripts from 0.5 μg CsCl 
purified and lineairized recombinant cDNA (pBSORL-CHH or pBHOA-CHH-B; See Chapter 
6 and 8). The CHH sequence in pBSORL-CHH is a cDNA encoding the first 29 amino acids 
of CHH and was obtained by means of PCR between two degenerated oligonucleotide primers 
(Ml and M2, See Chapter 7). This sequence differs at two positions from the actual CHH 
mRNA sequence. Radioactive probes were synthesized in a final volume of 10 μ\ containing 
lx optimalized transcription buffer (Promega), 500 μΜ concentrations of rATP, rCTP, and 
rGTP, 50 /tCi rUTP (800 Ci/mM; Amersham), 15 Units RNasin (Promega) and 5 Units RNA 
polymerase. After 30 min at 37 "C, the sample was loaded on a 7 M urea-5% Polyacrylamide 
gel to separate the synthesized RNA from its DNA template. After identifying the position of 
the cRNA probe on an autoradiogram, the probe was recovered by elution into 2.5 M 
ammonium acetate for 2.5 hrs at 56 CC, followed by an alcohol precipitation in the presence 
of 10 ßg yeast tRNA (Gibco-BRL). The precipitate was redissolved in hybridization buffer 
(80% formamide; 40 mM PIPES, pH 6.4; 400 mM NaCI; ImM EDTA) and a small aliquot 
was counted to determine the amount of radioactive label. 
Solution hybridization assay (RNase protection assay) 
RNA samples (2 μΐ each) were mixed with 23 μΐ hybridization buffer containing the 
RNA probe (40.000-50.000 cpm), heated at 85 °C for 5 min and hybridized for 16 hrs at 55 
"C. Following hybridization 300 μΐ of RNase buffer (10 mM Tris, pH 7.5; 5 mM EDTA, pH 
8.0; 300 mM NaCI), 8 μg RNase A (Boehringer-Mannheim) and 0.5 μg RNase Tl 
(Boehringer-Mannheim) were added and digestion took place at 37 °C for 30 min. After 
treatment with 2.5 μg Proteinase K/0.1% SDS for 30 min at 37 "C, the samples were phenol 
extracted, precipitated with ethanol (with 10 μg t-RNA as carrier), dissolved in dye-sampler 
and electrophoresed on a polyacrylamide-urea sequencing gel. After drying the gel was 
fluorographed with one or two intensifying screens (Dupont). The signals from the 
autoradiograms were quantified by scanning with an Pharmacia/LKB ultrascan XL 
densitometer in combination with the appropriate Gelscan H software. Values are given after 
background substraction by scanning an empty lane on the X-ray film. 
cDNA synthesis and PCR 
cDNA synthesis. Ten μg of total RNA from several tissues of the crayfish (See results 
and discussion) was dissolved in 10 μΐ bidest, heated at 65 °C for 3 min and quenched on ice. 
The poly(A)+ mRNA content was preferentially reverse transcribed into cDNA by priming 
with 100 ng oligo d(15)T (PL Biochemicals) using 200 Units cloned Moloney murine reverse 
transcriptase (Gibco-BRL) in a final reaction volume of 20 μΐ containing 50 mM Tris-HCl, pH 
8.3 at 22 0 C, 75 mM KCl, 3 mM MgC^, 500 μΜ of each dNTP, 35 Units RNAsin 
(Promega) and 10 mM dithiothreitol. After incubation for 1 hr at 37 "C the synthesized cDNA 
was diluted to 500 μΐ with bidest and stored at -20 °C until use. 
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PCR. Crayfish CHH sequences were specifically amplified in the PCR using the 
prepared cDNA pool and appropriate oligonucleotide primers (See also Chapter 7: primer S3 
(sense to a sequence in the 5' untranslated region of CHH mRNA) and primer SI (anti-sense 
to the mRNA encoding amino acids 12-22 of CHH). Amplifications were carried out in 1 χ 
Taq-buffer (10 χ Taq-buffer is 500mM KCl, lOOmM Tris-HCl, pH 8.4 at 22 "C , 30 mM 
MgCl2, 2 mM dNTP and 1 mg/ml gelatin) containing 10 μΐ of the diluted cDNA pool, 50 
pmol of each primer and 1.5 Units of Taq polymerase (Perkin-Elmer/Cetus). The mixture was 
overlaid with 50 μ\ mineral oil and forty cycles of PCR in a Perkin-Elmer/Cetus DNA cycler 
were carried out: denaturation at 94 "C, 30 sec; annealing at 65 "C, 2 min; extension at 72 
"C, 3 min; final extension for 10 min at 72 "C. Twenty μ\ of the amplification mixtures was 
electrophoresed on a 2% agarose gel, which was subsequently stained with ethidium bromide. 
RESULTS AND DISCUSSION 
Sensitivity of the RNAse protection assay and CHH expression in the eyestalk 
First, the sensitivity of the nuclease protection assay and its suitability for determining 
CHH mRNA levels in individual crayfish was tested. We analyzed a serial dilution of RNA 
extracted from medullae terminales to investigate the minimum amount of RNA necessary to 
obtain a reliable signal. Furthermore, RNAs were isolated from several tissues in order to 
determine the specificity of the assay and to search for other sites of CHH mRNA synthesis. 
RNA/RNA hybrids protected from RNase digestion were electrophoresed as shown in Fig. 1. 
Although a number of protected products were found, we conclude that only three bands (A, 
В and C) are the result of specific protection by CHH encoding mRNA for the following 
reasons: 
(1) The sizes of the three products matched the predicted length of protected mRNA. The 
recombinant used for the synthesis of the antisense RNA probe contains two mismatches, 
hence a mixture of three products is expected of which the relative amounts depends on the 
effectiveness of the RNase digestion. Since single-stranded DNA markers were used, which 
are known to migrate 10 % slower compared to RNA [177], the lengths of the indicated 
protected RNA products fully agrees with the expected sizes. 
(2) The three bands were absent in protections of RNA preparations from control RNA or 
non-nervous tissue RNA (lane 1 and 11-16). 
(3) The total amount of the three products decreased, when less target RNA was used in the 
protection assay, while the signal of the other bands apparantly did not change. 
(4) When the dilution experiment was repeated three times, the same bands were consistently 
found, although the mutual intensity among the three bands varied. The decrease of the total 
signal, as quantified by laser scanning, was directly related to the amount of RNA assayed. 
We conclude that this assay is reliable and sensitive enough for detection of CHH mRNA in 
individual animals. 
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Fig. 1. СНН mRNA in the medulla terminalis and various tissues from Orconectes limosus 
determined with the RNase protection assay. A labelled anti-sense RNA probe was protected 
from RNase digestion by a diluted series of RNA obtained from the medulla terminalis (lane 
2-7) and various other tissues (lane 8-16) and 20 ^g t-RNA as control (Lane 1). Protected 
RNA was analysed by electrophoresis on a 10 % sequencing gel. Exposure time: 72 h. 
Lane: 
1: 20 μg t-RNA 
2: 5.00 MTequivalents 
3: 2.50 MTequivalents 
4: 1.20 MTequivalents 
5: 0.60 MTequivalents 
6: 0.30 MTequivalents 
7: 0.15 MTequivalents 
8: Cerebral ganglia, 20 μ% 
Lane: 
9 : Thoracic ganglia, 20 ^g (10 animals) 
10: Abdominal ganglia, 20 ^g (10 animals) 
11: Green gland, 120 /ig 
12: Hepatopancreas, 80 μg 
13: Tail muscle, 100 μg 
14: Hind gut, 80 ^g 
15: Stomach, 50 μg 
16: Fore gut, 150 ng 
(10 animals) 
Arrows on the left indicate the migration distance of single stranded DNA markers run 
simultaneously: A = 68, В = 62, and С = 45 bases. 
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Fig. 2. CHH mRNA in the optic ganglia and various tissues from Homarus americanus 
determined with the RNase protection assay. A labelled anti-sense RNA probe (anti-sense to 
CHH-B) was protected from RNase digestion by RNA obtained from the four optic ganglia 
of the eyestalk (lane 2-5) and various other tissues (lane 7-13). Two controls: 20 μg t-RNA 
(lane 1) or no RNA added (lane 6). Protected RNA was analysed by electrophoresis on a 8 
% sequencing gel. The gel was exposed for 24 h. 
Lane: 
1: Control (20/ig t-RNA) 
2: Lamina ganglionaris (10 fig) 
3: Medulla externa (10 /ig) 
4: Medulla interna (10 μg) 
5: Medulla terminalis (10 /ig) 
6: Control (bidest) 
7: Tail muscle (100 μg) 
Arrows on the left indicate the migration distance of single stranded DNA markers run 
simultaneously: A = 170 and В = 110 bases. 
Lane: 
8; Ovary (150 ^g) 
9: Green gland (90 μg) 
10: Hepatopancreas (80 /ig) 
11: Cerebral ganglia (30 /ig) 
12: Thoracic ganglia (30 /ig) 
13: Abdominal ganglia (30 /ig) 
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In a similar approach we were able to screen individual optic ganglia of the lobster, H. 
americanus, for the presence of CHH mRNA. An even more complex pattern of protected 
bands resulting from RNA out of the medulla terminalis was observed (Fig. 2). This can be 
explained by the presence of two different transcripts, CHH-A and B, in the lobster (See 
Chapter 6), resulting in additional partly protected RNAs. For this reason we used the RNase 
protection assay merely as a way to study the presence of CHH transcripts (CHH A and B) in 
tissues of the lobster, rather than a tool for the quantification of mRNAs. The screening of 
various parts of the eyestalk, revealed that CHH transcripts are only present in the medulla 
terminalis. 
CHH expression in tissues other than the eyestalk 
Protection of crayfish RNA from nervous tissues other than the medullae terminales 
(Fig. 1) revealed the presence of CHH-encoding mRNA in the thoracic ganglia and, in much 
lower amounts, also in the cerebral ganglia and abdominal ganglia. The amount of CHH 
mRNA in the thoracic ganglia of ten crayfish, is estimated to be similar to the amount present 
in one medulla terminalis (Fig. 3.). No specific signals were found in RNA preparations from 
the green gland, hepatopancreas, tail muscle, hindgut, stomach or foregut of the crayfish. 
Similar results were obtained for the distribution of CHH mRNA in lobster tissues 
(Fig. 2). Small amounts of CHH transcripts were found in the cerebral ganglia, thoracic 
ganglia and abdominal ganglia. CHH encoding mRNA could not be detected in the ovaría, 
hepatopancreas, tail muscle or green gland of this crustacean species. 
PCR was used to confirm the tissue distribution of CHH mRNA in O. limosus. RNA 
from these tissues was converted into cDNA and CHH-encoding cDNA sequences were 
amplified by 40 cycles of PCR using a combination of two CHH-specific oligonucleotide 
primers. An aliquot of the synthesized PCR products was analyzed by means of size selection 
on an agarose gel followed by ethidium bromide staining (Fig. 4.). The expected PCR product 
of 350 bp was present in the cDNA samples starting with RNA from the medulla terminalis, 
cerebral ganglia, thoracic ganglia and abdominal ganglia, while no bands were observed 
starting with RNA from the hepatopancreas, tail muscle or green gland. 
To our knowledge, this is the first report demonstrating that CHH is not only 
expressed in the medulla terminalis, but also in the cerebral-, thoracic- and abdominal ganglia. 
With the use of immunocytochemistry and a radio-immuno assay low amounts of CHH 
material were detected in the pericardial organ of the crab C. maenas [124]. The fact that the 
pericardial organs act as neurohemal organs for neurosecretory cells originating in the thoracic 
ganglia favors the idea that this neurohaemal organ might be a site for CHH release. Such an 
alternative source of CHH could explain the outcome of experiments where CHH still could 
be detected in the hemolymph of destalked animals [120]. Additional experiments, e.g., 
involving the measurements of CHH mRNA levels in thoracic (or cerebral, abdominal) ganglia 
at different periods of time after eyestalk ablation might give indications for the physiological 
significance of the alternative sources of CHH synthesis. 
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Fig. 3. Densitometrie analysis of bands indicated with А, В and С in Fig. 1. Also indicated 
is the total absorbance (A+B+C). Shown are the results obtained from the serial dilution of 
medulla terminalis RNA and thoracic ganglia RNA (from 10 animals). Results are expressed 
as amount of absorbance detected with densitometric laser scanning. On the basis of the 
calibration curve the amount of mRNA encoding CHH in the thoracic ganglia of one 
individual is estimated to be equivalent to 0.10 medullae terminales. 
Fig. 4. Amplification of cDNA using 
CHH mRNA-specific primers. PCR 
products were electrophoresed on a 
2% agarose gel and stained with 
ethidium bromide. Lane 1, DNA 
size markers (given in nucleotides); 
Lane 2-7 amplificated cDNA 
synthesized from RNA isolated from 
M e d u l l a T e r m i n a l e s ( 2 ) , 
Hepatopancreas (3), Tail muscle (4), 
Green Gland (5), Cerebral ganglia 
(6), Thoracic ganglia (7), Abdominal 
ganglia (8) of the crayfish, O. 
limosus 
1 2 3 4 5 6 7 8 
564 — 
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We realize that expression and translation of CHH mRNA in certain cells, not 
necessarily implies that CHH synthesis is the main objective of these cells. It cannot be ruled 
out that the CHH expression in nervous tissue other than the X-organ is aimed for the 
production of CPRP, the peptide N-terminally flanking CHH in the bipeptide precursor protein 
(Chapters 5 and 7 of this thesis). This would not be unusual since differential processing is 
also described for several neuropeptide precursors such as POMC and enkephalins [57;138]. 
Changes in CHH mRNA levels during a day/night cycle. 
To determine whether CHH mRNA levels in the X-organ change during a day/night 
cycle, total RNA was isolated from both medullae terminales of individual crayfish at different 
time points. On day one, RNA was collected at four time points around the change from the 
light period to the dark period (17.00, 18.00, 19.00 and 20.00 h; lights off at 18.10 h). On 
day two, three more RNA samples were collected (9.00, 13.00 and 17.00 h). The CHH-
encoding mRNA levels were measured by means of the RNase protection assay and all 
samples were assayed simultaneously which allowed a comparison of relative CHH mRNA 
levels between all animals and time points. The results, summarized in Fig. 5., clearly 
demonstrate a variation in CHH mRNA levels. The lowest levels were found around the shift 
from the light to the dark period (18.00 hr), while the highest levels were found 5 hrs before 
the onset of the dark period (13.00 hr). 
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Fig. 5. RNase protection analysis of CHH mRNA during the course of a day/night cycle. 
RNA was isolated from medullae terminales from individual animals (O. limosus) and 
analysed with the nuclease protection assay. Results are expressed as amount of absorbance 
detected with densitometric laser scanning. Given values are the mean of four animals +/-
SEM. Only the values obtained at 13.00 and 18.00 h differ significantly from each other 
(p<0.05; Student's t test). 
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Statistical analysis, using Student's t test, demonstrated only a significant difference (at ρ < 
0.05) between these two time points. These results extend earlier observations concerning the 
biosynthetic activity of CHH-cells in the course of a day/night cycle [76]. Based on 
immunocytochemical and ultrastructural investigations, it was concluded that protein synthesis 
during the light period was rather constant, followed by an increase in synthetic activity 2 h 
before the start of the dark period. At the beginning of the dark period CHH is released into 
the hemolymph, resulting in an immediate rise of the CHH concentration in the hemolymph 
and in hyperglycemia 2 to 4 h later. This is accompanied by a decrease in synthetic activity of 
the CHH producing cells. The same process is repeated, although to a lesser extend, in the 
early morning period resulting in CHH release just before the start of the light period. The 
data provided here, demonstrate that CHH synthesis might directly be related to CHH mRNA 
expression. In this view, it seems more likely that control mechanisms of CHH synthesis act 
on the transcription or stability of CHH mRNA rather than on the translational level. 
In conclusion, the RNase protection assay is well suited for measuring mRNA levels 
encoding CHH. Improved sensitivity of the assay can be obtained by extended and perfectly 
matching RNA probes, while the use of synthetic CHH sense RNA might generate standard 
curves for absolute quantification of CHH mRNA [13]. The nuclease protection assay will be 
a useful tool in future studies on the regulation of CHH gene expression during adaption to 
changes in the internal and external environment. 
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GENERAL DISCUSSION AND SUMMARY 
The study described in this thesis is focussed on crustacean hyperglycemic hormones 
(CHHs). These important crustacean neuropeptides are synthesized in the neuroendocrine 
system of the optic ganglia in the eyestalks of decapod crustaceans. This system is the most 
prominent neuroendocrine regulation and integration center, controlling a diversity of 
physiological important processes such as colour change, reproduction, molting, ion balance 
and metabolism by converting internal and external stimuli into adequate neurohormonal 
responses (See Chapter 1). CHH is involved in the regulation of many processes: it plays an 
important role in glycogen metabolism, stimulates release of digestive enzymes, affects 
molting, is involved in the regulation of oocyte development and is associated with effects 
resulting from stress due to oxygen depletion and crowding. This diversity in physiological 
responses and its proposed keyrole in the regulation of adaptation to environmental changes 
led to many investigations pointing to the isolation and biochemical characterization of this 
neuropeptide from numerous crustacean species. Until recently, however, most information on 
the biochemical properties was restricted to the determination of amino acid compositions and 
estimation of molecular weights of, often partially, purified CHHs. 
The first part of this thesis deals with the elucidation of the biochemical nature of 
CHH, with special attention to the existence of CHH-isoforms. The development and use of a 
two-step HPLC separation system, based on differences in charge and hydrophobicity of 
peptides, in order to isolate and purify CHH isoforms from sinus glands of the lobster 
Homarus americanus is reported in Chapter 2. With this HPLC system two sets of two closely 
related peptides could be purified to homogeneity. SDS-urea-PAGE analysis and bioassays 
revealed that one pair contained two peptides of about 6.5 kDa and which are both 
hyperglycemic. The other doublet consisted of two peptides of about 8 kDa, only one of these 
two provokes a hyperglycemic respons in recipient animals. 
A more detailed chemical characterization of the four CHHs from H. americanus is 
described in Chapter 3. Structural differences between the two groups of isoforms were found 
in their amino acid sequences (partially determined by automated Edman degradation), amino 
acid compositions and precise molecular weights. With the use of peptide mapping we 
established that the isoforms in each group differ within the first eight amino acids from the 
N-terminus. However, this difference is not due to the presence of different amino acids in 
this region, since all four peptides have the same N-terminal amino acid sequence unto residue 
19. The results of the precise molecular weight determination of these fragments exclude that 
major amino acid side chain modifications in this region might be responsible for the observed 
differences: the fragments have identical molecular weights. Although not verified by 
experimental data, an explanation for the observed difference might be the presence of a D-
amino acid in one of the peptides. Finally, the analyses of the amino acid composition and 
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sequence of carboxy-terminal fragments revealed an identical sequence (residue 66-72) for all 
four CHH isoforms. 
In order to screen the general presence of a family of CHH isoforms in decapod 
crustaceans, the crayfish O. limosus was studied, which is described in Chapter 4. Sinus 
glands of this species contain at least one set of two CHH isoforms that were characterized by 
peptide mapping, determination of molecular masses and elucidation of (partial) amino acid 
sequences. It was revealed that the difference between CHH isoforms is also located within the 
first eight amino acids. Another structurally related peptide(s), probably representing two 
isoforms, was also identified and characterized by precise mass determination. 
CHH is synthesized as part of a larger preprohormone, which also contains a 
precursor-related peptide, N-terminally flanking CHH. Chapter 5 describes the isolation and 
sequence analysis of CHH Precursor-Related Peptides (CPRPs) from sinus glands of O. 
limosus and H. americanus. The sequences of these peptides are compared with the published 
sequence of the CPRP counterparts from the land crab, Cardisoma carnifex, and the shore 
crab, Carcinus maenas. This revealed a high sequence identity in the N-terminal region 
(residues 1-13) of the CPRPs of all four crustaceans species. Resemblances in the C-terminal 
domain are restricted to lobster and crayfish CPRPs on the one hand and to CPRPs from both 
crab species on the other hand. The strong conservation of the N-terminal sequence includes 
the preservation of a liable monobasic processing site (position 11), therefore, the CPRPs are 
likely to be biosynthetic intermediates from which a potential bioactive decapeptide can be 
derived. 
The second part of the thesis describes the successful combination of peptide sequence 
information with a molecular biological approach in order to clone cDNAs encoding CHHs 
from the lobster and preproCHHs from the crayfish. 
Chapter 6 describes the isolation and characterization of cDNA clones that encode two 
CHHs from the lobster, H. americanus. The Polymerase Chain Reaction (PCR) was used in 
combination with degenerated oligonucleotide primers to generate these cDNA clones. The 
sequences of these primers were derived from the amino acid sequences of CHH as reported 
in Chapter 3. The deduced amino acid sequences fully agree with the data on partial amino 
acid sequences, amino acid compositions and molecular masses of hyperglycemic peptides in 
the lobster, provided in Chapter 3. It is shown that both cDNAs encode two CHHs that differ 
at 6 amino acids (92% identity). A comparative analysis between the deduced amino acid 
sequences of the two lobster CHHs and the CHH sequence from the shore crab, C. maenas, 
shows a high degree of sequence conservation and allowed to speculate on biologically 
important regions within these neuropeptides. 
With a similar approach, a transcript encoding a part of a CHH from the crayfish, O. 
limosus, was characterized. This information was used to set up a series of PCR experiments 
and subsequent sequence analysis of generated (c)DNAs, as is described in Chapter 7. The 
results of these experiments demonstrated the presence of at least two different transcripts 
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encoding preproCHHs in O. limosus. The characterized transcripts have a length of ~1600 
nucleotides long, as is confirmed by Northern hybridization. The first transcript consists of an 
- 1 0 0 nucleotides untranslated 5' region, which is followed by an open reading frame of 450 
nucleotides and a putative untranslated trailer sequence of —1100 nucleotides. The coding 
region encodes a putative signal peptide of 26 amino acids, followed by a CPRP of 33 amino 
acids, a doublet of basic amino acids (Lys-Arg) and finally, a 72 amino acids long CHH. The 
sequence of the second transcript seems to be very similar, however, only the first 400 
nucleotides were determined. The obtained sequence differs only at 4 positions from the first 
transcript, resulting into three amino acid substitutions in the translated preprohormone. One 
of these substitutions includes the C-terminal amino acid of a CPRP, which confirms the data 
obtained from peptide sequencing (Chapter 5). During the study two kinds of PCR artifacts 
were observed, demonstrating that sequences obtained by PCR, in general, should be 
confirmed by other methods e.g., (c)DNA library screening, Northern hybridization or RNA 
mapping experiments. 
In the third part of the thesis the obtained molecular biological results were used to study the 
mechanisms that regulate CHH gene expression within the CHH-producing cell system. The 
aim of these introductory investigations was to extend our knowledge on the cellular dynamics 
of the aforementioned CHH-cells in relation to changes in the internal and external 
environment, which is thus far mainly based on immunocytochemical and histophysiological 
studies. 
In Chapter 8, non-radioactive labelled RNA probes, transcribed from a recombinant 
plasmid containing a CHH cDNA sequence of H. americanus were used succesftilly in an in 
situ hybridization assay in order to detect CHH-encoding mRNA in the eyestalks of this 
species. For the detection of CHH mRNA in the crayfish, non-radioactive labelled RNA 
probes were synthesized from a recombinant encoding the first 29 amino acids of CHH in this 
species. The specificity of the in situ hybridization reaction was confirmed by immunostaining 
with antisera against CHH on alternate sections and the absence of a hybridization reaction 
using control (sense) RNA probes. In addition, no hybridization was observed using the 
crayfish specific antisense RNA probe on lobster eyestalks. 
The first applications of a sensitive assay (RNase protection assay) in order to quantify 
CHH mRNA levels is presented in Chapter 9. First, the sensitivity of the assay was tested in 
O. limosus on serially diluted RNA extracted from a selected part of the eyestalk, the medulla 
terminalis containing the CHH-synthesizing perikarya from the X-organ. These data indicated 
that the assay was sensitive enough for CHH mRNA detection in individual animals. The 
specificity of the assay was checked by assaying RNAs extracted from several tissues 
including nervous tissue from non-eyestalk origin. Unexpectedly, it turned out that the CHH 
gene is also expressed in other parts of the central nervous system (cerebral-, thoracic-and 
abdominal ganglia). No CHH mRNA was found in other examined tissues. These observations 
were confirmed with a mRNA/PCR method using two CHH specific oligonucleotide primers. 
133 
General discussion and summary 
Finally, the nuclease protection was used to quantify changes in CHH mRNA levels in 
medullae terminales of individual crayfish during a day/night period. It is demonstrated that 
the highest levels of CHH mRNA are found 5 h before the onset of the dark period, while 
significant lower amounts were detected at the transition from the light to the dark period. 
A similar protection assay was used for the qualification of CHH mRNA in the lobster, H. 
americanus. Protection from RNase digestion was achieved with RNA isolated from the 
medulla terminalis, while no CHH mRNA was detected in the other optic ganglia (lamina 
ganglionaris, medulla interna and medulla externa). CHH transcripts were also found in the 
cerebral-, thoracic- and abdominal ganglia. 
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Het is voor alle dieren van levensbelang om met een gepast antwoord te kunnen 
reageren op veranderingen in het interne en externe milieu. In de eerste helft van deze eeuw 
dacht men dat hierbij twee systemen betrokken waren: het zenuwstelsel en het endocriene 
system. Volgens deze opvatting was het zenuwstelsel vooral betrokken bij de besturing van 
snelle processen veroorzaakt door, in de regel, kortdurende prikkels, terwijl het endocriene 
systeem voornamelijk langdurige processen controleerde die hun oorsprong vonden in 
langzame veranderingen in interne en externe omstandigheden. 
Deze verschillende eigenschappen zijn terug te vinden in de opbouw van beide 
regulatiesystemen. Het zenuwstelsel bestaat uit zenuwcellen (ook neuronen genoemd) die 
speciaal ingericht zijn voor de snelle overdracht van signalen. De cellichamen van deze 
neuronen ontvangen een signaal van andere neuronen of zintuigcellen en kunnen deze prikkel 
omzetten in een electrisch signaal, de actiepotentiaal. Deze actiepotentiaal wordt vervolgens 
getransporteerd over een zenuwceluitloper, het axon, naar andere cellen waar het eindigt op 
een gespecialiseerde structuur, de synaps. Middels de synaps wordt de prikkel overgedragen 
naar een andere cel doordat aan het axon uiteinde (presynaps) het electrische signaal wordt 
omgezet in een chemisch signaal (neurotransmitter) dat via de synaptische ruimte diffundeert 
en receptoren bereikt aan de postsynaptische zijde. Omdat de synaptische ruimte klein is, is 
het op deze manier mogelijk om met kleine hoeveelheden neurotransmitter, cellen aan de 
postsynaptische zijde te beïnvloeden. 
Het endocriene systeem bestaat uit secreterende cellen die tesamen endocriene klieren 
vormen. De synthese-activiteit van deze klieren en de afgifte van hun produkten wordt in de 
meeste gevallen gereguleerd door middel van chemische prikkels die elders worden 
geproduceerd. In het algemeen kunnen twee typen endocriene klieren onderscheiden worden: 
de steroid producerende- en de eiwit producerende klieren. In beide typen wordt het 
gesynthetiseerde product, hormoon genoemd, direct afgegeven aan het bloed. Hierdoor wordt 
een hormonale boodschap, in tegenstelling tot een neuronale boodschap, verdund en moet een 
veel langere weg aflegd worden om een doelwitorgaan te bereiken. Dit probleem is in de regel 
ondervangen door de aanmaak en afgifte van grote hoeveelheden hormoon of doordat de 
endocriene klier gelegen is in de buurt van het doelwitorgaan. Daarnaast beschikken 
doelwitorganen vaak over selectieve receptoreiwitten die gevoelig zijn voor kleine 
hoeveelheden hormoon. Dit receptormechanisme heeft als bijkomend voordeel dat één 
circulerend hormoon meerdere doelwitorganen tegelijkertijd kan beïnvloeden. 
Het dualistische concept van regulatie en communicatie door het zenuwstelsel en het 
endocriene systeem bleek in latere jaren te simplistisch te zijn. Allereerst, werd het 
neuroendocriene system ontdekt. Dit system combineert veel aspecten van zenuwcellen en 
eiwitproducerende endocriene klieren. Neuroendocriene cellen bezitten de mogelijkheid om 
eiwitten te synthetiseren die via axonen getransporteerd worden en direkt aan het bloed kunnen 
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worden afgegeven. De afgifte van deze eiwitten, neurohormonen, vindt plaats via 
neurohaemale eindigingen. Verder bleek dat zenuwcellen, naast neurotransmitters, ook kleine 
eiwitten, neuropeptiden, gebruiken voor de signaal overdracht binnen een synaps en dat beide 
typen boodschappers in hetzelfde axonuiteinde kunnen worden aangetroffen. Het is nu 
duidelijk dat het neuroendocriene systeem van groot belang is voor de regulatie van vitale 
levensprocessen en dat dit system voorkomt in alle diergroepen, van holtedieren tot 
zoogdieren. 
Voor functionele studies aan neuropeptiden en de coördinerende rol van 
neuroendocriene systemen in de aanpassing aan veranderingen in interne en externe 
omstandigheden zijn simpele neuroendocriene modelsystemen van wezenlijk belang. Voor veel 
onderzoek in de neurobiologie wordt daarom gebruik gemaakt van ongewervelde dieren, die 
relatief eenvoudige neuroendocriene systemen bezitten. Schaaldieren (krabben, kreeften, 
garnalen e.d.() zijn met name geschikt voor zulke studies, omdat uit onderzoek gebleken is dat 
neuropeptiden in deze diergroep een coördinerende rol spelen in de adaptatiefysiologie. Van 
bijzonder belang is het feit dat bij schaaldieren neuroendocriene systemen betrokken zijn bij de 
regulatie van zowel kortdurende als langdurende processen. Bijvoorbeeld, pigmentverplaatsing 
in de huid (ten einde de kleur van de achtergrond te kunnen aannemen), hartslag en 
bewegingsactiviteit zijn kortdurende en snelle processen die neuroendocrien gereguleerd zijn; 
koolhydraatstofwisseling, ademhaling en water- en ionenhuishouding zijn middentermijn 
processen die onder neuroendocrine controle staan en endogene ritmiek, groei en voortplanting 
zijn langetermijn processen die eveneens door middel van neuropeptiden gecoördineerd 
worden. 
Onderdelen van het neuroendocrine system worden in schaaldieren in het gehele 
zenuwstelsel aangetroffen. Het belangrijkste neuroendocriene systeem is gelegen in de oogsteel 
van deze dieren en wordt het Medulla Terminalis Ganglioniair X-orgaan sinusklier (MTGXO-
SG) complex genoemd. Dit systeem ontleent zijn naam aan de plaats waar de cellichamen van 
de neuroendocrine cellen gelegen zijn, namelijk op het laatste ganglion (Medulla Terminalis) 
van de vier optische ganglia in de oogsteel. Deze cluster van cellichamen werd reeds in 1882 
beschreven als X-orgaan, omdat de functie van deze cellen op dat moment nog onbekend was. 
Rond 1950 werd aangetoond dat deze cellen neuroendocrien (peptiderg) van aard waren en dat 
hun axonuitlopers een neurohaemaal afgiftegebied vormen, de sinusklier. Latere studies wezen 
uit dat deze sinusklier ook een klein aantal axoneindigingen bevat van andere neuroendocriene 
cellen, die verspreid liggen in alle vier de optische ganglia. Bovendien werden er ook 
verbindingen vanuit de hersenen met de sinusklier aangetoond. Tevens werd een tweede 
cluster van neuroendocriene cellichamen, gelegen aan de grens van de Medulla Externa, 
gevonden, die de sinusklier als neurohaemaal afgiftegebied gebruiken. Dit celcluster werd 
MEX-orgaan genoemd. In Fig. 1 van Hoofdstuk 1 is een schematische overiangse doorsnede 
van een oogsteel te zien met de ligging van de vier optische ganglia, beide X-organen en de 
sinusklier. Een lichtmicrospische opname van een oogsteel kan gevonden worden in Hoofdstuk 
8. 
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In het MTGXO-SG complex worden een aantal verschillende neuropeptiden 
gesynthesiseerd die betrokken zijn bij de regulatie van diverse biologische processen. Ter 
illustratie is in Fig. 2 van Hoofdstuk 1 een schema gepresenteerd waarin wordt aangegeven 
welke rol de oogsteel speelt in de ontvangst en integratie van interne en externe stimuli. 
Tevens is weergegeven hoe het neuroendocriene MTGXO-SG complex deze stimuli omzet in 
peptiderge signalen, die na afgifte uit de sinusklier, effecten hebben op een aantal 
verschillende doelwitorganen. Helaas zijn veel gegevens over de neuroendocriene regulatie 
door oogsteelpeptiden afkomstig van experimenten waarin fysiologische deficiënties bestudeerd 
werden ten gevolge van de verwijdering van de totale oogsteel. Hierbij werd zelden rekening 
gehouden met de onvermijdelijke bij-effecten van dergelijke ingrijpende operaties. Daarom 
zijn vermoedelijke neuroendocrine regulatiewegen aangegeven met stippellijnen. 
Het Crustaceëen Hyperglycemisch Hormoon (CHH) is een hormoon dat in de loop der 
jaren het meest bestudeerd is. Ongeveer 50 jaar geleden werd aangetoond dat oogstelen van 
schaaldieren een "diabetogene" (hyperglycemische) faktor bevatten. Injectie van oogsteel-
extracten leidde tot een verhoging van de bloedglucosespiegel en ongeveer 90% van de 
activiteit van deze faktor bevond zich in de sinusklier. Dit bioassay werd gebruikt om CHH te 
isoleren uit oogstelen van diverse soorten schaaldieren met behulp van "klassieke" 
zuiveringsmethoden. Deze aanpak bleek succesvol genoeg voor de ontwikkeling van 
polyclonale antilichamen die gericht waren tegen gedeeltelijk gezuiverd CHH van een 
rivierkreeft. Met behulp van deze antilichamen konden ongeveer 30-35 grote CHH-
producerende cellen (50 μπι) als een subgroep binnen het MTGXO-SG complex van deze 
kreeftensoort geïdentificeerd worden. Met behulp van deze immunocytochemische methode, 
werden later niet alleen CHH-cellen en axonbanen in verschillende schaaldiersoorten 
gekarakteriseerd, maar konden ook grote overeenkomsten in de morfologie van het CHH-
producerende celsysteem binnen alle onderzochte schaaldiersoorten aangetoond worden. 
Door immunocytochemische technieken te combineren met een fysiologische aanpak 
kon ook de secretorische dynamiek van deze cellen gedurende een dag/nacht cyclus bestudeerd 
worden. Het verloop van het glucosegehalte in de haemolymfe vertoont namelijk een 
dag/nacht ritmiek waarbij er twee tot vier uur na het begin van de donkerperiode een piek in 
het glucosegehalte optreedt. Er werd aangetoond dat de produktie van CHH en het transport 
vanuit de cellichamen naar de sinusklier, twee uur voor aanvang van de donkerperiode 
gestimuleerd wordt. De afgifte van het hormoon op het moment van de licht/donker overgang 
is vervolgens de oorzaak van de glucosepiek in het bloed twee tot vier uur later. Op basis van 
vervolgexperimenten werd geconcludeerd dat er hier sprake is van een endogene ritmiek die 
beïnvloed wordt door geïntegreerde signalen van een in de oogstelen gelegen biologische klok 
en van lichtstimuli. 
De regulerende rol van CHH bleek niet beperkt tot de koolhydraatstofwisseling. Het 
hormoon stimuleert namelijk ook de afgifte van spijsverteringsenzymen door de 
middendarmklier, het heeft effecten op de vervelling, is betrokken bij de regulatie van de 
ontwikkeling van eicellen en wordt geassocieerd met stresseffecten als gevolg van bijv. 
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zuurstoftekort. Deze diversiteit in fysiologische effecten was de aanleiding voor veel 
onderzoek naar de biochemische structuur en eigenschappen van dit hormoon in een aantal 
verschillende schaaldiersoorten. Tot voor kort echter, was men niet verder gekomen dan een 
schatting van de lengte (SO tot 60 aminozuren) en de aminozuursamenstelling van gedeeltelijk 
gezuiverd hormoon. Verder werd er verondersteld dat de verschillende effecten van CHH 
mogelijkerwijs niet toegeschreven moesten worden aan één eiwit, maar dat er sprake was van 
een aantal verschillende, maar in structuur op elkaar gelijkende, moleculen. Het ontbreken van 
verdere informatie omtrent de (bio)chemische structuur van CHH en CHH-isovormen was de 
direkte aanleiding voor het onderzoek zoals dat beschreven staat in dit proefschrift. 
Het eerste gedeelte van dit proefschrift betreft de zuivering en biochemische 
karakterizatie van hyperglycemische hormonen uit de sinusklieren van een tweetal 
schaaldiersoorten, de zeekreeft, Homarus americanus en de rivierkreeft, Orconectes limosus. 
In Hoofdstuk 2 wordt de ontwikkeling en het gebruik van een tweestaps HPLC 
zuiveringsprocedure beschreven, waarbij eiwitten op grond van verschillen in lading en 
wateroplosbaarheid van elkaar gescheiden worden. Met behulp van dit HPLC systeem konden 
twee groepen van twee sterk op elkaar gelijkende CHHs (CHH-isovormen) gezuiverd worden 
uit de zeekreeft, H. americanus. Van deze vier CHHs, aangeduid met CHH I, II, VI en VII, 
bleken er drie hyperglycemisch actief in de rivierkreeft, O. limosus (CHH I, II and VII). De 
molecuulgewichten van de hormonen werden bepaald op -6500 Da voor CHH I en II en 
- 8000 Da voor CHH VI en VII. 
Een meer gedetailleerde chemische karakterizatie van deze CHH isovormen uit 
sinusklieren van de zeekreeft is beschreven in Hoofdstuk 3. Allereerst werd voor alle vier de 
CHHs de volgorde van deze eerste 20 en laatste 7 aminozuren bepaald. Verder werd de 
aminozuursamenstelling en een nauwkeurige moleculaire massa van het gehele eiwit-molecuul 
vastgesteld. Op grond van deze gegevens werden de vier CHHs verdeeld in twee paren van 
twee sterk op elkaar gelijkende isovormen (CHH I/II en CHH VI/VII). Tussen deze twee 
paren werden verschillen gevonden: de aminozuurvolgordebepaling gaf een aparaginezuur op 
positie 20 voor CHH I en II, terwijl CHH VI/VII een asparagine bevatten op deze positie. De 
resultaten van de analyse van de aminozuursamenstelling en de moleculaire massa, gaven 
aanwijzingen voor additionele verschillen. De chemische aard van het verschil tussen twee 
isovormen binnen één paar kon niet achterhaald worden, wel werd aangetoond dat zowel CHH 
I en II als CHH VI en VII op identieke wijze van elkaar verschillen. Dit verschil werd ook 
gelokaliseerd en bevindt zich in de eerste 8 aminozuren. Opvallend genoeg bleken voor twee 
isovormen CHH fragmenten van aminozuur 1-8 (verkregen door gerichte proteolytische 
afbraak) niet te verschillen in molecuulgewicht; ook werden er geen verschillen in 
aminozuurvolgorde in deze regio gevonden. De meest voor de hand liggende verklaring lijkt 
daarom de vervanging van een L-aminozuur in de ene isovorm, door een D-aminozuur in de 
andere isovorm. 
In Hoofdstuk 4 wordt verslag gedaan van de zuivering en karakterizatie van CHH 
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isovormen uit de sinusklier van de rivierkreeft, O. limosus. Allereerst werd met behulp van de 
tweestaps HPLC methode in combinatie met bioassays van gezuiverde eiwitten, de CHHs in 
de sinusklieren van deze kreeften geïdentificeerd. Het meest voorkomende CHH werd nader 
gekarakterizeerd door bepaling van een gedeelte van de aminozuurvolgorde, de 
aminozuursamenstelling en het molecuul gewicht. Tevens werd aangetoond dat het hier om 
twee isovormen van sterk op elkaar gelijkende moleculen gaat, die verschillen in de eerste 8 
aminozuren. Verder werd er een nog een CHH molecuul geïdentificeerd dat mogelijk ook uit 
twee isovormen bestaat. Omdat er slechts weinig van dit eiwit aanwezig is in de sinusklier van 
deze kreeftensoort is hiervan alleen het precieze molecuul gewicht bepaald. 
CHH wordt gesynthetizeerd als onderdeel van een hoogmoleculair precursoreiwit 
(prohormoon) van —HO aminozuren dat vervolgens gesplitst wordt in CHH (72 aminozuren) 
en een CHH Precursor geRelateerd Peptide (CPRP). In Hoofdstuk 5 is de isolatie en 
sequentie-analyse van CPRPs uit sinusklieren van H. americanus en O. limosus beschreven. 
Deze aminozuursequenties worden vergeleken met de gepubliceerde sequenties van CPRPs uit 
de landkrab, Cardisoma carnifex en de Noordzee krab, Carcinus maenas. Uit deze 
vergelijking kon worden afgeleid dat het N-terminale gedeelte, aminozuur 1-13, van deze 
eiwitten een hoge mate van homologie vertoont, terwijl in de C-terminus de 
sequentiehomologie beperkt blijft tussen de CPRPs van de kreeften soorten enerzijds en de 
krab soorten anderzijds. In het N-terminale gedeelte van de eiwitten blijkt ook een potentiële 
proteolytische splitsingsplaats (op positie 11) geconserveerd te zijn. Dit suggereert dat de 
CPRPs biosynthetische intermediairen zijn, waaruit, na klieving, een potentieel bioaktief 
decapeptide ontstaat. 
In het tweede gedeelte van dit proefschrift is beschreven hoe met behulp van 
moleculair-biologische technieken de sequenties van twee CHHs uit de zeekreeft en de 
structuur van de CHH-precursor(s) uit de rivierkreeft opgehelderd konden worden. 
Hoofdstuk 6 beschrijft de generatie, isolatie en karakterizatie van cDNA klonen die 
voor twee CHHs van de zeekreeft, H. americanus, coderen. Hiertoe werd gebruik gemaakt 
van de Polymerase Ketting Reactie (PCR) in combinatie met ontaarde oligonucleotideprimers. 
De sequenties van deze primers waren afgeleid van de CHH aminozuur sequenties zoals 
bepaald in het eerste gedeelte van dit proefschrift (Hoofdstuk 3). De totale CHH 
aminozuursequenties, afgeleid van de cDNA sequenties, komen volledig overeen met de 
eerder verzamelde gegevens betreffende de particele aminozuursequenties, 
aminozuursamenstellingen en molecuul gewichten van CHHs uit de zeekreeft. Het blijkt dat 
beide CHHs uit 72 aminozuren bestaan en slechts op 6 plaatsen van elkaar verschillen (92% 
homologie). Verder zijn deze sequenties vergeleken met de aminozuurvolgorde van CHH van 
de crab, С. maenas, waardoor het mogelijk werd om potentieel biologisch actieve gebieden 
van deze hormonen aan te duiden. 
Op een vergelijkbare manier als beschreven in Hoofdstuk 6, bleek het ook mogelijk 
om een gedeelte van de mRNA-sequentie, coderend voor CHH in de rivierkreeft, O. limosus, 
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te verkrijgen. Uitgaande van deze sequentie-informatie in combinatie met een serie van PCR 
experimenten werden twee mRNA transcripten, van ongeveer 1600 nucleotiden lang, 
geïdentificeerd. Van één transcript werd de totale coderende sequentie bepaald. Hier werd uit 
afgeleid dat 450 nucleotiden van dit transcript vertaald worden naar aminozuren, welke 
tezamen de primaire structuur van het CHH preprohormoon vormen. In deze 
prohormoonstructuur wordt CHH aan de N-terminale zijde geflankeerd door een CPRP. Van 
het tweede transcript werd alleen de volgorde van de eerste 400 nucleotiden bepaald. Dit 
gedeelte codeert voor een bijna identieke CHH-preprohormoonsequentie met een CPRP dat 
slechts één aminozuur verschilt. De afgeleide aminozuursequenties van beide CPRPs komen 
volledig overeen met de sequenties zoals die bepaald werden via de eiwitchemische benadering 
(Hoofdstuk 5). 
Het derde gedeelte van dit proefschrift beschrijft hoe de informatie die verkregen werd uit de 
moleculair-biologische benadering gebruikt kan worden om de expressie van het CHH-gen te 
bestuderen. Het uiteindelijke doel van deze experimenten is om meer kennis te vergaren over 
de cellulaire dynamiek van de CHH-cellen in relatie tot veranderingen in het interne en 
externe milieu. 
In Hoofdstuk 8 is de ontwikkeling beschreven van een in situ hybridizatie assay ten 
einde mRNA coderend voor CHH aan te tonen in weefselcoupes. Door gebruik te maken van 
een antisense RNA probe, gelabeld met een enzymatisch detecteerbare marker (digoxigenine), 
kon het CHH mRNA in de CHH-cellen van de rivierkreeft, O. limosus, zichtbaar gemaakt 
worden. Op een vergelijkbare manier was het ook mogelijk om het CHH mRNA in de in de 
oogsteel gelegen CHH-cellen van de zeekreeft, H. americanus, aan te tonen. De specificiteit 
van de in situ hybridizatie werd benadrukt door het feit dat gelabelde RNA probes, specifiek 
voor het rivierkreeft CHH mRNA, geen reactie gaven in de CHH cellen van de zeekreeft. 
In Hoofdstuk 9 is aangetoond dat het mogelijk is om met een vloeistof-hybridizatie 
assay (RNase protectie assay) mRNA coderend voor CHH te kwantificeren. De gevoeligheid 
van het assay werd getest op een verdunningsreeks van totaal RNA uit de Medulla Terminalis 
van O. limosus. Uit deze experimenten bleek dat het mogelijk is om CHH mRNA 
hoeveelheden in individuele dieren te bepalen. Door deze gevoeligheid kon de expressie van 
het CHH-gen (CHH-genen) gedurende een dag/nacht cyclus gevolgd worden. Voorlopige 
resultaten wijzen er op dat ongeveer 5 uur voor de licht/donker overgang het meeste CHH 
transcript aanwezig is; deze hoeveelheid neemt af en is tijdens de overgang van licht naar 
donker op het laagste niveau. Deze gegevens leidden tot de veronderstelling dat de toename in 
eiwitsynthese-activiteit van de CHH-cellen (— 2 uur voor de licht/donker overgang) vooraf 
gegaan wordt door een verhoogde genexpressie. Door de sensitiviteit van het asssay bleek het 
ook mogelijk om CHH transcripten te detecteren in neuronen van het centraal zenuwstelsel die 
niet in de oogsteel gelegen zijn (hersenen, thoracale ganglia en abdominale ganglia). Deze 
gegevens werden bevestigd met behulp van PCR experimenten. 
Het RNase protectie assay bleek in aangepaste vorm ook toepasbaar op de detectie van 
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CHH mRNA in H. americanus. Op grond van deze experimenten werd aangenomen dat CHH 
transcripten in de oogsteel waarschijnlijk alleen voorkomen in de Medulla Terminalis en niet 
in de andere optische ganglia. Verder werden er ook in deze kreeftensoort CHH transcripten 
aangetoond in de hersenen, thoracale- en abdominale ganglia. 
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NAWOORD 
De stelling: "De donkere kamer van Damocles is de titel van een boek dat door een 
moleculair-bioloog geschreven had kunnen worden" is helaas niet toegevoegd aan dit 
proefschrift. Niettemin, wil ik op deze plaats duidelijk maken dat er nog al wat (technische) 
hobbels genomen moesten worden voordat het onderzoek zoals dat in dit proefschrift 
beschreven staat uitgevoerd kon worden. Verschillende mensen hebben op de diverse 
manieren bijgedragen aan de uiteindelijke totstandkoming van het produkt (het proefschrift) 
en/of het begeleiden, meebeleven van het proces (promotie-onderzoek) die ik op deze plaats 
wil bedanken. 
De professoren, J.-M Denucé, W. Hennig, E. Roubos, J.C.C. Schoenmakers van de 
KUN en J. Joosse, R.J. Planta van de VU zou ik willen bedanken voor het beschikbaar 
stellen van de diverse faciliteiten waardoor het mogelijk werd om een moleculair-biologische 
richting in te slaan en G.I. Tesser (KUN) voor zijn enthousiaste bij- en nascholings 
'cursussen' eiwitchemie. 
Prof. S.E. Wendelaar Bonga, alsmede dr. Gerard Martens en dr. Wijnand Geraerts 
ben ik erkentelijk voor het feit ze als leden van de manuscriptcommissie de ruwe versie van 
het proefschrift bijgeschaafd hebben (Gerard ook nog bedankt voor het corrigeren van de 
diverse publicaties). 
Het produkt kwam mede tot stand dankzij de directe hulp van K.P.L.C. Janssen (weet 
je al hoe oud Tigana is?) en 'Der' Tony (of Tony the cutter) Coenen. Verder wil ik bij deze 
ook de part-time dierverzorger Guus Goyvaerts, en de jongens uit de kelder cq. van het 
bureau John Stassen, Frans Gielen en 'Risky' Rob Donker bedanken voor het verzorgen van 
de dieren en de assistentie in de late uurtjes. Rien van der Gaag en Roel van der Schors 
waren medeverantwoordelijk voor de diverse aminozuur (sequentie) analyses, Daniel Soyez 
(bon courage) bemiddelde in de FAB/MS (SM/BAF ?) analyses. Eveline de Rijk (succes in 
november) en Ed Kuipers, studenten uit het pré-PCR tijdperk. Marcel aan de Brug en Joan 
Berkeljon wil ik bedanken voor hun hulp tijdens het onderzoek en Adriaan Verhoeven voor 
zijn assistentie bij het schrijven (zie Hoofdstuk 5!). Dat de gegevens die uit de diverse 
experimenten kwamen nu op papier staan is mede te danken aan de mensen van de afdeling 
illustratie/fotografie, het opgewekte humeur van Diskdoctor Hans Leenders (die het toch maar 
weer uitlegde), de computer van Diskdoctorandus Hans de Wit en (Drs?) Kees van Dun (die 
de inleiding op het Amerikaans controleerde). De omslag van het proefschrift werd gemaakt 
door Ine de Cock. 
Bij het acclimatisatie proces in mijn eerste periode in Nijmegen waren diverse mensen 
belangrijk. Zo wist Janine (Kallen) mij haarfijn uit te leggen dat er cellen te vinden waren 'in 
die witte massa'(ook bedankt voor je hulp bij het schrijven en je interesse voor zaken die niets 
met kreeften neuro-endocrinologie te maken hebben); Paul Balm en Peter Cruijssen maakten 
me snel wegwijs op het isotopenlab en de tweede verdieping. Terug in Amsterdam werden de 
in eerste instantie tegenvallende resultaten dragelijker gemaakt door de aanwezigheid van de 
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diverse Bio Boys (& girls). Vooral Dr. E. M. M. Vreugdenhil (Erno voor intimi) wil ik bij 
deze nog bedanken voor de 'theoretische' basiscursus moleculaire biologie en de gastvrijheid 
op het lab, Jantje. B. voor de PCR-tip en de praktische hulp en Guus Smit voor het 
ongebreidelde enthousiasme. Verder toonden Co Klootwijk en Harm van Heerikhuizen ook 
jaren later nog interesse voor mijn reilen en zeilen in Nijmegen. 
Nijmegen revisited bracht nog al wat opstart problemen met zich mee. In eerste 
instantie bleek ik bij Rob de Graaf aan het goede adres te zijn voor materiële en immateriële 
hulp, later herontdekte ik met de botanen (Koen Weterings en Ton Peeters) het spreekwoord: 
"gedeelde smart, is halve smart" en bleek Maarten van Riel m.i. op dezelfde golflengte te 
zitten. Samen met Martin Gerhardus ontwikkelde ik Modified Von Braun's en een frisse adem 
op vrijdagmorgen, terwijl Peter Janssen een jaar lang mijn klaagzangen aanhoorde. In dit 
verband, klagen en zeuren, wil ik ook Wim Geerts bedanken dat hij tijdens dergelijke 
periodes de zaken weer tot aardse proporties terug wist te brengen. Gelukkig waren er ook 
nog de weekeinden met de diverse dames en heren van Bio Bacchus (en F.J.), die misschien 
niet altijd van hoogstaand wetenschappelijk gehalte waren, maar er in ieder geval wel voor 
zorgden dat de accu weer werd opgeladen, nog bedankt. 
Tot slot, en zeker niet 'least' wil ik nog een paar mensen noemen zonder wie het 
allemaal niet gelukt was. Allereerst, mijn ouders die mij veel ruimte en de mogelijkheid 
geboden hebben om te gaan studeren, hetgeen uiteindelijk resulteerde in dit proefschrift. 
Verder Dominique, die nauw betrokken is geweest bij het produkt en het proces en die met 
zijn enthousiasme mij uit menig dalletje heeft geholpen. Ik ben benieuwd hoe we in de 
toekomst het welslagen van belangrijke experimenten moeten gaan coördineren. 
Mijn zeergeleerde copromotor, beste François, sorry voor de slapeloze nachten. Zonder te 
willen overdrijven, moet het toch van mijn hart dat jij, voor iemand met mijn karakter en 
soms chaotische werkwijze, waarschijnlijk de ideale begeleider bent geweest. Ik hoop dat je 
deze 'stijl', inzet en dit enthousiasme in de toekomst voortzet, zodat er meer mensen van 
kunnen genieten. 
Lieve Ans, bedankt dat je me hebt laten inzien het proces een bovenstijgende (of was het 
overstijgende) waarde heeft en mij de rust en ruimte hebt gegeven om het proefschrift te 
schrijven. Ik denk dat je nu wel meer aandacht zult krijgen. 
En voor iedereen, Hoi Hè. 
1S8 
СиКИСиьиМ VITAE 
De schrijver van dit proefschriñ is op 8 augustus 1957 in Leiden geboren. Tijdens een 
gelukkige jeugd doorliep hij achtereenvolgens met succes de lagere school en de middelbare 
school (ongedeeld VWO; Alkwin College, Uithoorn). In 1976 begon hij met de studie 
Biologie aan de Vrije Universiteit te Amsterdam. In november 1979 legde hij het 
kandidaatsexamen af (BI met wiskunde). Het hoofdvakonderzoek (Neurobiologie) werd 
verricht op de afdeling Vergelijkende Endocrinologie (prof. dr. J. Joosse, dr. W.P.M Gerearts 
en dr. R.H.M Ebberink) en de bijvakonderwerpen werden uitgevoerd op de afdeling 
Histologie (prof. dr. H.H. Boer, dr. W.P.W van der Knaap) en de afdeling Immunologie van 
de Faculteit Geneeskunde (prof. dr. T. Sminia). Tijdens de doctoraalfase werd een bijdrage 
geleverd aan het biologie-onderwijs (morfologie van gewervelde cq. ongewervelde dieren). 
Tevens werden de cursussen radiologische werkwijzen, vloeistof scintillatie metingen en 
gamma spectrometrie (dr. Spronk) en mariene Biologie (dr. F. Creutzberg, NIOZ, Texel) 
gevolgd. In februari 198S werd de studie Biologie afgesloten met het doctoraal examen. In 
maart 1985 volgde een aanstelling als wetenschappelijk assistent aan het Zoologisch 
Laboratorium I van de Katholieke Universiteit te Nijmegen (prof. dr. J.-M. Denuce) binnen de 
werkgroep Neuro-endocrinologie van schaaldieren (dr. F. van Неф). Van 1 november 1985 
tot 1 januari 1987 was de schrijver te gast op de afdeling Biochemie van de Faculteit 
Scheikunde, Vrije Universiteit, Amsterdam (prof. dr. R.J. Planta, dr J. Klootwijk, dr. H. van 
Heerikhuizen en dr. E. Vreugdenhil) ten einde zich te bekwamen in moleculair-biologische 
technieken. Naast het verrichten van onderzoek waarvan de resultaten in dit proefschrift zijn 
beschreven, werd een bijdrage geleverd aan het biologie onderwijs (cursussen vertebraten- en 
evertebratenmorfologie) en begeleiding van studenten tijdens research praktica en doctoraal 
stages. Tevens was de schrijver betrokken bij de begeleiding van studenten die deelnamen aan 
internationale uitwisselingsprojecten (ERASMUS, COMETT). Vanaf 1 januari 1991 is hij als 
adjunt-onderzoeker verbonden aan de Vakgroep Organismale Dierkunde van de Vrije 
Universiteit te Amsterdam in het kader van een EG samenwerkingsproject met de Universiteit 
van Sussex, Brighton, UK. 
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